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The thymus is the major site for T-cell generation and thus is important for the 
adaptive immune system. Development of a properly selected, functional T-cell 
repertoire relies on interactions between developing T cells and a series of 
functionally distinct thymic stroma cell types including the cortical and medullary 
thymic epithelial cells (TECs). The thymus is one of the first organs to degenerate in 
normal healthy ageing.  Related to this, there is strong interest in developing 
protocols for improving thymus function in patients by cell replacement or 
regenerative therapies.  Thymic epithelial progenitor cells (TEPCs) represent a 
potential source of cells for thymus transplantation.  However, the only source of 
these cells for transplantation is currently fetal thymus tissue. If TEPCs could be 
generated from pluripotent cells, this could provide an alternative source of cells for 
transplantation.  The work described in this thesis therefore had two central aims (i) 
to test the stability of thymic epithelial progenitor cells in vivo and (ii) to investigate 
the possibility of generating TEPCs or TECs from mouse embryonic stem (ES) cells. 
 
The forkhead transcription factor, Foxn1, is essential for the development of a 
functionally mature thymic epithelium, but is not necessary for formation of the 
thymic primordium or for medullary thymic epithelial sub-lineage specification. By 
reactivating Foxn1 expression postnatally in mice carrying a revertible hypomorphic 
allele of Foxn1, Foxn1R, I herein demonstrate that TEPCs that can express only low 
levels of Foxn1 mRNA can persist postnatally in the thymic rudiment in mice until at 
least 6 months of age, and retain the potential to give rise to both cortical and 
medullary thymic epithelial cells (cTECs and mTECs). These data demonstrate that 
the TEPC-state is remarkably stable in vivo under conditions of low Foxn1 




In parallel with this work, I confirmed the possibility of generating Foxn1-expressing 
cells from mouse ES cells by using a Foxn1 reporter cell line. As the thymic 
epithelium has a single origin in the third pharyngeal pouch (3pp) endoderm, I then 
tested whether or not TEPCs and /or TECs were generated during ES cell 
differentiation via existing protocols for generating anterior definitive endoderm 
differentiation cells from mouse ES cells. From this work, I showed that genes 
expressed in the 3pp and/or TEPC,-including Plet-1, Tbx1, Hoxa3 and Pax9, were 
induced by differentiation of ES cells using these protocols. I further showed that 
cells expressing both Plet-1, a marker of foregut endoderm and 3pp, and EpCAM, a 
marker of proliferating epithelial cells, were induced using a novel protocol (2i ADE) 
for generating ES cells from ADE. However, gene expression analysis and functional 
testing suggested that the majority of these cells were non-thymus lineage. I 
subsequently developed a novel protocol which combined this 2i ADE protocol with 
co-culturing of the differentiating ES cells with fetal thymic lobes, and demonstrated 
that this further induced 3pp and TEPC related genes. Finally, I modified the culture 
conditions in this protocol to conditions predicted to better support TEPC/TEC, and 
showed that in these conditions, the TEPC-specific markers Foxn1 and IL-7 were 
induced more strongly than in any other conditions tested. The data presented in this 
thesis therefore represent an advance towards an optimized protocol for successfully 
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ADE Anterior definitivce endoderm 
AFE Anterior foregut endoderm 
AVE Anterior visceral endoderm 
BM Bone marrow 
BSA Bovine serum albumin 
CMJ Cortico-medullary junction 
CoROC Compact reaggregate organ culture 
cTEC Cortical thymic epithelial cell 
DC Dendritic cell 
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DN Double negative 
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IC Isotype control 
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IP Intraperitoneal 
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mAb monoclonal antibodies 
MEF mouse embryonic fibroblast 
MHC Major histocompatibilty complex 
MHCII  Major histocompatibilty complex class II 
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NCC Neural Crest Cell 
NK Natural killer 
PBS Phosphate buffered saline 
qRT-PCR Quantitative real-time polymerase chain reaction  
R Foxn1R allele 
R26 ROSA26 locus 
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Chapter 1: Introduction 
1.1 Thymus 
The thymus is located in the central compartment of the thoracic cavity, above the 
heart and below the sternum, and is the primary site for T-cell development (Miller 
1961). The thymus has two functionally identical lobes. Each lobe can be 
histologically divided into two main compartments, the cortex and the medulla, and 
is surrounded by a mesenchymal capsule. The cortex and medulla each contain 
distinct thymic epithelial cell (TEC) types. Together with other non-epithelial cells, 
such as dendritic cells, macrophages and mesenchymal cells, these cells produce the 
unique microenvironment needed to support T-cell differentiation. (Figure 1.1). They 
are collectively termed the thymic stroma, which comprises five percent of the cells 
in the thymus. The remaining ninety five percent are developing T cells, or 
thymocytes (Nowell, Farley et al. 2007). 
 
1.1.1 Thymocytes 
Bone-marrow derived haematopoietic progenitor cells enter the thymus through the 
large vessels located at the cortico-medullary junction (CMJ) region. They then 
travel first through the cortex and then the medulla, and finally exit the thymus 
through the vasculature to the peripheral immune system (Petrie 2002).  
 
The earliest T-cell progenitors do not express CD4 or CD8, and are therefore called 
double negative (DN) cells. Four different DN stage can be identified based on CD25 
and CD44 expression. (DN1: CD44+CD25-; DN2: CD44+CD25+; DN3: CD44-
CD25+; DN4: CD44-CD25-)(Godfrey, Kennedy et al. 1993). These cells give rise to 
CD4+CD8+ double positive cells, which undergo positive selection to become single 
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Figure 1.1 Thymus structure and function A) Image shows thymus dissected from a 
six week old C57BL/6 mouse (Nowell, Bredenkamp et al. 2011). B) Haematoxylin and 
eosin staining of a human thymus section. Arrows indicate cortex and medulla (Image 
from M. Ritter). C) Thymus structure and T-cell development process (Blackburn and 
Manley 2004) See text for explanation. D) Zones of thymocyte maturation. (a) shows the 
histologically defined cortical and medullary regions. (b) shows intrathymic zones 
identified on the basis of thymocyte maturation stage. Z-1, Z-2 and Z-3 are the areas 
predominantly containing DN1, DN2 and DN3 thymocytes, respectively. In Z-4, DN3 
cells become pre-DP cells. IZ-5, also contains DP thymocytes, and in Z-6, thymocytes 





During their migration, the developing T cells, or thymocytes, interact with the 
different cell components of the thymus. First, they become committed to the T-cell 
fate and then, through positive selection, thymocytes with the ability to recognize 
self-MHC, are selected to survive and expand. Subsequently, through a process 
termed “negative selection”, T-cells which are self-reactive are eliminated. In this 
way, a diverse repertoire of peripheral T-cells is generated (Starr, Jameson et al. 
2003).  
 
TECs play an important role during the whole of T-cell development. When bone 
marrow (BM)-derived progenitor cells first seed the thymus, T-cell lineage 
commitment requires Notch (N1) receptor-mediated signalling (Radtke, Wilson et al. 
1999; Wilson, MacDonald et al. 2001). There are two main classes of transmembrane 
bound ligands for Notch signalling, one is Jagged 1 and 2, and the other is Delta-like 
(DL) 1, 3 and 4 (Maillard, Fang et al. 2005). It would be interesting to address which 
ligand plays an essential role through Notch signalling in supporting the normal T-
cell development. All these ligands can be detected within the functional TECs, 
except DL3 (Harman, Jenkinson et al. 2003). Meanwhile, Jagged 1-/- and Jagged 2-/- 
mice have normal T-cell development (Jiang, Lan et al. 1998; Mancini, Mantei et al. 
2005) and thus DL3, Jagged1 and 2 are excluded from the candidates. Although 
overexpression of DL1 in stromal cells can support T-cell development in vitro 
(Schmitt and Zúñiga-Pflücker 2002), conditional inactivation of DL1 in either thymic 
epithelial cells or thymocytes does not inhibit T-cell development in vivo (Hozumi, 
Negishi et al. 2004). Recent study also shows that the expression of DL1 in TECs 
cannot be detected (Koch, Fiorini et al. 2008).  Therefore, focus is changed to DL4. 
Inactivation of DL4 in TECs leads to a complete block of T cell development 
coupled with the ectopic appearance of immature B cells, while loss of DL4 in 
hematopoietic progenitors doesn’t affect T-cell development. Furthermore, the 
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phenotype of DL4 inactivation in TECs is consistent with the inactivation of N1 in 
BM-derived progenitor cells. Together, these observations suggest that, in the T cell 
lineage, commitment from the pro-T-cell to Pre-T-cell stage requires that DL4 is 
expressed in TECs to activate N1-mediated signalling in BM-derived progenitors 
(Koch, Fiorini et al. 2008). TECs also support T-cell development through 
expression of Interleukin-7 (IL-7). IL-7 is a pleiotropic cytokine that is produced by 
thymic and bone marrow stromal cells (Fry and Mackall 2002). IL-7 expression is 
initiated in the thymic-fated domain of the early primordium by E11.5 and shows 
differences in localization and frequency of expression in fetal and adult TECs 
(Zamisch, Moore-Scott et al. 2005). Mutation of the receptor of IL-7 (IL-7R) leads to 
a block in thymocyte expansion occurring before the onset of  T cell receptor gene 
rearrangement at the DN stage (Peschon, Morrissey et al. 1994). IL-7 signaling also 
promotes the survival of DN thymocytes undergoing transition to double positive 
(DP) thymocytes (Trigueros, Hozumi et al. 2003) and proliferation of positively 
selected single positive (SP) thymocytes (Hare, Jenkinson et al. 2000). Therefore, IL-
7 expressed by TECs is essential for T-cell development. 
 
 
1.1.2 Thymic epithelial cells 
Thymic epithelial cells (TECs) form a 3 three dimensional network structure within 
the thymus (van Ewijk, Wang et al. 1999). There are a variety of different TEC types 
within both the cortex and the medulla, based on morphology and antibody staining 
profile. Ultrastructural morphology studies demonstrated six types of epithelial cells 
within the human thymus (Vandewijngaert, Kendall et al. 1984). Later on, through a 
series of international workshops, the staining patterns of approximately 50 TEC-
specific monoclonal antibodies (mAb) on multiple species including human and 
mouse, were tested. From this, seven clusters of thymic epithelial staining patterns 
(CTES) were identified and used to designate individual mAb (Table 1.1)(Kampinga, 
5 
 
Berges et al. 1989; Boyd, Tucek et al. 1993).  
 
1.1.2.1 Subcapsular epithelium and cortical epithelium 
The subcapsular epithelium separates the outer capsule, which is mainly composed 
of connective tissue, from the inner thymic epithelium. It also separates the lobulated 
cortex from the trabeculae, which penetrate from the capsule into the cortex to the 
cortico-medullary junction. The subcapsular epithelium is mainly composed of the 
type 1 epithelial cells, and is reactive to CTES II mAbs (Boyd, Tucek et al. 1993).  
 
The thymic cortex proper lies directly under the subcapsular epithelium and can be 
separated into three main epithelial types: type II, type III and type IV. They were 
identified based on their electron lucency, and are described as “pale”, “intermediate” 
and “dark”, respectively (Vandewijngaert, Kendall et al. 1984). Their locations and 
morphological characteristics are summarized in Table 1.2. Although all cortical 
epithelial cells are reactive to CTES III mAbs, Type II and III could be distinguished 
from Type IV by strong expression of MHC Class II (Boyd, Tucek et al. 1993). The 
high expression of MHC Class II could be consistent with the possible role of these 
cell types in mediating positive selection of developing thymocytes. The cytoplasm 
of Type II and Type III cells was found to be able to completely surround 
lymphocytes (Vandewijngaert, Kendall et al. 1984) and thus is identical to the 
description of “thymic nurse cells” which were thought to play a role in positive 
selection of thymocytes (Wekerle and Ketelsen 1980; Ritter, Sauvage et al. 1981).  
 
Antibodies for detecting different cytokeratins can also be used to classify different 
type of thymic epithelial cells. For example, a K8+K5-K14-K18+ phenotype broadly 
identifies cortical thymic epithelial cells, with exception of a small population of 
cTECs at the cortico-medullary junction, which is K8+K5+K14-K18+ (Klug, Carter et 
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al. 1998; Klug, Carter et al. 2002).  
 
1.1.2.2 Medullary epithelium 
Medullary epithelium also contains a variety of thymic epithelial cell types. These 
are generally reactive to CTES II and IV mAbs (Table 1.1), although Type III, Type 
V and Type VI were also found in the medulla through ultrastructural analysis. Based 
on their morphology as described in Table 1.2, Type V cells are classified as 
undifferentiated cells and Type VI are proposed as differentiated cells that can 
express hormones in supporting thymocytes development (Vandewijngaert, Kendall 
et al. 1984). All medullary epithelial cells are MHC Class I positive, but are variable 
for MHC Class II expression (Boyd, Tucek et al. 1993). In contrast to cortical 
epithelium, medullary thymic epithelial cells are predominantly K8-K5+K14+K18-  




CTES group Specificity 
I Panepithelium 
II Subcapsule/perivascular, medulla 
Medullary-network, Hassall’s Corpuscles (HC) 
Subcapsule/perivascular (II.A thick; II.B thin) 
III Cortex 
III.A: pan cortex 
III.B: pan cortex, infrequent subset medulla 




Pan medullary, HC 
V Hassall’s Corpuscles 
V.A: HC 
V.B: HC, myeloid cells 
V.C: HC, associated medullary Ep 
V.D: HC, associated medullary Ep, subset leukocytes 
V.E: HC, associated medullary Ep, subcapsular Ep 
VI Type 1 Epithelium 
XX Miscellaneous 
XX.A Minority subcapsule, majority cortical and medullary Ep 
XX.B Minority of cortical and medullary Ep 
XX.C Minority medullary Ep, cortical thymocytes 
Table 1.1 Cluster of thymic staining patterns. Summarized by Boyd et al (Examples 





















round euchromatic nucleus 
well-developed Golgi 
complex 
short profiles of RER 
electron-dense granules 
tubular structures 
scattered in cortex and 
medulla 
predominant in outer cortex 
Type 3 
"intermediate" 
spectrum in morphology 
between type 2 and type 4 
euchromatic or 
heterochromatic, 
irregularly shaped nucleus 
dilated cisternae of nucleus 
and RER 






irregularly shaped nucleus 
dilated cisternae of nucleus 
and RER 
residual bodies, swollen 
mitochondria 
deep cortex 





rounded nucleus with some 
heterochromatin 
polyribosomes 
small bundles of tonofilaments 
small desmosomes 
in groups in cortico-medullary 
region 
scattered in medulla 
Type 6 
"large-medullary" 
large, rounded nucleus, either 
eu- or heterochromatic 




scattered in medulla 
adjacent to large Hassall's 
corpuscules 
part of small Hassall's 
corpuscules 
Table 1.2 Morphological characteristics and location of types of epithelial cells in 




1.1.3 Non-epithelial stroma cells 
In addition to the epithelial cells, the thymus stroma also contains bone marrow 
(BM)-derived dendritic cells and macrophages (Boyd, Tucek et al. 1993). Dendritic 
cells mainly reside in the CMJ and medulla and display strong expression of MHC 
Class II (Duijvestijn and Hoefsmit 1981; Boyd, Tucek et al. 1993). These cells play 
an important role in negative selection stage of the T cell repertoire (Ardavi´n 1997). 
Recently, a study by Dudakov and colleagues showed that dendritic cells also secrete 
IL-23 in response to thymus damage, and that this secreted IL-23 further induces the 
lymphoid tissue inducer (LTi)-like cells to secret IL-22, which enhances the 
proliferation and survival of TECs. This study therefore reveals a crucial role for 
dendritic cells in endogenous thymic repair (Dudakov, Hanash et al. 2012), in 
addition to their role in negative selection 
 
Within the thymus, macrophages mainly reside in the cortex and CMJ region. The 
morphology of the macrophages varies depending on their location, and they also 
show varying levels of MHC Class II expression. (Milicevic, Milicevic et al. 1987; 
Boyd, Tucek et al. 1993). It has been demonstrated that macrophages play an 
important role in removal of the apoptosed thymocytes within thymus through 
phagocytosis and subsequent DNA degradation (Odaka and Mizuochi 2002; Esashi, 
Sekiguchi et al. 2003). 
 
Neural crest (NC) – derived mesenchymal cells form the outer layer of the thymus 
capsule. NC cells which migrate into the thymus eventually differentiate into 
pericytes and smooth muscle cells, which form the supportive network for the blood 
vessels (Le Lièvre and Le Douarin 1975; Foster, Sheridan et al. 2008). The NC–
derived mesenchymal cells, along with cTECs, also express extracellular matrix 
which could be important for the thymocyte differentiation (Boyd, Tucek et al. 1993; 
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Savino, Villa-Verde et al. 1993).  
 
1.2 Thymus organogenesis 
1.2.1 Cellular basis of thymus organogenesis 
The thymus is derived from the third pharyngeal pouches, which are bilateral 
outpocketings of pharyngeal endoderm and bud out from the endoderm at day 9 of 
embryonic development (E9.0) in the mouse (Figure 1.2a). Overt thymus 
organogenesis occurs from approximately E11 in the mouse, when the common 
thymus-parathyroid rudiments are growing out from the distal aspect of the third 
pharyngeal pouches (Figure 1.2b). At this stage, each rudiment is surrounded by a 
condensing population of mesenchymal cells derived from the NC. These cells 
support the growth and development of the primordium and will eventually form the 
capsule (Figure 1.2c). After further outgrowth, the common primordia finally 
separates from the pharynx by E12.5. The separated primordia migrate toward the 
anterior chest cavity (Figure 1.2d). By E13.5, the parathyroid and thymus domains 
resolve into physically separated organs. The thymus continues to migrate to the 
midline, whereas parathyroids migrate to the lateral margins of the thyroid gland 





Figure 1.2 Thymus Organogenesis. See text for explanation. (from: Blackburn and 
Manley, 2004) 
 
1.2.2 Cellular Interactions during thymus organogenesis 
1.2.2.1 Lympho-Epithelial Cross-Talk 
The first wave of haematopoietic progenitor cells seeds the thymus at about E11.5 
(Owen and Ritter 1969; Fontaineperus, Calman et al. 1981), after formation of the 
thymus-parathyroid common primordium. The initial differentiation of TECs does 
not require inductive signals from lymphocytes (Klug, Carter et al. 2002); in the 
absence of lymphocytes, the differentiating thymus can give rise to cortical and 
medullary subsets which display normal gene expression profile and retain their 
functional capacity until E15.5 (Klug, Carter et al. 2002). However, the later stages 
of thymus epithelial cell maturation, expansion and maintenance require lympho-
epithelial cross-talk (Ritter and Boyd 1993; Anderson and Jenkinson 2001). One 
example comes from research on Lymphotoxin ß receptor (LTßR) and its ligands 
lymphotoxin ß (LT ß) and LIGHT in the maintenance of the normal thymic 3-
dimensional epithelial network. It has been shown that mature single-positive 
thymocytes are the main source of LTßR ligands, whereas LTßR is found on mTECs.  
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LTßR-/- mice display an abnormal mTEC network (Boehm, 2003). 
 
1.2.2.2 Epithelial/mesenchymal interactions 
The mesenchyme derived from neural crest cells (NCCs) is important for the thymus 
development. The first evidence came from Auerbach in 1960. At E12.5, the 
surrounding mesenchyme was removed from the thymus lobe; such lobes, when 
further cultured in fetal thymus organ conditions, could not give rise to a normal 
thymus (Auerbach, 1960). One possible way in which mesenchymal cells influence 
thymus organogenesis involves the provision of growth factors. In situ hybridization 
has show that Fibroblast growth factor 10 (Fgf10) is expressed in the mesenchymal 
cells of the thymic capsule, whereas fibroblast growth factor receptor 2 isoform IIIb 
(FgfR2IIIb), the receptor for Fgf7 and 10, is expressed in thymic epithelial cells at 
E12.5 (Revest, 2001).  Furthermore, FgfR2-IIIb-/- mice demonstrate a block in the 
growth of the thymic epithelium from E12.5 (Revest, 2001). Although NCC-derived 
mesenchyme is necessary for generation of a normal thymus, initial pouch formation 
and thymus epithelial cell fate chosen do not appear to require 
epithelial/mesenchymal interactions, as mutant mice with a defect in NCCs develop 
an ectopic but properly patterned thymus (Griffith, Cardenas et al. 2009). 
 
1.2.3 Molecular regulation of thymus development 
The mechanisms that direct pharyngeal endoderm morphogenesis and patterning, and 
organogenesis of the various pharyngeal endoderm-derived organs are not 
completely understood. The following section describes several key genes which 
have been identified to have specific roles in thymus development based on genetic 
analyses. 
 
1.2.3.1 Tbx1  
Tbx1 is one of the T-box family genes. This family of genes is characterized by the 
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presence of a region of homology to the DNA-binding domain of the T (Brachyury) 
locus product (Bollag et al. 1994). The expression patterns of the T box genes, Tbx1-
Tbx5, has been described during the early mouse development. Of these, Tbx1 was 
first detected in mesoderm within the E7.5 egg cylinder. At E9.5, Tbx1 was found in 
the pharyngeal region including the first to third pharyngeal pouch epithelium and 
the first to third pharyngeal arch mesenchyme cells. Tbx1 expression was also found 
in the Otic vesicle at E9.5. Wholemount in situ hybridization also suggested Tbx1 
expression in non-pharyngeal region derived organs by E12, such as lung epithelium 
and spinal column (Chapman, Garvey et al. 1996).  
 
Homozygosity for Tbx-1 null mutation in the mouse results in failure of second and 
third pharyngeal arch and pouch formation during development. Interestingly, the 
adult phenotype of Tbx1-/- mice models the human DiGeorge/velocardiofacial 
syndrome (DGS/VCFS), including hypoplasia of the thymus and parathyroid 
(Jerome and Papaioannou 2001). Temporal-specific mutation of Tbx1 established a 
crucial time interval for the requirement of Tbx1 in thymus development, of between 
E7.5 to E11.5, as deletion of Tbx1 before E8.5 led to athymia, deletion at E9.5 and 
E10.5 led to the thymus hypoplasia, and deletion after this time did not affect thymus 
formation. By lineage tracing, the Tbx1 expressing cells at E8.5 contributed 
significantly to the thymus primodium in comparison with the limited contribution of 
E9.5 Tbx1 expressing cells (Xu, Cerrato et al. 2005). In spite of the importance of 
Tbx1 in thymus formation, these data indicate that Tbx1 is not needed for thymus 
formation after E10.5. During the thymus/parathyroid primordium formation, Tbx1 
was found only expressed in the dorsal part of the 3rd pharyngeal pouch at E10.5, and 
was only expressed in the parathyroid-domain of the thymus/parathyroid common 
primordium at E11.5 (Liu, Yu et al. 2007). Manley and colleagues suggested a model 
for the Tbx1 regulation of thymus and parathyroid organogenesis. Before E9.5, 
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deletion of Tbx1 leads to failure of pouch formation and this leads to the subsequent 
failure of thymus formation. Deletion of Tbx1 between E9.5 and E10.5 leads to the 
size reduction of the third pharyngeal pouch and thus leads to the thymic hypoplasia. 
Tbx1 expression after E10.5 is needed only for parathyroid formation and the 
repression of Tbx1 may be required for the thymus formation (Nowell, Farley et al. 
2007; Manley and Condie 2010).  
 
1.2.3.2 Hoxa3  
Hox genes play an important role during vertebrate axial patterning during 
development, which includes regulation of the segmentation of hindbrain and axial 
skeleton (Krumlauf 1994; Alexander, Nolte et al. 2009). Hoxa3, a member of the 
Hox gene family, was found to be expressed in the third and fourth pharyngeal 
pouches, surrounding Neural Crest Cells (NCCs) and third and fourth pharyngeal 
arches. Its mutation leads to athymia and other pharyngeal organ defects (Manley 
and Capecchi 1995; Manley and Capecchi 1998). Unpublished data from the Manley 
lab suggested that third pharyngeal pouch formation does not require Hoxa3, but that 
later, patterning of the organ domains within third pharyngeal pouch, or the initial 
stage of organogenesis requires Hoxa3. It has also been demonstrated that Hoxa3 
expression in pharyngeal endoderm rather than in NCC is required for the third 
pharyngeal pouch patterning and initial organ development (unpublished data of 
Masuda et al., summarized in Manley and Condie 2010), although deletion of Hoxa3 
expression in NCCs leads to failure of organ separation and migration.  
 
1.2.3.3 Pax1 and Pax9 
Pax genes are a family of transcription factors that act as developmental control 
genes during embryogenesis (Walther, Guenet et al. 1991; Buckingham and Relaix 
2007). The Pax gene family members Pax1 and Pax9 are each expressed in the 
pharyngeal endoderm from E8.5.  In Pax9-null mice, the invagination of the 
15 
 
endodermal cell layer of the developing thymus into the surrounding mesenchymal 
tissue is disturbed and an ectopic thymus forms located within the pharynx. Although 
the thymus primordium is colonized by T-cell precursors, failure of thymopoiesis is 
observed from E15.5 (Hetzer-Egger, Schorpp et al. 2002). In situ hybridizations 
detected Pax1 expression in the endoderm of the foregut region as early as E8.5. At 
E9.5, transcripts were present in the first two pharyngeal pouches and by E10.5, clear 
expression was also observed in the third pharyngeal pouch. A large number of TECs 
are Pax1+ and evenly distributed throughout the thymus primordium in day 12.5 
embryos. With increasing age, the proportion of Pax1-expressing cells is reduced and 
in the adult mouse only a small fraction of cortical thymic epithelial cells retains 
strong Pax1 expressoin. Mutations of the Pax1 gene leads to thymus hypoplasia, also 
indirectly affects the maturation of thymocytes (Wallin, Eibel et al. 1996). 
 
1.2.3.4 Foxn1 
Foxn1 is the gene mutated in the nude mouse, which exhibits a phenotype of athymia 
and hairlessness (Nehls, Kyewski et al. 1996). Mutation of Foxn1 in humans causes 
the same phenotype (Frank, Pignata et al. 1999). Foxn1 is first detectable by RT-PCR 
at E9.5 (Nehls, Pfeifer et al. 1994) but is not detectable by in situ hybridization or 
reporter gene expression until E11.25, when it is specifically expressed in the third 
pharyngeal pouch (Gordon, Bennett et al. 2001). Although failure of Foxn1 
expression leads to athymia, Foxn1 is not responsible for the initial 
thymus/parathyroid primordium formation or for thymic epithelial lineage 
specification. Rather, Foxn1 is required in a cell-autonomous and dosage dependent 
manner for the further development of specified TECs (Blackburn, Augustine et al. 
1996; Nehls, Kyewski et al. 1996; Nowell, Bredenkamp et al. 2011). In the absence 
of Foxn1 expression, TECs undergo developmental arrest at an early progenitor cell 
stage, and clonal reactivation of expression leads to generation of a thymic lobule 
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containing both cortical and medullary TECs, that can support T-cell development 
(Bleul, Corbeaux et al. 2006). In addition, through affecting the TEC development, 
Foxn1 is also required for the initial hematopoietic progenitor cell colonization of the 
thymic primordium and for seeding of the primordium with vascular endothelial 
progenitors (Itoi, Kawamoto et al. 2001; Mori, Itoi et al. 2010).  
 
1.2.3.5 Regulatory network 
Eyes absent gene 1 (Eya1) is expressed in third pharyngeal endoderm pouch, the 
mesenchyme surrounding it and the third pharyngeal ectoderm cleft at E9.5. 
Mutation of this gene results in failure of the thymus-parathyroid common 
primordium formation. Furthermore, the expression of Six1, mutation of which also 
leads to an absence of thymus, was found to be down-regulated within the 
pharyngeal region of Eya1-/- embryos, indicating Eya1 acts upstream of Six1 (Xu, 
Zheng et al. 2002).  
 
Pax1 expression is reduced in the third pharyngeal pouches of Hoxa3 null mutants, 
suggesting that Hoxa3 acts upstream of Pax1 (Manley and Capecchi 1995). The 
observation that the mutant phenotype of Eya1 is similar to the mutant phenotype of 
Hoxa3 (Manley and Capecchi 1995; Manley and Capecchi 1998; Xu, Zheng et al. 
2002) and expression of Hoxa3 in the third pharyngeal pouch was not altered in Eya1 
mutants, suggested that Hoxa3 acts upstream of Eya1. A Pax-Eya–Six–Dach 
regulatory network was found during eye development of Drosophila (Wawersik and 
Maas, 2000), and expression of Pax1 and 9 in third pharyngeal pouches is not altered 
in Eya1 mutants. Thus, a Hox-Pax-Eya-Six network might exist in regulating thymus 
and parathyroid development. However, in more recent study, expression of Eya1 
and Six1 were found independent of Pax1 and Pax9 expression. Moreover, 
expression of Pax1 was shown to require Eya1 and Six1, and Tbx1 expression was 
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also reduced in mutant of Eya1. These data suggest that rather than acting in a 
classical ‘cascade’, these transcription factors may form a complex regulatory 
network, and that Eya1 may act as early at the pharyngeal endoderm patterning stage 
(Zou, Silvius et al. 2006).   
 
 
1.3 Thymic epithelial progenitor cells 
 
1.3.1 Single origin for the cortical and medullary thymic 
epithelial compartments 
A once prevailing hypothesis suggested that the cortex and the medulla are derived 
from the ectoderm and endoderm respectively, based on histological studies. Other 
studies, such as chick-quail chimera analysis, suggested that both cortical and 
medullary compartments are derived from isolated endoderm. This controversy was 
resolved by the work of Blackburn and colleagues (Blackburn, 2004; Gordon, 2004). 
First, the contact between the third pharyngeal pouch endoderm and third pharyngeal 
cleft ectoderm was confirmed as early as E10.5. However, a subsequent separation 
process between those two germ layers was found, based on analysis of apoptosis 
between E11.5 and E12.0. As the next step, the authors specifically marked the 
ectoderm using a cell-tracker dye, to trace the fate of the third pharyngeal ectoderm 
during embryo development in vitro for 30 hrs. The embryos used were isolated at 
E10.5 and analyzed at E11.5, the time window during thymus organogenesis in 
which the ectodermal contribution to the thymus had been argued to occur. No 
labelled ectoderm cells were found to contribute to the developing thymus in this 
experiment. Finally, the strongest evidence in this study was that the third pharyngeal 
pouch endoderm, isolated before contact with pharyngeal ectoderm (around E9.5), 
was shown to generate a functional thymus including both cortical and medullary 
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compartments after being ectopically transplanted under the kidney capsule of either 
nude or syngeneic wild type recipient mice. Interestingly, if the whole third 
pharyngeal compartment at the same stage was transplanted, the outcome was worse 
than transplanting third pharyngeal pouch alone, suggesting inhibition of thymic 
development by the ectoderm or other components of third pharyngeal pouch. 
Together, these data argued strongly in favor of a single-origin of the two 
compartments of the thymus and also suggested the existence of a common 
progenitor in the foregut endoderm for both cortical and medullary epithelial cells.  
 
1.3.2 An MTS20+24+ (Plet-1+) phenotype identifies thymic 
epithelial progenitor cells 
Identification and characterization of the progenitor cells for a particular somatic cell 
lineage in vivo is important for understanding how the tissue is generated and 
maintained, and is also required for investigation into generating cells of a particular 
lineage from ES cells differentiation in vitro. Thus a high fidelity marker, or markers, 
for identifying and isolating the progenitor cells is crucial. It has been established 
that mAbs MTS20 and MTS24, which recognize the orphan protein Plet-1, identify 
TEPCs within the fetal thymus until at least E15.5 (Bennett, Farley et al. 2002; 
Depreter, Blair et al. 2008). First, the MTS20 and MTS24 determinant expression 
profiles are consistent with those expected of TEPC markers (i.e. they mark a 
population in the third pharyngeal pouch and later thymus primordium, that initially 
represents the major epithelial cell type, and subsequently decrease with thymus 
maturation). Secondly, MTS20+24+ cells purified from the thymus primordium at 
E12.5, followed by reaggregated fetal thymic organ cultures, can give rise to all 
thymic epithelial cell type based on expression of the adult cortical and medullary 
epithelial markers (Julie Sheridan and Clare Blackburn unpublished). Finally, 
ectopically transplanted MTS20+MTS24+ cell reaggregates generated vascularized 
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thymi with both cortical and medullary structures, capable of attracting lymphocytes 
and supporting T-cell differentiation. This study did not determine whether the E12.5 
thymic MTS20+24+ population predominantly contained a common-progenitor for 
cortex and medulla, or contains distinct cortical and medullary progenitors already 
specified from earlier endoderm epithelial cells of wider potency.  
 
1.3.3 Clonal evidence for a common progenitor for cortical 
and medullary TECs 
It is well established that Plet-1 marks TEPCs, as described above. However, the 
possibility of generating both cTECs and mTECs from a single cell (common 
progenitor cell/bi-potent progenitor cell) was not demonstrated until recently. A 
single MTS24+ cell isolated at E12.5 from the thymus lobes of a genetically modified 
mouse that constitutively expressed eYFP, was injected into an E12.5 wild type 
thymus lobe. This lobe was grafted under the kidney capsule. Subsequent tracing of 
eYFP expressing cells demonstrated the ability of this single injected cell to generate 
cTECs and mTECs (Rossi, Jenkinson et al. 2006). Another clonal assay, conducted 
by Bleul and colleagues, demonstrated the presence of bi- and uni-potent progenitor 
cells for the cortical and medullary compartments in the neonatal mouse thymus, 
using short term lineage tracing. This analysis also showed that, in the absence of 
Foxn1, bi-potent progenitor cells persisted postnatally and indicated that these cells 
could give rise to a functional thymic microenvironment including both cortical and 
medullary compartments after reversion of the Foxn1 allele (Bleul, Corbeaux et al. 
2006). Collectively, the above work strongly suggested the existence of a common 
thymic epithelial progenitor cell, which can differentiate into all cortical and 
medullary epithelial cell types. Characterization of this common progenitor, 
understanding how it is generated and what controls its differentiation should 




1.3.4 Foxn1 and TEPC 
As described above, data on the neonatal clonal reactivation of the common TEPCs 
demonstrate that TEPCs form independently of Foxn1, but that Foxn1 is required for 
their development into functionally mature cortical and medullary TECs (Bleul, 
Corbeaux et al. 2006). Interestingly, in the Foxn1-/- mouse, a Cldn4+ epithelial 
population could be observed in the E13.5 thymus primordium (Nowell, 
Bredenkamp et al. 2011). As it has been demonstrated that Cldn4+ cells appearing at 
the same stage in the wild type thymus primodium exclusively give rise to medullary 
TECs and thus represent the earliest medullary thymic epithelial progenitor cells 
(mTEPCs) (Hamazaki, Fujita et al. 2007), these data together indicate that the 
divergence of medullary progenitors is Foxn1 independent. 
 
It is not clear whether the divergence of cortical thymic epithelial progenitor cells 
(cTEPCs) from the common progenitor is Foxn1 independent. However, the 
expression of CD205, which was recently identified as the earliest cortical epithelial 
lineage specific marker (Shakib, Desanti et al. 2009), can be detected within the 
thymus primordium only in the presence of Foxn1 (Shakib, Desanti et al. 2009), 
(Nowell, Bredenkamp et al. 2011), thus suggesting a role for Foxn1 in divergence of 
cortical progenitors.  
 
The requirement for different Foxn1 expression levels in regulating the lineage 
restricted progenitor cell differentiation and subsequent cortical and medullary 
epithelial cells maturation is carefully addressed in the recent published paper by 
Nowell and colleagues (Figure 1.3; Nowell, Bredenkamp et al. 2011).  This shows 
that Foxn1 is required at multiple stages of TEC differentiation in the fetal and 
postnatal thymus, from exit from the earliest progenitor cell state to terminal 
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1.4 Potential to use embryonic stem cells to derive 
thymic epithelial progenitor cells 
1.4.1 Embryonic stem cells 
 
Both mouse (Evans and Kaufman 1981; Martin 1981) and human (Thomson 1998) 
embryonic stem (ES) cells are derived from the inner cell mass (ICM) of the embryo 
at the blastocyst stage. These cells can expand indefinitely in culture and remain 
pluripotent (Smith 2001). ES cells can be differentiated in vitro into endoderm, 
mesoderm, ectoderm and their derivatives, such as hepatocytes, hematopoietic cells, 
and neural cells. Therefore, ES cells are believed to hold a great promise as an 
unlimited source of cells for regenerative medicine (Murry and Keller 2008).  
 
The initial derivation of mouse ES cells and their subsequent culture originally relied 
on feeder cells, which are mitotically inactivated mouse embryo fibroblast cells, and 
batch-selected fetal calf serum (Smith 2001). Later, the cytokine leukaemia 
inhibitory factor (LIF) was found to be able to activate STAT3, and together with 
bone morphogenetic protein (BMP) or serum was sufficient to support derivation and 
maintenance of mouse ES cells (Ying, Nichols et al. 2003). More recently, a 
chemically defined medium was derived. Through inhibition of glycogen synthase 
kinase-3 (Gsk3) by CHIRON99021 and mitogen-activated protein kinase (Mek) by 
PD0325901, mouse ES cells are shielded from differentiation stimuli, which act via 
the endogenous repressor activity of Tcf3 (Wray, Kalkan et al. 2011) and Fgf 
activated Mek-Erk signalling pathway (Kunath, Saba-El-Leil et al. 2007), 
respectively, and are thus maintained in a ground state of self-renewal (Ying, Wray et 
al. 2008). This “2 inhibitor” (2i) medium was also used to successfully to derive and 




In comparison with the serum containing culture method, mouse ES cells cultured in 
2i medium are more homogeneous in morphology. The expression of the 
pluripotency markers Rex1, and key regulators, such as Nanog and Klf4, is also 
homogenous in 2i culture mouse ES cells, while mouse ES cells cultured in serum 
always have a considerable proportion of cells which have lost expression of these 
markers (Chambers, Silva et al. 2007; Toyooka, Shimosato et al. 2008; Niwa, Ogawa 
et al. 2009; Wray, Kalkan et al. 2010; Marks, Kalkan et al. 2012). Mouse ES cells 
cultured in 2i show a higher efficiency than mouse ES cells cultured in serum when 
differentiated to neuroectoderm (Marks, Kalkan et al. 2012). This approach, of 
growing mouse ES cells in a fully defined medium that maintains ground state 
pluripotency, is thought to offer an easier and more accurate way of studying 
regulation of pluripotency and of mouse ES cell differentiation.  
 
1.4.2 Endoderm formation during embryo development 
 
During the mouse embryo development, the ICM at the blastocyst stage will give rise 
to the epiblast and the primitive endoderm. The former gives rise to the whole fetus, 
and the latter to parietal endoderm and visceral endoderm. All three germ layers, 
endoderm, mesoderm and ectoderm, are generated through a process called 
gastrulation. The initiation of gastrulation in the epiblast is marked by formation of 
the primitive streak (PS) at the posterior part of the epiblast plate. Cells on the dorsal 
surface of the epiblast migrate to the PS in a posterior direction and, together with 
the cells surrounding the PS, transfer through the PS to the ventral part and then 
migrate in an anterior direction and form a new cell layer. Cells remaining on the 
epiblast surface will form the ectoderm. The new cell layer underneath will 
subsequently form the endoderm and mesoderm. The endoderm, or primitive gut 
tube, will first form at the two distal ends and these portals will migrate towards each 
other. In combination with the embryonic turning, this finally closes in the middle 
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and forms the entire primitive gut tube. The whole endoderm gut tube is regionalized 
from anterior to posterior into foregut, midgut and hindgut. The foregut endoderm 
gives rise to the pharyngeal endoderm and its derivatives, such as thymus and 
parathyroid. The respiratory system, including trachea and lung, together with the 
liver and pancreas are generally also considered as foregut endoderm derivatives, 
although they develop from a more caudal position. The mid-gut will give rise to the 
small intestine and the hind gut will give rise to large intestine and colon (Wells and 
Melton 1999; Zorn and Wells 2009).  
 
1.4.3 Differentiation of embryonic stem cells into definitive 
endoderm cells 
 
1.4.3.1 ES cell differentiation to definitive endoderm cells through 
embryoid body formation 
ES cells can spontaneously form an aggregate, called an embyoid body (EB) when 
cultured in suspension. The precise interactions happening within an EB are still 
unclear, but it is believed that ES cells can re-initate the developmental program of 
the ICM and thus to some extent recapitulate embryonic development at this early 
stage (Smith 2001). For example, self-organization such as anterior-posterior 
polarization, formation of a primitive streak-like structure, and epithelial-to-
mesenchymal transition have been observed during EB formation, and were 
demonstrated to be dependent on Wnt signalling (ten Berge, Koole et al. 2008)  
 
The initial attempts to generate mature definitive endoderm (DE) derivatives relied 
on the spontaneous differentiation of EBs. Progenitor cells representing DE 
derivatives, such as hepatic or pancreatic cell lineage could then be isolated and 
further cultured in specific medium for their maturation. This type of method is 
relatively easy but has low efficiency (Smith 2001). However, an improved version 
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of this approach, with limited exposure to serum during EB formation, was found to 
enhance the efficiency of differentiating ES cells to definitive endoderm cells, based 
on the relative gene expression profile and functional assays. Activin A is a TGFβ 
family member which binds the same receptors as Nodal and thus triggering similar 
intracellular signaling events. It is widely used as an alternative of Nodal in cell 
culture due to its easier access through manufacture and lower cost. Administration 
of Activin A in serum-free medium during EB formation produced a similar result in 
terms of DE differentiation. In addition, a Brachyury-positive population was 
generated using this method, and its potential to generate both mesoderm and 
endoderm derivatives was tested via both gene expression profiling and kidney sub-
capsule transplantation. This was the first demonstration of defined conditions for 
derivation of DE cells, and established the important role of Activin A in directing 
cell fate determination within the in vitro cell culture (Kubo, Shinozaki et al. 2004).  
 
1.4.3.2 ES cell differentiation though a stepwise monolayer 
culture protocol 
 
The most efficient method for generating definitive endoderm cells from ES cells 
published to date was established for human ES cells by D’Amour and colleagues, 
and is also based on manipulation of the Nodal signalling pathway (D'Amour, 
Agulnick et al. 2005). In D’Amour’s study, medium with a series of different 
concentrations of serum supplemented with a high concentration of Activin A was 
tested for the DE induction efficiency based on the expression pattern of DE and 
non-DE markers. SOX17 is expressed in DE and in primitive endoderm (PrE) and its 
derivatives visceral endoderm (VE) and parietal endoderm (PE). FOXA2 is expressed 
in DE and also mesoderm, but not in PrE/VE/PE. Thus the combined expression of 
SOX17 and FOXA2 can be used to identify DE. It was found that the presence of 
Activin A (100ng/ml) and low serum concentrations produced cultures consisting of 
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up to eighty percent SOX17+FOXA2+ cells. During the differentiation process, 
NODAL and FGF8 expression, signifying the initial transition towards primitive 
streak-like cells, was first found, followed by the up-regulation of primitive streak 
markers such as brachyury, FGF4 and WNT3. Subsequently, with the rapid down-
regulation of these primitive streak makers, the DE markers such as SOX17 and CER 
exhibited rapid up-regulation. This temporal sequence of gene expression, 
characteristic of hES cell differentiation to DE is similar to the transitions that occur 
in the course of DE generation in vivo, suggesting a successful DE differentiation 
protocol. The potential of DE to give rise to its derivatives, such as liver and 
intestine, was verified through analysis of teratomas in the same study (D'Amour, 
Agulnick et al. 2005). 
 
It has been reported that Activin A is present in the mouse embryo fibroblast-
conditioned medium (MEF-CM), which is used for human ES cell maintenance 
(Beattie, Lopez et al. 2005). McLean and his colleagues demonstrated that 
suppression of phosphatidylinositol 3-kinase (PI3K) signalling alone could promote 
the human ES cells cultured in MEF-CM to differentiate into DE, and thus indicated 
a role of PI3K in blocking the differentiation of hES cells in response to Activin A 
(McLean, D'Amour et al. 2007). Further work indicated that insulin and insulin-like 
growth factor present in fetal calf serum (which is required at a concentration of 
twenty percent to promote self-renewal of hESCs), act through PI3K signalling to 
antagonize differentiation of hESCs, and thus further indicated why only in low 
concentrations of fetal calf serum (D'Amour, Agulnick et al. 2005) could Activin A 
promote DE differentiation (McLean, D'Amour et al. 2007). In summary, this 
research indicated that Activin A can efficiently specify DE from human embryonic 
stem cells only when PI3K is suppressed. In mouse ES cells, it has been 
demonstrated that the PI3K-Akt signalling pathway was activated by LIF signalling. 
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Through stimulation of transcription of Tbx3, the PI3K-Akt pathway can activate 
Nanog and Sox2, two transcription factors which together with Oct4 compose the key 
regulatory circuit for mouse ES cell pluripotency. Therefore, inhibition of PI3K may 
lead to the loss of pluripotency of mouse ES cells and thus promote differentiation 
(Niwa, Ogawa et al. 2009). However, whether PI3K plays the same role in human ES 
cells is unknown. 
 
The thymus is derived from most anterior part of the endoderm. Therefore, 
knowledge of induction and monitoring the anterior-posterior patterning of the 
endoderm gut tube is important for directing ES cell differentiation to TEPC. 
Recently, Morrison and colleagues have developed a protocol for generating anterior 
definitive endoderm (ADE) cells from ES cells using the transcription factor Hex and 
the chemokine receptor Cxcr4 1 as markers (Morrison, Oikonomopoulou et al. 2008). 
Previous studies suggested that Hex is expressed in both anterior visceral endoderm 
(AVE) and ADE (Thomas, Brown et al. 1998), while Cxcr4 is expressed in migrating 
mesoderm and definitive endoderm cells during gastrulation but not in the visceral 
endoderm (McGrath, Koniski et al. 1999; Yasunaga, Tada et al. 2005). Morrison and 
colleagues, therefore, used a combination of those two markers to identify the ADE 
population (and exclude visceral endoderm) in their ES differentiation system. A 
series of culture conditions were tested both in aggregation culture (through EB 
formation) and adherent monolayer culture. This modified protocol give rise to up to 
1Cxcr4 is the receptor of chemokine ligand 12 (CXCL12). Analysis conducted on a lymphoma cell line 
demonstrated that CXCL12-Cxcr4 can activate multiple signal transduction pathways to modulate cell 
migration and proliferation (Ganju, Brubaker et al. 1998). In mice, CXCL12 and Cxcr4 are expressed in 
migratory cells during gastrulation and at later stages in developing neuronal, cardiac, vascular, 
hematopoietic and craniofacial tissues. At gastrulation, Cxcr4 expression is found within migrating 
mesoderm and definitive endoderm, whereas its ligand CXCL12 is found within the ectoderm 
(McGrath, Koniski et al. 1999). It, therefore, seems likely that Cxcr4 will have a role in activating signal 
transduction pathways required for migration of the anterior definitive endoderm cells to the 
anterior part of the embryo. 
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eighteen percent of Hex+Cxcr4+ cells in serum-containing aggregation culture, and 
thirteen percent in chemically defined adherent monolayer culture. The anterior 
definitive endoderm character of Hex+Cxcr4+ was confirmed through both gene 
expression pattern analysis and functional analysis. This population was also 
demonstrated to be able to be expanded for many passages while maintaining its DE 
derivative differentiation potential. Surprisingly, adding Fgf4 in from day 3 to day 7 
to the chemically defined ADE induction monolayer culture significantly increased 
the Hex+Cxcr4+ percentage to twenty one percent. This finding is somewhat 
surprising, given the role of Fgf4 in promoting posterior and inhibiting anterior 
endoderm cell fate during mouse embryo development (Dessimoz, Opoka et al. 
2006). Although the expression of Hex in the 3pp and thymus primordium has not 
been reported, Hex is initially expressed widely in the floor of the foregut endoderm. 
The restriction of Hex later to the thyroid and liver suggested distinct early and late 
functions (Thomas, Brown et al. 1998; Grapin-Botton and Melton 2000). Therefore, 
the findings of Morrison and her colleagues may also be useful for generation of 
TECs from ES cells.  
 
1.4.3.3 ES cells differentiation to DE through genetic 
modification.  
1.4.3.3.1 Genetic modification to integrate reporter genes 
It is important to monitor the appearance of specific cell types during the course of 
ES cell differentiation in culture. Additionally, the ability to purify the desired cells, 
such as progenitors or precursors, may also be important for the final generation of 
mature cell types. Unless suitable specific cell surface markers and antibodies exist, 
cells can only be characterized by morphological changes, which is insufficient and 
sometimes misleading. To solve this problem, identification and purification of 
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specific ES cell-derivatives using stably integrated fluorescent reporter genes is 
widely used. For example, to monitor the pluripotency state of ES cells, plasmids 
containing enhanced green fluorescent protein (EGFP) reporter gene under control of 
the OCT4 promoter were transfected to the hES cells. Clonal cell lines were 
generated via transfection and showed normal pluripotent characteristics including 
the ability to produce all three gem cell lines (Gerrard, Zhao et al. 2005). In another 
example, to distinguish definitive and visceral endoderm, a mouse ES cell line that 
carries GFP and human IL2Rα marker genes in the goosecoid (Gsc) and Sox17 loci, 
respectively, was generated for monitoring the gene expression during the ES cells to 
DE cells differentiation (Yasunaga, Tada et al. 2005). 
 
1.4.3.3.2 Genetic modification to direct differentiation toward specific 
lineages 
By ectopic expression or silencing of key developmental genes, genetically modified 
ES cells can be induced to differentiate toward specific lineages. In an excellent 
study recently published by Rossant and colleague, endodermal progenitors were 
generated by SOX transcription factor expression in human ES cells (Seguin, Draper 
et al. 2008). Expressing SOX7 in human ES cell lines (one hundred and twenty fold 
increase over wild type) conferred on the cells an extraembryonic (ExEn) endoderm 
progenitor identity. Over-expression of SOX17 (twenty five-fold increase) conferred 
DE progenitor identity on the human ES cells. Both the SOX7 over-expressing line 
and SOX17 over-expressing line were tested through teratoma and microarray assays, 
suggesting their ExEn and DE identity, respectively. Under the neural differentiation 
protocol, neither the SOX7 over-expressing line nor SOX17 over-expressing line 
could generate any neural lineage cells. ExEn inducing culture had no effect on the 
SOX17 over-expressing line cells. However, in the absence of DE induction using 
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exogenous factors, seventy four percent of the SOX17 over-expressing line cells 
already demonstrated a DE state based on co-expression of Cxcr4 and cKit. It was 
also shown that differentiation of the SOX17 over-expressing line cell line to DE 
derivatives, such as hepatocytes and endocrine pancreatic cell was more efficient 
than differentiation initiated from wild-type ES cells. Most importantly, the SOX17 
over-expressing cell line directly differentiated to DE without the use of Activin A, 
and even showed more robust end-stage marker expression than the cells undergoing 
an activin A-dependent differentiation process. These “endodermal progenitor” cells 
were easily expanded and maintained all the above characteristics after up to 20 
passages. Thus ectopic expression of SOX17 may be a good way to generate the DE 
derivatives, including thymic epithelial cells, efficiently and homogeneously.  
 
1.4.3.4 Efficient ES cells differentiation to DE cells directed by 
small molecules 
A series of novel attempts to direct cell specification from both mouse and human ES 
cells based on the use of small molecules has been reported by Melton and 
colleagues (Borowiak, Maehr et al. 2009). In a screen of 4000 compounds, two small 
molecules were found to direct differentiation of ES cells into endodermal lineage. 
Nearly eighty percent of mouse ES cells appeared to form definitive endoderm after 
induction, and a high output of pancreatic progenitors was demonstrated. Although 
again the data did not really show whether the cells have the potential to give rise to 
any ADE derivatives, such as thymus, the microarray data showed a similar gene 
expression profile between the small molecule-induced ES cells and E7.75 Sox17+ 
endoderm cells purified from embryos. The specific biochemical targets of these 
small molecules are unknown, but a high level of Smad2 phosphorylation and an 
increase of Nodal expression were detected after treatment with either of the two 
compounds, suggesting an interaction between the compounds and the components 
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of TGFß signalling pathway. A small molecular which can induce a substantial 
number of Pdx-1 positive pancreatic progenitor cells from definitive endoderm cells 
derived from human ES cells is also found within the same group.  (Chen, Borowiak 
et al. 2009). The small molecular induction seems economical, convenient, and 
efficient. However, further work is required to demonstrate the reproducibility of 
these data and their suitability for generating ADE.   
 
1.4.3.5 Towards embryonic stem cells to thymic epithelial cells 
differentiation 
Definitive endoderm cells give rise not only to thymic epithelial cells but also other 
derivatives, such as liver and pancreas. So it is important to impose foregut 
endoderm, or more accurately, the pharyngeal endoderm fate on cells generated 
during ES cell differentiation, in order to specifically derive thymic epithelial cells. It 
has been demonstrated that during EB formation, several pharyngeal-endoderm 
related genes can be detected (Hidaka, Nitta et al. 2010, and previous work in this 
lab, see Figure 5.1). This raised the question of how to enrich for a cell population 
expressing these genes. Hidaka and his colleague found that during EB formation 
based on the hanging drop method, if serum was withdrawn on day 4 and the cells 
were then cultured as attached EBs, the expression of pharyngeal endoderm and 
pharyngeal pouch formation related genes was enhanced on day 7. Expression of 
Tbx1, Pax1, Pax9, Vgll2, Six1, and Eya1 were detected in this study.  Later, on day 
12 and day 13, Hoxa3 and Foxn1 expression was also found to be enhanced in 
comparison with the serum and flow-cultured EBs. Interestingly, this method was 
originally designed for enhancing the output of cardiomyocyte derivation. Moreover, 
a transient small population of Nkx2.5+E-cadherin+ cells was observed and found to 
be further enriched for pharyngeal endoderm genes. This is interesting, as Nkx2.5 
was originally identified as an highly specific marker for deriving cardiomyocytes 




Green and his colleagues have recently demonstrated a stepwise induction method 
for deriving ADE and subsequently the pharyngeal endoderm from human ES (hES) 
cells (Green, Chen et al. 2011). First, hES cells acquired the differentiation stimuli 
through EB formation. The EBs were then dissociated and cultured in a monolayer. 
Activin A was introduced first to induce the expression of primitive streak-genes and, 
later on, definitive endoderm specification. To acquire foregut endoderm identity, 
dozens of combinations of inhibitors or inducers were tested, assaying expression of 
foregut endoderm marker genes. Inhibition of Activin A after initial endoderm 
induction, together with addition of Noggin (the antagonist of BMP4), was found to 
be most beneficial for more specific foregut endoderm induction. Finally, a 
combination of different growth factors and cytokines was shown to induce lung and 
pharyngeal pouch-specific marker expression. However, differentiation markers for 
thymus were not found. In summary, this paper indicated a complex role for Activin 
A in specification of pharyngeal endoderm, and points to the possibility of deriving 
more anterior endoderm cell types than liver and pancreas. 
 
There are several papers published regarding directing ES cells differentiation to 
thymic epithelial cells, but none of them demonstrates reliable evidence for the 
success of TEC induction (Lai and Jin 2009; Inami, Yoshikai et al. 2011). 
 
Work from Lai and Jin (Lai and Jin 2009) suggests that TEPCs can be derived by 
directly adding FGF-7, FGF-10, BMP4 and EGF to undifferentiated monolayer ES 
cells or to EBs 2 days after formation. After 10 days, they found up to twenty percent 
(in monolayer culture) and nine percent (3D culture) EpCAM+ cells, which had 
significantly higher expression of Pax1, Pax9, Foxn1 and Plet-1 than the EpCAM- 
cells. Eighty percent of the EpCAM+ cells were K5 and K8 double positive. Further 
functional testing demonstrated that these EpCAM+ cells, when reaggregated with T 
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cell progenitors, could form a thymus structure and support T-cells differentiation 6 
weeks after grafting under the kidney capsule, while EpCAM+ cells alone or 
EpCAM- cells reaggregated with T progenitor cells could not form thymus structure. 
It is surprising that a method that omitted the definitive endoderm induction step 
proved so efficient. The reasons for adding of FGF-7 and FGF-10 are based on the 
finding that NCC-derived mesenchymal cells support thymus organogenesis by 
secreting these growth factors. However, neither the initial 3pp endoderm identity or 
the thymic epithelial fate require these induction signals from the NCC-derived 
mesenchyme. They are required for expansion of TEPCs once formed. Similarly, 
FGF signalling, BMP4 and EGF play different roles in different temporal and spatial 
stages during the embryogenesis (Zorn and Wells 2009). So it is surprising that this 
combination of different factors could give the desired outcome.  
 
However, this is not the first report suggesting that ES cells can be induced to 
produce differentiated cells types without recapitulating the developmental steps that 
occur in vivo. Functional hepatocytes can be induced from human ES cells in vitro 
culture in the presence of dimethyl sulfoxide (DMSO), hepatocyte growth factor 
(HGF) and other growth factors and cytokines without understanding the exact 
mechanism (Hay, Zhao et al. 2007). However, the subsequent study suggested that 
forcing cells to differentiate to definitive endoderm cells (an intermediate step which 
occurs in vivo) at the beginning of cell culture can increase the efficiency of 
hepatocyte differentiation from human ES cells (Hay, Zhao et al. 2008). Interestingly, 
during T-cell development, exogenous delivery of OncostainM (OSM) or transgenic 
expression of this cytokine can induce efficient T-cell differentiation without the 
need for a thymus, the organ normally required for T-cell differentiation (Clegg, 
Rulffes et al. 1996). This further suggested that it is possible to produce a terminally 
differentiated cell type without mimicking the exact process that occurs in vivo. This 
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is understandable, as signals (e.g. positional signal from 3D organization) that might 
induce and maintain certain precursor states or terminal differentiated cell types are 
likely to be absent in vitro and thus extra or different types of manipulation may be 
required. This may explain why the approach used by Lai and Jin (2009)  proved 
successful in generating TEPCs. Another thing that needs to be considered is the 
suitability of EpCAM as the marker for TEPCs during ES cell differentiation. 
EpCAM is expressed by many proliferating epithelial cell types and is not a specific 
TEPC marker. A more specific TEPC marker, such as Plet-1, should have been used 
in this study. Of note is that mouse ES cells express low levels of EpCAM, without 
induction of differentiation, in both serum-containing (Gonzalez, Denzel et al. 2009) 
and chemically-defined medium, as shown later in this thesis (Figure 6.2 B and 
Figure 6.11 B) This means that cells sorted only on the basis of EpCAM expression 
may include undifferentiated ES cells, which could lead to teratoma formation after 
transplanting under the kidney capsule, as reported for an experiment described later 
in this thesis (Figure 6.10). Similarly, K5 and K8 co-expression is a characteristic of, 
but does not define, TEPCs. The claim that a thymus structure had been formed from 
sorted “TEPCs” in this paper was based only on the K5 and K8 expression pattern. 
None of the different subtypes that a thymus should contain, such as UEA-1+ 
medullary TECs or Ly51+ cortex TECs were demonstrated, and nor were any 
functional characteristics of TECs, such as MHC Class II expression, demonstrated. 
Therefore, further work is required to better characterize the putative TECs produced 
by the system reported by Lai and Jin (2009). 
 
Inami and colleagues have also recently reported an induced pluripotent stem cell 
(iPSCs) to TECs protocol with a detailed stepwise induction procedure (Inami, 
Yoshikai et al. 2011). First, iPSCs were induced to differentiate to mesoendoderm 
and subsequently to definitive endoderm cells by using Activin A and the GSK3 
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inhibitor LiCl. The growth factors FGF-8, FGF-7, FGF-10 and BMP4 were added 4 
days later, based on the literature that these growth factors and morphogens are 
needed during thymus organogenesis. Gene expression patterns including for some 
key transcription factors required during thymus organogenesis, such as Hoxa3, 
Pax1, Pax9, Eya1, Six1 and Foxn1, were tested, and expression of these markers 
during differentiation was confirmed. A small population of EpCAM+MTS24+ cells 
was also found. However, no functional evidence was provided and the TEPC 
character was only confirmed by phenotype.  
 
1.5 Aims 
The overall aim of this PhD project was to differentiate mouse ES cells to TEPCs. To 
approach this, it was important and necessary to define the TEPC clearly in vivo 
before the in vitro induction work. Therefore, the initial aim of this work was to 
determine whether a functional TEPC could persist from the fetal thymus 
development stage to the postnatal mouse, if the cells ability to express Foxn1 was 
limited genetically (Figure 1.4; Chapter 3), and to determine for how long this 
population could persist in vivo (Chapter 4).  
 
To achieve the aim of differentiating mouse ES cells to TEPCs, an appropriate 
induction protocol for ES cells to ADE is required. Therefore, I next tested a series of 
existing and modified ADE differentiation protocols, with the aim of determining in 
which condition genes related to thymus development were most strongly induced 
and of testing the capacity of cells induced by these protocols to contribute to mature 
TECs networks in vivo (Chapter 5 and 6). The final aim was to build on these 




Figure 1.4 Early thymic epithelial lineage specification and persistence of 
common or lineage restricted progenitor cells at postnatal stage - Known and 
unknown. “×” on arrows: a particular lineage specification is blocked; “?”: persistence of 
such a cell type needs to be confirmed; “?” in square: questions that can be possibly 
addressed in this thesis; “√”: tissue structure observed; “×”: tissue structure not 




Chapter 2 Material and Methods 
2.1 Mice 
All animal work was conducted according to UK Home Office guidelines, as 
established in the ANIMALS (SCIENTIFIC PROCEDURES) ACT 1986.  
 
2.1.1 Mice strains 
Foxn1R/R (Nowell, Bredenkamp et al. 2011) and Rosa26CreERt2/+ (Hameyer, Loonstra 
et al. 2007) mice were maintained as homozygotes. Foxn1-/- (Nehls, Kyewski et al. 
1996) mice were maintained as heterozygotes on a C57BL/6 background. Foxn1R/R 
mice were crossed with Foxn1+/- to generate Foxn1R/- mice, which were then crossed 
with Rosa26CreERt2/+ mice, as decribed.  Genotyping was performed on ear biopsy 
samples at 4 weeks of age.  
 
2.1.2 Tamoxifen treatment 
4-hydroxy-tamoxifen (4OHT) (Sigma-Aldrich) was dissolved in ethanol (20mg/ml) 
and stored at -80℃ until required. When needed, 4OHT was further diluted in a 
cremophor (Sigma-Aldrich)/PBS carrier and was delivered to the mice by a single 
intraperitoneal (IP) injection. Injection volumes varied from 200μl to 400μl, 
depending on the 4OHT dose required (250μg, 500μg, 1mg, 1.5mg and 2mg as 
described in Result Chapter 3). Mice were analyzed 7 weeks after injection. 
 
To treat reaggregates in CoROC culture, pre-dissolved 4OHT in ethanol (20mg/ml) 
was diluted in culture medium to final concentration as 1μM. 
 
Tamoxifen citrate salt (Sigma-Aldrich) was used to deliver Tamoxifen through the 
drinking water. Tamoxifen citrate salt was dissolved in ethanol (10mg/ml) and stored 
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in aliquots at -80℃.When needed, tamoxifen citrate salt was diluted in the drinking 
water to 0.1mg/ml. Tamoxifen-treated water was changed on a weekly basis.  
 
2.2 Immunohistochemistry 
2.2.1 Tissue preparation 
Dissected thymic tissue was washed in PBS, embedded in OCT compound (Sakura), 
frozen on dry ice and then stored at -80℃. Frozen tissue blocks were cryo-sectioned 
to 6-8 μm sections and collected on Poly-L-Lysine coated slides that were either 
fixed immediately or stored at -80℃. 
 
2.2.2 Tissue Staining 
Slides were removed from -80℃ and left to reach room temperature before fixation 
in -20℃ acetone for 2 minutes. Sections were air dried, circled with a hydrophobic 
marker pen and further air dried for 15 minutes. Sections were then rinsed in PBS, 
and blocked using 5% serum (secondary antibody host species) in PBS-T (0.1% 
Tween 20 (Sigma)) for 15 minutes at room temperature. Primary antibodies were 
prepared in PBS at the appropriate concentration and incubated on each section for 
either 1 hour at room temperature or at 4℃ over-night (O/N). Sections were then 
washed in PBS-T for 3x 5 minutes. Secondary antibodies were applied in the same 
manner for 1 hour and then washed in PBS-T for 3x 5 minutes. Sections were rinsed 
in dH2O after the final wash and air dried at room temperature. Sections were either 
mounted in 50% glycerol and analyzed immediately, or in Vectshield (Vector 
Laboratories) and allowed to set at 4℃ O/N before analysis. A Leica AOBS confocol 
microscope was used for fluorescent imaging. 
 
2.2.3 Antibodies 




Antibody Name Clone Isotype Source Working 
Conc. 




1 in 3 
Anti-Pan-keratin Polyclonal Rabbit IgG DAKO 17μg/ml 
Anti-Keratin 5 AF138 Rabbit IgG Covance 2.5μg/ml 
Anti-Keratin 8 Troma 1 Rat IgG2a DSHB Hybridoma 
Stock (1:5) 
Anti-Keratin 14 AF64 Rabbit IgG Covance 2.5μg/ml 
UEA-1 n/a Lectin Vector 
Laboratories 
5μg/ml 
Anti-MHCIIB M5/114.15.2 Rat IgG2b BD 
Bioscience 
2.5µg/ml 





CD45 30-F11 Rat IgG2b eBioscience 10µg/ml 
Ly51 6C3 Rat IgG2a BioLegend 10µg/ml 
Cldn4 Polyclonal Rabbit IgG Invitrogen 0.5μg/ml 
H-2Kb AF6-88.5 IgG2a,k BD 
Pharmingin 
1.25μg/ml 
Secondary antibodies used:goat anti-rabbit IgG-Alexa488, goat anti-rat IgG2a-
Alexa647, streptavidin-Alexa647 and streptavidin-Alex488 (1:1000). 
Isotype controls: rat IgG2a and IgG2b, rabbit IgG (BD Pharmingen or eBioscience).  
2.3 Flow cytometry 
2.3.1 Cell preparation 
2.3.1.1 Lymphocytes 
Dissected thymi, trimmed of connecting tissue and fat, or whole thymic rudiment 
tissue regions were collected in Hanks Balanced Salt Solution (HBSS) (Sigma). The 
tissue was then cut into several pieces and mechanically disaggregated between two 
glass slides; dissociated lymphocytes were collected in a petri dish in HBSS. The 
remaining tissue fragments and cell suspension were then filted through a 70µm cell 
strainer into a fresh 50ml centrifuge tube. The petri dish was then rinsed with 10ml 
HBSS and this was transferred into the same 50ml tube through the cell strainer. 
Cells were collected by centrifugation at 1500rpm (284rcf) for 10 minutes at 4oC, the 
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supernatant was discarded and the cell pellet was resuspended in 1 - 10ml FACS 
wash (PBS with 5% FCS), depending on cell number. Red blood cell lysis was 
performed if there was significant red blood cell contamination, as was the case 
following thymic rudiment tissue dissaggregation. If required, collected cells were 
resuspended in 1ml 1x Red cell lysis buffer (Biolegend) and incubated at room 
temperature for 5 minutes. The lysis reaction was inactivated by the addition of 4ml 
FACS wash (5% FCS in PBS), the cells were collected by centrifugation at 1500rpm 
for 5min, and then resuspended in 1-10ml FACS wash. Cell number was determined 
by counting cells in a Neubauer hemocytometer. For cell staining, 5x106 cells were 
transferred to a 5ml FACS tube, and the volume was adjusted to 100μl with FACS 
wash.  
2.3.1.2 Thymic epithelial cells 
Freshly dissected thymi were transferred into RPMI medium in a petri dish, and the 
blood vessels and fat were removed. Thymi were minced up as finely as possible 
using scissors and then 5ml of pre-warmed dissociation buffer (RPMI containing 
1.25mg/ml Collagenase D (Roche), and 140-220U/ml DNase I) was added. The cells 
were  incubated at 37oC for 15 minutes, with gentle pipetting every 5 minutes. After 
incubation, the undissociated tissue fragments were allowed to collect at the bottom 
of the tube before the dissociated cells in suspension were transferred to a new 50ml 
tube on ice through a 70µl cell strainer. A further 5ml of pre-warmed dissociation 
buffer was added to the tube and same dissociation procedure was repeated twice. 
Finally, the remaining tissue fragments were treated with another dissociation buffer  
(5ml RPMI containing 1.25mg/ml Collagenase/Dispase (Roche) and 140-220U/ml 
DNase1 ) for 30min at 37oC, with gentle pipetting every 15 minutes. Dissociated 
cells were transferred to the same tube through a cell strainer. Cells were collected by 
centrifugation at 1500rpm (284rcf) for 10min at 4℃. Cell number was then 





2.3.1.3 TECs enrichment 
Thymic epithelial cells were enriched, prior to flow cytometric analysis or isolation, 
by depletion of lymphocytes (Gray, Fletcher et al. 2008). Anti-CD45 labelled 
microbeads (Miltenyi Biotech) were incubated with the dissociated postnatal thymic 
cell preparations (5μl of microbeads per 107 cells). Cells were then run through the 
AutoMACS (Miltenyi Biotech) using the DepleteS programme and then collected by 
centrifugation. 
 
2.3.2 Cell staining  
For lymphocyte analysis, Fc receptors were blocked prior to staining by a 15min 
incubation with a CD16/32 antibody (BioLegend). 100ul of FACS wash containing 
the primary antibody or directly-conjugated antibody was then added to each tube 
and incubated for 20min on ice. Cells were then washed once in 1ml FACS wash and 
collected by centrifucgation at 1500rpm (284rcf) for 5min at 4℃. Cells were 
incubated with secondary antibody (if applicable) for a further 15min and then 
washed again. Cells were then re-suspended in 200μl FACS wash and either 7AAD 
(1:40) or Dapi (1:20,000) were added prior to analysis to gate out dead cells.  
 
2.3.3 Flow cytometry procedure 
Single stain, isotype and fluorescent minus one (FMO) controls were prepared for 
each flow cytometry experiment. Cells were analyzed on a FACSCalibor or a LSR 
Fortessa (Becton Dickinson). Cells sorting was conducted by Simon Monard or 
Olivia Rodrigues on FACS Aria II or FACS Jazz cell sorters (Becton Dickingson). 
Flow cytometric data obtained were analyzed using FlowJo.  
 
2.3.4 Antibodies 






Clone Isotype Conjugate Source Working 
Conc. 





CD4 H129.19  Rat IgG2a  FITC, PE BD 
Pharmingen  
2.5μg/ml  
CD8 53-6.7  
 
Rat IgG2a  
 
FITC, PE BD 
Pharmingen 
2.5μg/ml 
CD25 3C7  
 
Rat IgG2b  
 
PE eBioscience 1μg/ml 
 
CD44 1M7 RatIgG2b APC eBioscience  2μg/ml 





CD31 390 RatIgG2a FITC, APC BD 
Pharmingen 
2.5μg/ml 
Ter119 Ter119 Rat IgG2b APC, FITC BD 
Pharmingen 
1μg/ml 





CD11b M1/70 RatIgG2b FITC BD 
Pharmingen 
2.5μg/ml 
CD19 1D3 RatIgG2a FITC BD 
Pharmingen 
2.5μg/ml 
EpCAM G8.8 RatIgG2a FITC,PE Biolegend 2μg/ml 
Cxcr4-APC 2B11/CXCR4 RatIgG2b,k APC BD 
Pharmingen 
2.5μg/ml 
MTS20/24 antibodies were kind gifts from by R.L Boyd at Monash University, 
Melbourne, Australia. The isotype of the MTS20 antibody is RatIgM, and of MTS24 
is RatIgG2a. The working concentration for these antibodies is neat. The secondary 
antibody chosen for MTS20 is PE labled mouse anti RatIgM, for MTS24 is goat anti 
Rat IgG-Alex488. 
 
2.4 Intrathymic cell count 
Dissected thymus or thymic rudiment tissue was processed as described in 2.3.1.1. 
The total number of cells (Nt) were counted before cells were processed for cell 
staining. Cells were then stained with CD45, CD4 and CD8 and analysed by flow 
cytometry. For analysis in FlowJo, non-viable cells were gated out, and the 
percentage for CD45+ cells was recorded (P45). Cells were further analysed with CD4 
and CD8 and the percentage of double positive CD4+CD8+ cells was recorded (Pdp). 




For statistics analysis of sample groups, t-tests were calculated using Microsoft 
Excel, Fisher’s Exact test was calculated online (http://vassarstats.net/index.html) 
and that analyses of variance, Kruskal-Wallis tests and regression analyses were 
calculated using GraphPad Prism software.  
 
2.5 Reaggregate organ culture  
Compact reaggregate organ culture (CoROC) was previously developed in the 
Blackburn laboratory (Sheridan, Taoudi et al. 2009). This technique, as described in 
Figure 2.1, was used in this thesis. Unless otherwise stated, the medium used for 
reaggregated culture was GMEM/FCS medium (described in section 2.8.1) with  
50U/ml penicillin and 50μg/ml streptomycin. 
 
 
Figure 2.1 Overview of the CoROC technique. A single cell suspension is drawn into 
a nonbevelled pipette tip, which is then sealed with folded Parafilm. During 
centrifugation, a compacted cell mass forms. On removal of Parafilm, the compacted 
mass is extruded onto a membrane at the gas-liquid interface for reaggregation and 




2.6 Cell culture  
2.6.1 ES cell maintainence 
2.6.1.1 Serum conditions 
Mouse E14tg2a ES cells at early passage (p14-p30) were cultured in gelatin-coated 
flasks or plates (Iwaki). The medium used was GMEM/FCS with 1× leukaemia 
inhibitory factor (LIF) (see below). The medium was changed every two days, cells 
were passaged 1 in 10 (or 0.5 × 106 per 25 cm2 flask) every 3 or 4 days.  
 
GMEM/FCS medium: 
Glasgow minimum essential medium (GMEM) (Invitrogen), with: 
10% foetal calf serum (FCS),  
1 × nonessential amino acids,  
4mM glutamine,  
2mM modium pyruvate,  
0.1mM 2-mercaptoethanol,.  
 
2.6.1.2 Serum-free conditions 
A vial of early passage E14tg2a mouse ES cells, that had previously been cultured in 
the serum containing medium (GMEM/FCS+Lif)(Ying, Nichols et al. 2003) were 
thawed and cultured in the same medium for expansion. One week later, the cells 
were passaged and transferred to 2i medium (Ying, Wray et al. 2008) (see below). ES 
cells were maintained in 2i medium for at least 1 week using standard techniques 
before differentiation protocals were conducted. Cells were passaged every 3 or 4 
days, at a ratio of 1 in 8 (or 0.5 × 106 cells per 25cm2 flask). 
 
2i Medium: 




CHIRON99021: 3μM (Stemgent) 
PD0325901: 1μM (Stemgent) 
 
2.6.2 Cell differentiation 
2.6.2.1 Anterior definitive endoderm differentiation protocol 
An unpublished, confidential protocol from Dr. Gillian Morrison (University of 
Cambridge), which is based on a previously published protocol from Morrison et al. 
(Morrison, Oikonomopoulou et al. 2008), was used to generate definitive endoderm 
cells from E14tg2a ES cells. Briefly, ES cells were cultured in 2i medium and 
differentiation was initiated at day 2 after the most recent passage of the cells. Cells 
were dissociated with Accutase to single cells and replated on gelatin coated culture 
plates. For a 6 well culture plate (Iwaki), 3x104 cells were plated into one well in 3 
ml of medium. No passaging was needed during the 7 day DE differentiation 
protocol. This protocol has two main stages with a medium change at day 2 (medium 
1 to medium 2) and a further change into medium 2 on day 4. The protocol is 
described below. 
 
DE differentiation protocol summary: 
Day 0 – plate out in media 1 
Day 2 – change to media 2 
Day4 – replace media 2 
 
Media 1: N2B27 base 
  3uM CHIRON99021 
  20ng/ml Activin A 
  10ng/ml FGF4 
  1ug/ml Heparin 
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  50nM PI-103 
Media 2: SF5 Base* 
  3uM CHIRON99021 
  20ng/ml Activin A 
  10ng/ml FGF4 
  1ug/ml Heparin 
  50nM PI-103 
  20ng/ml EGF 
 
*SF5 Base medium: 
DMEM/F12( - L-glutamine) 500ml 
Beta-mercaptoethanol  0.55ml 
L-glutamine 2mM   5.0ml 
N2(Gibco)    2.5ml 
B27(Gibco)    5.0ml 
 
N2B27 was prepared in house or purchased from Stem Cell Sciences Inc. 
 
2.6.2.2 Embryoid body formation  
E14tg2a cells, previously cultured in GMEM/FCS+Lif medium, were trypsinised and 
collected by centrifugation. Cells were resuspended in GMEM/FCS without LIF at a 
density of 105 cells/ml . 10µl drops of this cell suspension were pipetted onto the 
inside of a lid of a 140 mm petri dish (Sterlin Ltd). A repeat pipettor was used to 
achieve consistent results. The lid was then placed back on its base which contained 
20ml PBS for a humid environment. Cells were incubated for 2 days to allow 
spontaneous EB formation to occur. Aggregates were then flooded from the lid with 
media into 90 mm petri dish (Sterlin Ltd.). Aggregates were then cultured in 
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suspension for 5 days in 15ml GMEM/FCS. Media was not changed or changed once 
depending on the EBs density. To change media, suspension EBs were transferred to 
a conical bottomed tube and allowed to settle by gravity before media was replaced.  
 
2.6.2.3 EB differentiation with Activin A  
ES cells previously cultured in 2i medium were dissociated to single cells with 
Accutase and then plated in a 90 mm petri dish (Sterlin Ltd) for spontaneous EB 
formation. 10ml medium with 5x104 cells were used for each 90mm petri dish. 
Medium conditions used are described below: 
 
Serum containing culture: 
Day 0 - Day 2: GMEM/FCS 
Day 2 - Day 7: N2B27 plus 20ng/ml Activin A, 20ng/ml EGF 
 
Chemically defined medium: 
Day 0 – Day 2: N2B27 plus 10ng/ml BMP, 20ng/ml Activin A 
Day 2 – Day 7: SF5 plus 20ng/ml EGF, 10ng/ml FGF4 
 
2.6.3 Growth factors, cytokines and inhibitors 
The growth factors, cytokines and inhibitors used for cell culture are listed below: 
Name Cat No. Supplier 
Activin A PHG9014 Invitrorgen 
FGF4 PHG0154 Invitrogen 
CHIRON 99021 04-0004 Stemgent 
PD0325901 04-0006 Stemgent 
Heparin H3149-10KU Sigma 








2.7 X-gal staining 
2.7.1 X-gal staining on co-cultured EBs or ES cells 
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Cultured EBs or cells were washed in PBS, and then washed in X-gal wash for 3 x 
5min at 4℃. Samples were then fixed in X-gal fix for 20min at 4℃, and washed in 
X-gal wash for 3x 20min at room temperature. X-gal stain solution was then added to 
cover the sample surface, and staining process was performed at 37℃ in dark for 18 
hours. X-gal stain solution was removed and X-gal fix solution was added to prevent 
leaching of the X-gal reaction product. Samples were stored at 4℃ or immediately 






0.1 M phosphate buffer (pH 7.3) 
2 mM MgCl2 






Made up in X-gal wash mixed with: 
0.024% spermidine 
5 mM K3FE(CN)6 
5 mM K4FE(CN)6 
0.0014% NaCl 







0.1 M phosphate buffer (pH 7.3) 
0.2% glutaraldehyde 
2 mM MgCl2 
5 mM EGTA 
 
2.7.3 FDG staining 
FDG staining was conducted using FluoReporter ® lacZ Flow Cytometry Kits, 
according to the manufactures instructions. 
2.8 Q-PCR 
Cells were collected and lyzed in QiaZol (Qiagen). RNA was extracted according to 
the manufacturers instructions (QIAzol Handbook,  Qiagen). RNA quality and 
quantity was analysed using the Nanodrop. cDNA was synthesized from total RNA 
using SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen), according 
to the manufactures instructions. cDNA was diluted three or five-fold with PCR 
grade water and 2.5μl was added to the following reaction: 5µl of 2× Lightcycler 480 
Probes Master, 0.05µl of each 10 µM primer, 0.1µl of 100× UPL probe, PCR grade 
water to 10µl. Reactions were performed on a Roche LightCycler 480 instrument 
(384 System) using the standard run protocol. At least 3 technical repeats were 
performed per sample and data were analysed using the LightCycler 480 software 
(v1.5). Standard curves were established for each gene analysed using E14.5 
EpCAM+ TECs cDNA or E12.5 whole thymic lobe cDNA. Dilutions series was set 
as 1, 10-1, 10-2, 10-3, 10-4 (where 1 represents the 1/2.5 diluted cDNA sample). 
 
2.8.1 Primer and probe 
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The following primers2 were used for QRT-PCR analysis: 
Primer Sequence (5’-3’) UPL probe 
α-tubulin F CGGACCACTTCAAGGACTAAA 58 
α-tubulin R ATTGCCGATCTGGACACC  
Oct-4 F GTTGGAGAAGGTGGAACCAA 95 
Oct-4 R CTCCTTCTGCAGGGCTTTC  
Nanog F CCTCCAGCAGATGCAAGAA 25 
Nanog R GCTTGCACTTCATCCTTTGG  
Rex1 F GCACACTCACTCTATTGAGAGA 
AGAA 
16 
Rex1 R CAGCTCCTGCACACAGAAGA  
Sox17 F CACAACGCAGAGCTAAGCAA 97 
Sox17 R CGCTTCTCTGCCAAGGTC  
Hex F TCAGAATCGCCGAGCTAAAT 2 
Hex R CTGTCCAACGCATCCTTTTT  
Plet-1 F CATCCGTGAAAATGGAACAA 20 
Plet-1 R TCACAGTTGGAGTCGTGTTTATG  
Tbx1 F GCTGTGGGACGAGTTCAATC 104 
Tbx1 R ACGTGGGGAACATTCGTCT  
Hoxa3 F CAAGGCAGAACACTAAGCAGAA 78 
Hoxa3 R GTCACCAGCGCAGCTCTC  
Pax1 F CTCCGCACATTCAGTCAGC 105 
Pax1 R TCTTCCATCTTGGGGGAGTA  
Pax9 F AGCAGGAAGCCAAGTACGG 33 
Pax9 R TGGATGCTGAGACGAAACTG  
Foxn1 F TGACGGAGCACTTCCCTTAC 42 
Foxn1 R GACAGGTTATGGCGAACAGAA  
IL-7 F CTGCTGCAGTCCCAGTCAT 10 
IL-7 R TCAGTGGAGGAATTCCAAAGAT  
 
  
2 All primers were designed on line by Universal ProbeLibrary System (Roche). 
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Chapter 3 Investigation of the capacity of 
thymic epithelial progenitor cells to persist in 
vivo. 
3.1 Introduction 
The existence of a common progenitor cell that can generate both cortical and 
medullary TEC compartments has been demonstrated within both fetal thymic 
primordium and the neonatal mouse (Bleul, Corbeaux et al. 2006; Rossi, Jenkinson et 
al. 2006). Using a revertible Foxn1 null allele, bi-potent progenitor cells were shown 
to persist until the neonatal period (postnatal day 14) in Foxn1 null mice. When the 
Foxn1 allele was reverted, a single progenitor cell could give rise to both cortex and 
medulla and subsequently support T-cell development (Bleul, Corbeaux et al. 2006). 
 
A hypomorphic Foxn1 allele, Foxn1R, was previously generated in our lab (Figure 
3.1). Due to the splicing around the inserted sequence, this allele can express only 
15% of wild type (WT) Foxn1 expression levels.  Further analysis demonstrated that, 
as in Foxn1-/- mice, the development of the Foxn1R/- thymus was arrested at the early 
primordium stage and remained non-functional throughout life with respect to 
supporting T cell development. However, Foxn1R/- mice expressed CD205, the 
earliest marker known so far for cortical specific epithelial progenitor cells (Shakib, 
Desanti et al. 2009), in the thymus primordium at E15.5. Moreover, while the Plet-1-
:Plet-1+ epithelial cell ratio was maintained from E13.5-E15.5 in Foxn1-/- mice, this 
ratio increased within Foxn1R/-.  Plet-1 is the earliest TEPC marker and the loss of its 
expression accompanies thymic epithelial lineage differentiation (Bennett, Farley et 
al. 2002). A low level of MHC Class II expression was also detected on TECs from 
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Foxn1R/- mice at this stage. It was also been demonstrated that even in the Foxn1-/- 
mice, K5hiCldn4hi cells could be detected at E13.5.  Cldn4hi cells at this stage in the 
wild type thymus have been demonstrated to be medulla-specific thymic epithelial 
progenitor cells (Hamazaki, Fujita et al. 2007). This suggested that at low Foxn1 
expression levels, at least some TEPCs become committed to the cortical and 
medullary TEC lineages (Nowell, Bredenkamp et al. 2011). Therefore, it was 
important to determine whether at low levels of Foxn1 expression, the common 
TEPCs, or cortical and medullary sub-lineage restricted TEPCs persisted, and also to 




Figure 3.1. Wild-type Foxn1 allele and Foxn1R allele.  A LoxP flanked cassette 
containing the 5’ engrailed 2 splice acceptor site (SA), the SV40TAg coding region, an 
internal ribosome entry site coupled to an enhanced green fluorescent protein/neomycin 
resistance fusion protein (IRES-EGFPneo), and the CMAZ transcriptional pause was 
inserted into intron 1b of the Foxn1 locus of mouse ES cells. E, exon. The SV40 T 
antigen was originally introduced to allow TEPC cells derived from these mice to be 
immortalized in vitro and was demonstrated to not affect TEC differentiation and 
function in this model, and the revertibility of the Foxn1R allele was also 
demonstrated (Figure adapted from Nowell, Bredenkamp et al. 2011).  
 
A Foxn1 reversion model was subsequently created by crossing the Foxn1R/- mouse 
53 
 
with Rosa26CreERt2 (Hameyer, Loonstra et al. 2007) to generate 
Foxn1R/nu;Rosa26CreERt2 mice (R/-;CreERt2). Unlike the Foxn1SA2/SA2 strain (Bleul et 
al 2006), the R/-;CreERt2 mice expresses a low level of Foxn1 (7% of WT Foxn1 
expression). Adult R/-;CreERt2 mice had a normal skin phenotype but were athymic 
(Dr. Craig Nowell’s previously unpublished data in Blackburn’s Lab), as expected 
from studies of Foxn1R/- mice (Nowell, Bredenkamp et al. 2011) and carrier injected 
R/-;CreERt2 mouse (Figure 3.2). Using this model, I investigated whether the 
common thymic epithelial progenitor cells or the sub-lineage specified medullary 
thymic epithelial progenitor cells (mEPC) and cortical thymic epithelial progenitor 
cells (cEPC) could persist in postnatal mice.  
 
3.2 Results 
3.2.1 Reversion of the Foxn1R allele leads to thymus 
development in R/-;CreERt2 mice 
To test whether functionally competent thymic epithelial progenitor cells were still 
present in adult R/-;CreERt2 mice, 2-4 month old R/-;CreERt2 mice were injected 
intraperitoneally (IP) with 4-hydroxytamoxifen (4OHT). This allowed me to 
determine whether, by recovering the capacity of TECs to express wild-type levels of 
Foxn1, the structure and function of the thymus could also be recovered. I first tested 
5 different doses of 4OHT; 250μg, 500μg, 1mg, 1.5mg and 2mg. Carrier only 
injection was used as a control. Mice were analyzed after 7 weeks for structural and 
functional changes.  
 
For histological and immunohistochemical analysis, 8 μm cryosections were cut for 
each thymus / thymic rudiment (see Materials and Methods). Every 30th section was 
stained with α-pan-cytokeratin (PanK) and 4’6-diamidino-2-phenylindole (Dapi) in 
order to determine the position of the potential thymus / thymic rudiment within the 
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whole block (Figure 3.2 and Figure 3.14). The general outcome, and the age and dose 
of 4OHT for each mouse processed for immunohistochemical analysis were 





Age Outcome No. of Mice 
Carrier 2-4 months No reactivation >3 
250μg 2-4 months No reactivation >3 
500μg 2-4 months Reactivated >3 
1mg 4 months Reactivated 1 
1.5mg 4 months Reactivated 1 
2mg 4 months Reactivated 1 
Table 3.1 Mice processed for immunohistochemical analysis 
 
The R/-;CreERt2 mice injected with carrier-only contained a small thymic rudiment, 
and histologically showed a cystic epithelial structure (Figure.3.3). No cortex and 
medulla organization could be observed. Most epithelial cells (PanK+) co-expressed 
Keratin 5 (K5) and Keratin 8 (K8), two markers widely used to identify the medulla 
and cortex in the mature WT thymus, respectively, (Klug, Carter et al. 1998) and co-
expressed on the progenitor cells during ontogeny (Bennett, Farley et al. 2002).  
More than 50% of epithelial cells were positive for Plet-1, which marks the earliest 
progenitor cells present during thymus organogenesis (Bennett, Farley et al. 2002) 
and also marks the thymic remnant within an adult nu/nu mouse (Blackburn, 
Augustine et al. 1996).  Therefore, the epithelial cells detected here were 
indistinguishable from the Foxn1R/- thymus, which is composed of undifferentiated 
TECs (Nowell, Bredenkamp et al. 2011).  
 
MHC Class II is considered to be a marker of mature functional TECs (Bonfanti, 
Claudinot et al. 2010). It is also expressed in macrophages, monocytes, dendritic 
cells and B cells (Ting and Trowsdale 2002). The carrier injected R/-;CreERt2 mice 
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are athymic, have no functional thymic epithelial cells and so cannot support T-cell 
development. It is, therefore, interesting that MHC Class II staining was present in 
most of the epithelial area of carrier-only injected mice, as previously observed in 
Foxn1R/- mice (Nowell, Bredenkamp et al. 2011). 
 
The 250μg4OHT injected mouse showed the same cystic epithelial structure and 
immunostaining profile as carrier-only injected and R/- mice (Figure 3.2), indicating 










Figure 3.2 R/-;CreERt2 mice were injected intraperitoneally with 250μg 4OHT. After 
7 weeks, the thymus or thymic rudiment was microdissected and processed for 
cryosectioning.  8µm sections were cut, and groups of 3 adjacent sections were placed 
on a single Poly-L-Lysine coated slide. The slides numbers (s36 etc) are listed in the 
left panel of the figure.   So that 40 slides here have 120 sections and thus covers 
960µm.  Images show pancytokeratin (PanK, green) and DAPI (blue) staining of every 
30th section from a block containing one thymus/thymic rudiment. PanK was used to 
identify the epithelial cells. Dapi (Blue) was used to marker the cell position. There are 
two main epithelial cell area (Area A and Area B) detected within most of the sections. 
Sections were localized in the actual histological order. Area A in slide 56 is shown in 
two images due to the size of the section. All pictures are at the same magnification 







Figure 3.3 Immunohistochemical analysis of carrier-only injected R/-;CreERt2 
mice. At least two 2-4 month old R/-;CreERt2 mice were injected with carrier only. 7 
weeks later, the mice were examined for the presence of an overt thymus, and the 
region containing the thymic rudiment was microdissected and processed for 
cryosectioning.  No overt thymus-like organs were found.. 8 μm cryosecions were cut 
and stained for the markers indicated on the photographs. Carrier-only injected R/-
;CreERt2 mice contained a thymic rudiment which showed a cystic epithelial 
morphology, with most of the PanK+ epithelial cells co-expressing K5, K8 and Plet-1. 
Scale bars: 300 μm, images shown are representative of at least two individual mice. 





At all doses above 500 µg of 4OHT injection, a thymic structure with both cTECs 
and mTECs was clearly observed based on K5, K8 and DAPI staining (Figure 3.5). 
UEA-1, which marks medullary TECs (Figure 3.6), and Ly51, which marks mature 
cortical TECs (Figure 3.7) were detected within the two compartments, respectively. 
Notably, UEA-1 staining was also detected, although in fewer cells, in the carrier-
only and 250ug-4OHT injected thymi. This is consistent with the staining profile in 
nu/nu mice (Figure 3.3, 3.4) (Nowell, Bredenkamp et al. 2011). In thymi from mice 
that received 1mg, 1.5mg and 2.0mg 4OHT, MHC Class II, a marker of mature 
TECs, also showed staining profile indistinguishable from that seen in WT thymi 
(Figure 3.8). 
 
For all of the reactivated thymi, i.e. all the doses above 500 μg 4OHT, Plet-1+ areas 
of undifferentiated tissue could be seen adjacent to the thymus structure. These were 
histologically similar to the undifferentiated tissue within the carrier-only injected R/-
;CreERt2 mice (Figure 3.3) and nude mice (Blackburn, Augustine et al. 1996), 
suggesting that these cells were non-reactivated TEPCs. These regions were clearly 
different from the scattered Plet-1+ areas normally observed within a WT thymus, 
and detected within the medulla formed following Foxn1 reactivation (Figure 3.4).  
 
These data established that in the postnatal R/-;CreERt2 mice, reversion of the 
Foxn1R allele lead to thymus generation, suggesting the presence of persisting thymic 
epithelial progenitor cells. The amount of thymus tissue appeared to be proportional 
to the dose of tamoxifen, indicating that the number of TEPCs reactivated was higher 
at higher doses. The presence of a well-organized structure containing most major 
cortical and medullary TEC sub-types, especially within the high-dose injected mice, 











Figure 3.4 Immunohistochemistry staining profile of Plet-1 on all doses of 4OHT 
injected R/-;CreERt2 mice. 2-4 month old R/-;CreERt2 were injected with 4OHT or 
carrier only. 7 weeks later, the thymi or thymic rudiments were dissected and processed 
for cryosectioning. 8 μm cryosections were cut and stained with MTS24 (mAb for Plet-1) 
and PanK. 250μg 4OHT injected mouse showed the same cystic epithelial morphology 
and Plet-1 staining profile as the carrier-only injected mice did (A 250μg and B Carrier). 
Plet-1+ non-reactivated epithelial cells were evident adjacent to the thymic tissue (shown 
in A 1mg, A 1.5mg and B 500μg, B 1mg) and Plet-1+ cells within medullary area as 
normal WT thymus did (as shown in A 1.5mg, A 2mg, A WT) could be observed in all 
doses above 500 μg 4OHT injected mice. Images shown are representative of mice 
receiving the different doses. C: cortex, M: medullar, N: non-reactivated area. n=2 for 
carrier-only, 250μg and 500μg 4OHT injected mice. n=1 for 1 mg, 1.5mg and 2mg 4OHT 
injected mice. (Dr. Craig Nowell performed the staining work for carrier-only and 500μg 










Figure 3.5 Immunohistochemical staining profile of K5 and K8 on 4OHT injected 
R/-;CreERt2 mice. 2-4 months old R/-;CreERt2 were injected with 4OHT or carrier only. 
7 weeks later, thymi or thymic rudiments were dissected and processed for 
cryosectioning. 8 μm cryosections were cut and stained with K5 (green) and K8 (red). 
The 250μg 4OHT injected mouse shows a cystic epithelial structure co-expressing K5 
and K8. Individual K5-/lowK8+DAPIdense cortical and K5+/K8lowDAPIdim medullary 
compartments can be observed within all mice that received 500μg or higher doses of 
4OHT. n=2 for carrier-only, 250μg and 500μg 4OHT injected mice. n=1 for 1 mg, 1.5mg 















Figure 3.6 Immunohistochemical staining profile of UEA-1 and PanK on 4OHT and 
carrier-only injected R/-;CreERt2 mice. 2-4 months old R/-;CreERt2 were injected with 
4OHT or carrier only. 7 weeks later, thymi or thymic rudiments were dissected and 
processed for cryosectioning. 8 μm cryosections were cut and stained with PanK 
(green) and UEA-1 (red). Carrier-only and 250μg4OHT injected mice showed a epithelial 
structure and UEA-1 expression could be detected only occasionally and without clear 
boundary of expression area (A 205g and B Carrier). UEA-1-marked medullary areas 
can be detected in all mice receiving 500μg or higher doses of 4OHT (A and B). n=2 for 
carrier-only, 250μg and 500μg 4OHT injected mice. n=1 for 1 mg, 1.5mg and 2mg 4OHT 






Figure 3.7 Immunohistochemical staining profile of Ly-51 and PanK on 4OHT 
injected R/-;CreERt2 mice. 2-4 months old R/-;CreERt2 were injected with 4OHT or 
carrier only. 7 weeks later, thymi or thymic rudiments were dissected and processed for 
cryosectioning. 8μm cryosections were cut and stained with Ly-51 (red) and PanK 
(green). Ly-51 a marker of mature cortical epithelial cells, exclusively marked the cortex 










Figure 3.8 Immunohistochemical staining profile of MHC Class II and PanK on 






Figure 3.8 Immunohistochemical staining profile of MHC Class II and PanK on 
4OHT and carrier-only injected R/-;CreERt2 mice. 2-4 months old R/-;CreERt2 were 
injected with 4OHT or carrier only. 7 weeks later, thymi or thymic rudiments were 
dissected and processed for cryosectioning. 8μm cryosections were cut and stained with 
PanK (green) and MHC Class II (red). Carrier-only and 250μg4OHT injected mice 
showed a cystic epithelial structure and expressed MHC Class II in the majority of the 
epithelial cells (A 250g and B Carrier). MHC Class II positive cells could be detected in 
both cortical and medullary regions in all  mice that received 500μg or higher doses of 
4OHT (A and B), and the expression patterns were same as the WT C57BL/6. n=2 for 






3.2.2 Functional analysis of the thymi generated upon 
reactivation of Foxn1R allele. 
Thymopoiesis, the process by which haematopoietic progenitor cells become mature 
T-cells, occurs as thymocytes migrate through the thymus and requires interaction 
with a variety of thymic stroma cell types. The process of T-cell development can be 
monitored using a series of cell surface markers. In the earliest stages of 
development, thymocytes lack expression of CD4 and CD8, and are called double 
negative cells (DN, CD4-CD8-). As the developing thymocytes migrate through the 
cortex to the sub-capsular area, they become committed to the T-cell fate and 
eventually start to express both CD4 and CD8, becoming double positive thymocytes 
(DP, CD4+CD8+). DP thymocytes migrate through the cortex back to the medulla, 
just before entering the cortex, they become single positive immature T cells 
(CD4+CD8- or CD4-CD8+), and subsequently mature in medulla (Petrie and Zuniga-
Pflucker 2007).  
 
I used flow cytometry analysis to test the different population of intrathymic 
lymphocytes. No DP cells were detected in carrier-only injected mice (Figure 3.9), 
consistent with the athymic phenotype observed by immunohistochemistry (IHC) 
analysis (Figure 3.3). The thymus from 1mg 4OHT injected mice contained DP cells, 
as well as the later stage single positive (SP) cell types, although more than half of 
the cells were still double negative (DN). With the increasing 4OHT dosage, the DP 
proportion increased, consistent with reactivation of Foxn1 having occurred in more 
progenitor cells within the higher dose 4OHT injected mice, as suggested by IHC 
(Figure 3.9). The total number of DP cells within each thymus was determined for 
each dose of tamoxifen. While the carrier-only injected mice contained no 
intrathymic DP cells, at doses of 4OHT above 500µg, the injected mice contained DP 
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cells. With increasing doses of 4OHT, more DP cells were detected (Figures 3.9 and 






Figure 3.9 CD4 and CD8 intrathymic lymphocyte staining profile in carrier-only 
and 4OHT injected R/-;CreERt2 mice. The thymus from a 6 week old C57BL/6 wild 
type mouse, and thymi from carrier-only or 4OHT injected R/-;CreERt2 mice were 
dissected and thymocytes were collected by mechanically homogenizing the thymic 
tissue. Cells were stained with antibodies specific for CD45, CD4 and CD8, or 
appropriate isotype controls, and were first analyzed by flow cytometry on the base of 
forward and side scatter (FSC/SSC). Then, 7AAD or DAPI was used to gate out the 
dead cells, and CD45 was used to identify intrathymic haematopoietic cells before 
further analysis of developing T-cell subsets. Carrier-only injected mice contained no 
CD4+ CD8+ DP cells. 1mg and 1.5mg 4OHT injected mice contained DP and SP cells, 








Figure 3.10 Number of DP cells within carrier-only or 4OHT injected R/-;CreERt2 
mice. Thymus from a 6 week old C57BL/6 wild type mouse, and thymi from carrier-only 
or 4OHT injected R/-;CreERt2 mice were dissected and thymocytes were collected by 
mechanically homogenizing the thymic tissue. Before staining, red blood cells were 
lysed, and the total live cell numbers were counted. Cells were processed and analyzed 
as in Figure 3.9. Total DP cell numbers were determined from the total cell number, 
percentage of CD45+ cells and the percentage of DP cells as shown in Figure 3.9. Y axis 
is displayed in logarithmic scale. Samples presented here were processed at the same 
time. At least two more samples within the same age for WT (Chapter 4 Figure 4.3) and 
Carrier (previous work by Dr. Craig Nowell), respectively, were conducted and showed 




The DN population can be further divided based on CD25/CD44 staining (Godfrey, 
Kennedy et al. 1993). These stages are called DN1-4. Cells mature in a sequence 
from CD44+CD25-lin- (DN1) to CD44+CD25+ lin- (DN2) to CD44-CD25+ lin- (DN3) 
to CD44-CD25- lin- (DN4), where lin is a cocktail of antibodies for lineages 
containing CD3, CD4 and CD8 for lymphocytes , NK1.1 for nature killer cells, 
Ter119 for red blood cells, CD19 for B cells and Mac1 for Macrophage. 
 
In the carrier-only injected mice, most Lin- cells fell within the DN1 quadrant 
(Figure 3.11). The small number of cells within the DN4 proportion was eliminated 
by CD45 staining in later experiments, using 16-channel flow cytometry.  The 
absence of DN2, DN3 and DN4 suggested either a block of T-cell maturation from 
DN1 to DN2 or that the thymus rudiment failed to attract any lymphocytes. The 
absence of CD45+ cells in thymic rudiments from 250μg 4OHT injected mice 
supported the latter possibility (Figure 3.12).  
 
DN2 and DN3 cells were detected in 1mg 4OHT injected mice, and the proportion 
and number of cells in each of these populations both increased when the 4OHT dose 
was increased to 1.5mg. These data provided a further demonstration of T-cell 
development at the DN stage within the thymus generated upon reversion of the 
Foxn1R allele in Foxn1R/- mice.  
 
R/-;CreERt2 mice injected with 250µg 4OHT failed to attract lymphocytes, 
consistent with the non-reactivated status described above. CD45+ lymphocytes were 
detected within the rebuilt thymic tissue of 500µg 4OHT-injected R/-;CreERt2 mice 
(Figure 3.12), and both DP and SP cells were also detected (data in Figure 3.13 from 
Dr. Craig Nowell). consistent with the presence of thymic tissue demonstrated by 






Figure 3.11 DN1-4 subset profile within Carrier-only and 4OHT injected R/-
;CreERt2 mice. Thymus from a 6 week old C57BL/6 wild type mouse, and thymi from 
carrier-only or 4OHT injected R/-;CreERt2 mice were dissected and thymocytes were 
collected by mechanically homogenizing the thymic tissue. Stained cells were first 
analyzed on the base of forward and side scatter (FSC/SSC). Then, 7AAD or DAPI was 
used to gate out the dead cells. To avoid contamination with other lymphocytes,, 
samples were stained with a lineage cocktail of FITC conjugated antibodies (lineage –
FITC) to gate out all the DP and SP T-cells (CD3, CD4, CD8) and other lymphocytes 
lineages (NK1.1 for Nature Killer cells, Ter119 for red blood cells, CD19 for B cells, Mac1 
for Macrophages). Thymic rudiments from carrier-only injected R/-;CreERt2 mice 
contained no DN2 and DN3. Thymi from 4OHT injected R/-;CreERt2 mice contained 
DN1, DN2 and DN3 populations, and the proportion increased with increasing 4OHT 






Figure 3.12 CD45 positive cells can be detected within thymic tissue from mice 
receiving 500μg 4OHT but not within the thymic rudiment of mice receiving 250μg 
4OHT. Samples were prepared as for other immunohistochemical staining described. 
There were no CD45+ cells within 250μg 4OHT injected R/-;CreERt2 thymic rudiment, 
consistent with lack of Foxn1 reactivation. There were, although much fewer than the 
WT control, CD45 positive cells detected within thymic area of 500μg 4OHT-injected R/-
;CreERt2 mice. WT is a 6 week old CBA adult thymus. Green channel for WT shows 
MHC H2-K positive cells. Green channel for 250μg and 500μg 4OHT injected mice 







Figure 3.13 CD4 and CD8 intrathymic lymphocyte staining profile in untreated, 
carrier-only and 500μg 4OHT injected R/-;CreERt2 mice. Sample prepared and 
stained as Figure 3.9 described. R/-;CreERt2: 2-4 month-old; WT: C57BL/6 6 week old. 
(Data from Dr. Craig Nowell) 
  
In summary, the presence of all thymocyte subsets defined by CD44, CD25, CD4 
and CD8 in R/-;CreERt2 mice receiving 500µg or higher doses of 4OHT confirmed 
the functionality of the thymi generated upon Cre-mediated reversion of Foxn1R 
allele. 
 
3.2.3 A Single injection of high dose of 4OHT led to multiple 
independent reactivations each gave rise to a thymic lobe 
with both cortical and medullary compartments. 
Within the high dose (1mg, 1.5mg and 2mg)-4OHT injected R/-;CreERt2 mice, there 
were always several separate lobes (at least 3 for 1mg, 5 for 1.5mg and 2mg, Figure 
3.14) within each thymus, indicating that a series of independent reactivation events 
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had occurred after injection. All these lobes contained both cortical and medullary 
compartments.  There were clear boundaries between each lobe, and they all 
surrounded a cystic epithelial cells region which was histologically the same as the 
carrier-only injected thymi. This suggested that all these lobes originated and budded 
from these un-differentiated thymic epithelial cells.   
 
The accurate size of each independent thymic lobe was not determined precisely, 
however, the regenerated lobes resulting from treatment with different doses of 















Figure 3.14 Histological structure of thymic tissue blocks resulting from 
administration of high dose 4OHT to R/-;CreERt2 mice. Images show sections 
through the thymus recovered from a (A) 1mg 4OHT injected mouse. (B) 1.5mg 4OHT 
injected thymus. (C) 2.0mg 4OHT injected thymus. Every 30th section was stained with 
PanK and DAPI. The sections presented here are annotated with their numerical 
position in the series of sections (numbers are shown beside the images). Where the 




In this chapter, I have demonstrated that administration of 4OHT to 2-4 months old 
R/-;CreERt2 mice, in order to activate Cre recombinase and therefore to cause 
reversion of the Foxn1R allele, resulted in generation of functional thymi with a 
organized thymic structure. These data contributed to a recent paper investigating the 
function of Foxn1 in TECs (Nowell, Bredenkamp et al. 2011). Previous work in this 
lab has shown that R/-;CreERt2 mice express Foxn1 at 7% of the WT level (Nowell, 
Bredenkamp et al. 2011). Therefore, data presented here suggest that at this level of 
Foxn1 expression, thymus development was arrested and un-differentiated TECs 
persisted postnatally, as in the Foxn1-/- thymus (Bleul, Corbeaux et al. 2006). When 
Foxn1 expression was restored, a functional thymus with both cortical and medullary 
TECs was generated, indicating that a thymic epithelial progenitor cell population 
persisted postnatally in R/-;CreERt2 mice. Since the data presented in this chapter 
were obtained from 2-4 month-old mice (4 month-old for 1mg, 1.5mg and 2mg 
4OHT injected mice. Table 3.1), they extend the findings of Bleul et al (2006) who 
demonstrate that clonal reactivation of a Foxn1 null allele in neonatal mice resulted 
in generation of an intact thymus. 
 
This lab has recently shown Foxn1 is not required for medullary thymic epithelial 
cell sub-lineage specification. Furthermore, specification of both cortical and 
medullary thymic epithelial progenitor cells was observed in Foxn1R/- mice (Nowell, 
Bredenkamp et al. 2011). This suggested that sub-lineage specified thymic epithelial 
progenitor cells might exist within the postnatal R/-;CreERt2 thymic rudiment. We 
especially carefully looked at the 500µg 4OHT injected R/-;CreERt2 mice, since this 
was the lowest dose of 4OHT at which reactivation was seen. We found no cortical-
only or medullary-only regions in any thymic tissue generated by reactivation of 
Foxn1. Thus, we could not find direct evidence for the existence of cortical or 
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medullary sub-lineage specified progenitor cells in the R/-;CreERt2 thymic rudiment. 
This suggested that, although at least medullary sub-lineage specific TEPCs arise 
independent of Foxn1 expression, in the absence of Foxn1 or in the low level of 
Foxn1 expression, only the common TEPCs can persist to the postnatal stage.  
 
It could also be possible that mTEPCs can persist, but can only generate mTECs in 
the presence of differentiating cTECs (or thymocytes). Similarly, if cTEPCs persist, 
they might only be able to generate cTECs in the presence of differentiating mTECs 
(or thymocytes). The immunohistochemical staining profile of the R/-;CreERt2 
thymic rudiment with Plet-1, UEA-1 and MHC Class II indicated the heterogeneous 
character of the un-differentiated cystic epithelial cells within both carrier-injected 
and 4OHT injected mice. This suggested that the common thymic epithelial 
progenitor cells do not represent all of the cells, within these thymic rudiments. To 
further address the questions about which progenitor cell types could exist within the 
postnatal thymic rudiment, different cell population could be separated based on 
different staining profiles and tested through ectopic transplantation. Also, chimaeric 
mice could be made to look at the distribution of cells from different source in 





Chapter 4: Investigation of the persistence of 
thymic epithelial progenitor cells in aged mice 
4.1 Introduction 
In Chapter 3, I demonstrated that a functional thymic epithelial progenitor cell pool 
exists in R/-;CreERt2 mice up to 4 months of age. Therefore, I next set out to 
determine how long these progenitor cells could persist in vivo.  
 
This work was started one year after the initial work on the younger R/-;CreERt2 
mice. Surprisingly, in contrast to my previous findings, tamoxifen-independent 
reversion of the R allele was observed in R/-;CreERt2 mice without 4OHT induction 
(see 4.2.1).  In this chapter, I determine whether this tamoxifen-independent 
reversion can be used to assay the persistence of thymic epithelial progenitor cells in 
R/-;CreERt2 mice.   
4.2 Results 
4.2.1 Detection of spontaneous (ligand-independent) 
CreERt2-mediated recombination in R/-;CreERt2 mice 
The initial evidence for the occurrence of spontaneous recombination came from 
histological analysis of a carrier-only injected 6 month old R/-;CreERt2 mouse. A 
thymus structure containing both cortical (PanK+CDR1+) and medullary 
(PanK+K14+) thymic epithelial tissue was observed in this mouse. The wild type-like 
MHC Class II profile on the thymic tissue suggested that the thymic tissue was 
functional (Figure 4.1 A). A series of small lobes containing both cortex and medulla 
was observed adjacent to the un-differentiated cystic epithelial cells (Figure 4.1 B), 
suggesting that a series of recombination events had occurred. DP thymocytes were 
subsequently also found, in some R/-;CreERt2 mice of other ages that were either 
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carrier-only injected or untreated (Table 4.2).  Together, these data demonstrated the 
occurrence of spontaneous recombination of the R allele in R/-;CreERt2 in the 
absence of 4OHT induction.  
 
To determine the cause of this spontaneous recombination, I compared the 
intrathymic CD4 and CD8 staining profile of R/-;CreERt2 mice and R/- mice. While 
DP cells could be easily detected within untreated aged R/-;CreERt2 mice, there were 
no DP cells within the aged R/- mice. It indicate that the spontaneous recombination 
was CreERt2-dependent (Figure 4.2). 
 
This demonstrated that the tamoxifen-independent reversion of the Foxn1R allele 
observed in R/-;CreERt2 mice was caused by this spontaneous activity of the 
CreERt2 recombinase. A low-level of spontaneous recombination in the 
Rosa26CreERt2 mouse strain was previously reported in un-induced 
Rosa26CreERT2;EGFP mice (Hameyer, Loonstra et al. 2007). Low-level 
spontaneous recombination in other CreERt2 transgenic mice strains in the absence 








Fig 4.1 Detection of spontaneous reversion of the R allele in aged R/-;CreERt2 
mice. A representative sample of carrier-only injected 6 months old R/-;CreERt2 mice. 
One month after injection, the thymus was dissected and analyzed through 
immunohistochemistry. (A) The carrier-only injected mice contained a thymus structure 
which contained both cortex and medulla, marked by CDR1 and K14, respectively. The 
presence of PanK+MHCII+ cells suggested that the TECs in this thymus were functional. 
Scale bar: 150um. (B) shows a series of small thymic lobes found in a carrier-only 
injected mouse, suggesting the occurrence of multiple spontaneous recombination 








Figure 4.2 Comparison of R/-;CreERt2 and R/- mice. Thymic rudiments, or thymic 
tissue, was microdissected from two randomly selected, untreated 11 month old R/-
;CreERt2 mice and two untreated R/- mice (7m and 11m old, respectively) and 
processed through flow cytometry analysis to determine the CD4 and CD8 staining 
profile. The R/-;CreERt2 mice showed a significant proportion of DP cells within the 
CD45+ population (33.9%  and 85.6%, respectively) while the R/- mice contained few if 
any DP cells (0.13% and 0.27%). A WT of C57BL/6 was used as a positive control, and 




4.2.2 Investigation of the frequency of spontaneous 
recombination with age in R/-;CreERt2 mice. 
As it appeared from my initial experiments that the proportion of R/-;CreERt2 mice 
in which a spontaneous recombination event had occurred increased with age, I next 
tested whether analysis of untreated R/-;CreERt2 mice could be informative 
regarding the length of time for which thymic epithelial progenitor cells could persist 
in vivo in this mouse strain.  
 
The rationale used in these experiments was as follows.  If un-recombined functional 
progenitor cells persist in aged R/-;CreERt2 mice, and spontaneous recombination 
occurs throughout the lifespan, we might expect to see a continuous increase in TEC 
number (and thus thymus size) with age. Proliferation of pre-existing TECs 
generated by spontaneous recombination that occurred at a previous time point is 
unlikely to contribute to the increase in total TEC number, because all mature TECs 
undergo an age-related involution which starts to occur from 6 week old within wild 
type thymus and eventually leads to a decrease of functional TEC number with age 
(Chinn, Blackburn et al. 2012; Griffith, Fallahi et al. 2012) (Section 4.2.3 & 4.2.4).To 
test whether spontaneous recombination continued to occur even in aged mice, and 
thus whether a pool of un-reactivated cells persisting as the R/-;CreERt2 mice aged 
could still give rise to mature TECs, I therefore next set up a series of R/-;CreERt2 
mice of different ages and different treatments, and determined thymus size in each 
of these mice. The number of DP thymocytes is proportional to the number of 
functional mature TECs, unless TECs are functionally compromised (Klug, Crouch 
et al. 2000; Jenkinson, Rossi et al. 2007; Nowell, Bredenkamp et al. 2011) and 
therefore, the number of DP cells was used to assay relative thymus size. As age-
related thymic involution causes a decrease in thymocyte number with age (Section 




A total of seventy six R/-;CreERt2 mice were analyzed in these experiments. These 
were separated into 4 different groups on the basis of age: 2 months, 4 months, 6 
months and 10 months old. Each age group was further divided into 3 subgroups: 
uninjected, carrier injected and 2mg 4OHT injected. Males and Females were equally 
distributed within the different treatments (Table 4.1). 
 
The uninjected or carrier injected R/-;CreERt2 mice were sacrificed at the age 
shown, and the total number of DP T-cells within the thymus/thymus rudiment were 
counted. The total number of DP cells in R/- mice (male: 440, and female: 608) was 
used as control to set the background level of the DP cells in the absence of reversion 
of the R allele.  R/-;CreERt2 thymi which had the same or fewer DP cells in the 
thymus than the R/- mouse were categorized as not containing a spontaneous 
recombination event. Table 4.2 summarizes the data from the uninjected and carrier 
injected R/-;CreERt2 mice.  
 
Although evidence of spontaneous recombination was found in all four age groups, 
the frequency varied with age (Table 4.2A and 4.2B), with a trend to more 
recombination in older mice. This showed that the occurrence of spontaneous 
CreERt2–mediated reversion of the R allele accumulated over time. These results 
showed that a pool of progenitor cells must still exist and be able to be reactivated 
until at least 6 months old in males, and at least 4 month old in females, because 
mice lacking a tamoxifen-independent recombination event were present until these 
ages.  
 
Therefore, we can conclude that the TEPCs in low Foxn1 expression R/-;CreERt2 
mice are stable, retaining the capacity to differentiate into functional TECs, for at 
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least 6 months in vivo.  
 
 
       Male  Female 
Age (months)  2 4 6 10  2 4 6 10 
Uninjected  0 3 9 4  0 7 4 1 
Carrier  1 4 2 2  2 7 4 0 
Tamoxifen  2 3 6 3  1 5 5 1 




Age   2 months 4 months 6 months 10 months 
   Total  NoR % NoR   Total  NoR % NoR  Total  NoR %  NoR   Total  NoR % NoR 
Male Un-injected  0 n/a n/a  3 0 0  9 1 11.1%  4 0 0 
 Carrier  1 1 100%  4 1 25%  2 0 0  2 0 0 
 Combined  1 1 100%  7 1 14.3%  11 1 9.1%  6 0 0 
                  
Female Un-injected  0 n/a n/a  7 2 28.6%  4 0 0  1 0 0 
 Carrier  2 1 50%  7 0 0  4 0 0  0 n/a n/a 
 Combined  2 1 50%  14 2 14.3%  8 0 0  1 0 0 
Table 4.2A. Evidence for continued tamoxifen-independent recombination with age in R/-;CreERt2 mice.  
  
Age (months) 2 months 4 months 6 months 10 months 
No recombination 2 3 1 0 
Recombination 1 18 18 7 
Total 3 21 19 7 
% Recombination 33.3% 85.7% 94.7% 100% 
Table 4.2B: Comparison of Recombination Frequency with Age.  
 
Table 4.2. Evidence for continued tamoxifen-independent recombination with age in R/-;CreERt2 mice. Table 4.2A shows the total number of 
uninjected (Uninj) and carrier-only injected (Carrier) R/-;CreERt2 mice analysed within each age group, and the gender of each mouse (Total No. 
column).  Mice which had almost the same or fewer intrathymic DP thymocytes as R/- mice were regarded as showing no evidence of tamoxifen-
independent recombination (no recombination; NoR) column.  In both males and females the proportion of mice showing no evidence of tamoxifen-
independent recombination decreased with age. In females, all mice showed evidence of tamoxifen-independent recombination by 6 months old, while 
males this status at 10 months old. Table 4.2B shows pooled results for males and females which demonstrated a significant difference in 






4.2.3 Analysis of the effect of ageing on DP cell numbers in 
WT thymi. 
In both mouse and human, the thymus undergoes a stereotypical degeneration with 
age, known as involution. This involves a decrease in thymus size and cellularity, with 
decreased numbers of thymic epithelial cells (TECs), structural changes, and 
decreased thymopoiesis (Linton and Dorshkind 2004; Gray, Seach et al. 2006).  
 
To interpret the data on the number of total DP cells over the life span in R/-;CreERt2 
mice, we also needed to consider the potential impact of age-related involution on 
TECs that had arisen from tamoxifen-independent reversion of the Foxn1R allele. 
Therefore, to understand how thymus involution affects the total DP cell number, I 
first counted the total DP cells with age in C57BL/6 WT mice. As expected, age-
related involution was observed within C57BL/6 mice. This was represented by a 
decrease in the total number of DP thymocytes with age (Figure 4.3). The overall 
decrease in DP cells was was significant by 1-way ANOVA and the differences 
between 1.4 and 6 months and between 1.4 and 10 months were significant by post-
hoc tests (Figure 4.3). Pairwise differences were also compared by Student’s t-tests 
(Figure 4.3). After 4.5 to 6 months, the rate of decrease slowed. The observed decline 
in DP cell numbers is consistent with previous reports showing a decline of thymus 
size (Gray, Seach et al. 2006) and total DP cell numbers (Min, Montecino-Rodriguez 





Age (n)  Age in month (n) P value 
1.4 (7) v 4.5 (3) 0.05 
1.4 (7) v. 6 (4) 0.02 
1.4 (7) v. 10 (3) 0.02 
4.5 (3) v. 6 (4) 0.47 
4.5 (3) v. 10 (3) 0.05 




Figure 4.3. DP cell number within the WT thymus decreases with age. At least three 
WT C57BL/6 males for each age group were used to count the total DP cell number 
within the thymus. The average value and standard deviation are shown in the graph. 
The Y axis is displayed in linear scale. The p value was generated using Student’s t test 
and is listed in the table, together with the sample number analyzed for each age group. 
DP cell numbers also differed significantly among ages overall by 1-way analysis of 
variance (p = 0.0290). Comparison of individual ages to the initial 1.4-month values by 
Bonferroni post-hoc tests showed cell numbers had declined significantly at 6 months (p 






























4.2.4 Analysis of DP cell numbers in uninjected, carrier-only 
and 4OHT injected R/-;CreERt2 mice thymus with age 
The absolute number of DP cells in the un-injected, carrier-only injected and 2.0mg 
4OHT injected R/-;CreERt2 mice was then analyzed. Again, background numbers of 
DP cell numbers was determined from the R/- mouse. 
 
There were no significant differences among ages in the number of DP cells in R/-
;CreERt2 mice (Figure 4.4). Unlike the wild-type control mice (Figure 4.3), there was 
no decline with age and, if anything, there was some evidence of a trend for an 
increase with age. An increase in DP cells could be due either to the growth of TECs 
generated by tamoxifen-independent recombination in young mice, or to an increase 
in the tamoxifen-independent recombination events and thus activation of additional 
thymic epithelial progenitor cells with age. As WT C57BL/6 mice undergo age-related 
thymus involution from 6 weeks after birth, we assume that any TECs generated by 
tamoxifen-independent recombination before this age, would undergo the same 
process – and indeed that age-related thymic involution would affect TECs generated 
at any age after 6 weeks (Griffith, Fallahi et al. 2012). As there was no evidence for a 
decline in DP cell numbers with age in R/-;CreERt2 mice over 10 months (Figure 
4.4), we conclude that un-reactivated TEPCs may persist until at least between 6 and 
10 month old and that, throughout this period, TEPCs continue to undergo 
reactivation events to generate new mature TECs. Importantly, although the Foxn1R 
allele expresses SV40 T antigen under the control of the Foxn1 promoter, the SV40 T 
antigen cDNA is excised upon reversion of the allele, so T antigen is no longer 
expressed in TECs and does not complicate interpretation of these data. 
 
The female R/-;CreERt2 mice showed a similar picture to the males (Figure 4.5) and 
there were no significant differences among ages. There was a non-significant trend 
for an increase in DP cell numbers with age in carrier-injected females but not 
uninjected females. These data suggest, in female mice, that a TEPC pool persists 
until at least between 4 months to 6 months old (Figure 4.5) and can generate new 
mature TECs upon reactivation of the Foxn1 R allele. 
 
Both male and female 4OHT-injected mice showed a slight increase of total DP cells 
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with age too. Initial multiple pairwise comparisons using t-tests suggested a 
significant increase in DP cells between 2 and 4 months for tamoxifen-treated males 
(Figure 4.6). However, further investigation using a 1-way analysis of variance 
(ANOVA), to reduce the risk of false-positive significant differences, revealed no 
overall significant differences among ages for tamoxifen-treated males (p = 0.1642). 
As there were only one 2-week and one 10-week sample for tamoxifen-treated 
females, a 1-way ANOVA was not appropriate. If recombination occurs only in some 
mice, the distribution of cell numbers may not be normal so the 1-way ANOVA was 
repeated with a non-parametric Kruskal-Wallis test. There were no significant 
differences overall among ages for either tamoxifen-treated males (p = 0.2564) or 
tamoxifen-treated females (p = 0.9615). (Kruskal-Wallis test results are included in 
the legends for Figures 4.4-4.7.) 
Results for tamoxifen-treated males were pooled to increase the number of samples 
per age but again there were no significant differences overall among ages by either 1-
way ANOVA (p = 0.7656) or non-parametric Kruskal-Wallis test (p = 0.4441). Linear 
regression analysis was used in an attempt to test whether age-related changes in DP 
cell numbers in tamoxifen-treated R/-;CreERt2 mice differed significantly from those 
in wild-type mice. Linear regression lines were fitted to data shown for wild-type 
males in Figure 4.3 and the combined male and female data for tamoxifen-treated R/-
;CreERt2 mice. The results, shown in (Figure 4.7), showed that the slope of the 
change in DP cell numbers differed significantly from zero for wild-type males (p = 
0.0061) but not for tamoxifen-treated R/-;CreERt2 mice (p = 0.3822) and that the two 
slopes differed significantly from one another (p = 0.0014). Although a linear 
regression may not be a realistic model for these age-related changes, the significant 
difference between the two slopes suggests that cell numbers do not decline in 
tamoxifen-treated R/-;CreERt2 mice and may actually increase with age. This further 
suggested a TEPC pool persists as mice aged (Figure 4.6).  
 
Table 4.2A,B shows that young mice have a lower incidence of tamoxifen-
independent recombination than older mice. As this alone would explain the observed 
increase in average DP cell number with age in the uninjected and carrier-only 
injected mice, I also analyzed the data separately for only the R/-; CreERt2 mice that 
were classified as having ‘reactivated’ cells (more DP cells than control R/- mice) in 
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the three treatment groups (uninjected, carrier-injected and 4OHT-injected). This 
analysis showed a similar pattern, confirming that reactivation of long-term persisting 
progenitor cells within R/-;CreERt2 thymus occurred until at least 6 months of age. 
(Figure 4.8-4.10) 
 
In summary, as Foxn1R allele reversion was confirmed in Chapter 3 to cause 
generation of functional mature TECs, I conclude that a functional progenitor cell 




Figure 4.4 Quantification of DP cell number in uninjected and carrier-only injected 
Male R/-;CreERt2 mice with age. R/-;CreERt2 mice of untreated (Uninjected) and 
carrier-injected mice of the age groups shown, were analysed to determine the total 
number of DP cells.  For the injected mice, analysis was 5 weeks after the 
injection(Carrier). Data points shown each represent an individual mouse.  The mean 
number of total DP cells (horizontal bar), and the p value determined by Student’s T test 
result are also shown. One male R/- mouse (solid triangle) was used to determine the 
background (dashed line) of total DP cells in the absence of reversion of the Foxn1R 
allele. Y axis is displayed in logarithmic scale. If cell numbers change in some mice but 
not others the distribution of cell numbers may not be normal at each time point. For this 
reason, the analysis was repeated using the non-parametric Kruskal-Wallis test. In 
agreement with the individual t-tests, this showed no overall significant differences 
among the three ages for either uninjected males (p = 0.2746) or carrier-injected males 





Figure 4.5 Quantification of DP cell number in uninjected and carrier-only injected 
Female R/-;CreERt2 mice with age. Female R/-;CreERt2 mice of untreated 
(Uninjected) and carrier-injected mice of the age groups shown, were analysed to 
determine the total number of DP cells.  For the injected mice, analysis was 5 weeks 
after the injection(Carrier). Data points shown each represent an individual mouse.  The 
mean number of total DP cells (horizontal bar), and the p value determined by Student’s 
T test result are also shown. One female R/- mouse (solid triangle) was used to 
determine the background (dashed line) of total DP cells in the absence of reversion of 
the Foxn1R allele. Y axis is displayed in logarithmic scale. In agreement with the 
individual t-tests, the non-parametric Kruskal-Wallis test also showed no overall 
significant differences among the three ages for either uninjected females (p = 0.4267) or 





Figure 4.6 Quantification of DP cell number in 4OHT injected R/-;CreERt2 mice with 
age. 4OHT-injected R/-;CreERt2 mice of the age groups shown, were analysed to 
determine the total number of DP cells. Analysis was 5 weeks after the injection. Data 
points shown each represent an individual mouse.  The mean number of total DP cells 
(horizontal bar), and the p value determined by Student’s T test result are also shown. 
One male and one female R/- mouse (solid triangle) were used to determine the 
background (dashed line) of total DP cells in the absence of reversion of the Foxn1R 
allele. The top panel shows data collected from males, and the bottom panel shows data 
collected from females. Y axis is displayed in logarithmic scale. Despite one significant t-
test for males (2 vs. 4 months), the non-parametric Kruskal-Wallis test showed no overall 
significant differences among the three ages after tamoxifen treatment for either males (p 






Figure 4.7 Linear regression lines for decline in DP cell numbers in wild-type males (data 
from Figure 4.3) and changes in DP numbers for combined data for tamoxifen-treated R/-
;CreERt2 males and females (Figure 4.6). The p-values for differences in the slopes of 






Figure 4.8 Total DP cells within the uninjected and carrier-only injected Male R/-
;CreERt2 mice with age (sample carrying DP cells below the background level were 
excluded). Data demonstrated same as Figure 4.4 except the mice showing no evidence 





Figure 4.9 Total DP cells within the uninjected and carrier-only injected Female R/-
;CreERt2 mice with age (sample carrying DP cells below the background level were 
excluded). Data demonstrated same as Figure 4.5 except the mice showing no evidence 







Figure 4.10 Total DP cells within the 4OHT injected R/-;CreERt2 mice with age. 
(sample carrying DP cells below the background level were excluded). Data 
demonstrated same as Figure 4.6 except the mice showing no evidence of recombination 




4.2.5 Establishment of a transplantation-based assay for 
testing progenitor cell persistence within Foxn1R/-; 
Rosa26CreERt2 mice 
The data presented before suggested that a TEPC pool persisted in aged R/-;CreERt2 
mice. However, we wished to provide direct evidence confirming this conclusion. We 
also wished to determine the potential of these cells to give rise to both mature cTECs 
and mTECs. As tamoxifen-independent CreERt2 activity was observed in most if not 
all R/-;CreERt2 mice by 6 months old, use of tamoxifen to induce recombination 
could not be used to unequivocally show that new TECs could be generated from 
persisting progenitors. Therefore, we chose to establish an assay system to address 
this issue. This required that un-reactivated progenitor cells could be isolated by flow 
cytometric cell sorting, allowing the reversion of R allele of these cells to be induced 
by subsequent 4OHT treatment.  
 
In this section, I first explain the strategy used for development of this assay system.  I 
then validate the assay using a series of control experiments. Finally, I test putative 
thymic epithelial progenitor cells isolated from R/-;CreERt2 mice. 
 
4.2.5.1 Experimental Strategy:  
4.2.5.1.1 Isolation of putative thymic epithelial progenitor cells from R/-
;CreERt2 mice. 
Plet1 marks undifferentiated thymic epithelial progenitor cells in fetal wild type thymi 
(Bennett, Farley et al. 2002).  In the Foxn1R/-;Rosa26CreERt2 mouse line, in the absence 
of tamoxifen-mediated recombination, more than fifty percent of TECs were Plet-1 
positive (Chapter 3). Furthermore, following 4OHT-induced Cre-mediated 
recombination, a Plet-1+ area was always found adjacent to the area of Plet-1 negative 
thymus tissue. We therefore hypothesised that, in this model, persisting thymic 
epithelial progenitor cells would be marked by Plet-1 and thus that Plet-1 could be 
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used to isolate un-reactivated progenitor cells from Foxn1R/nu; Rosa26CreERt2 thymi. A 
caveat for this approach was that Plet-1 positive cells are also found in the thymic 
medulla, and these cells if present in a reactivated area would also be purified with the 
un-reactivated cells. Therefore, the presence of the R allele in the sorted cells was 
used to determine whether and to what extent this occurred.  
4.2.5.1.2 Reaggregated Organ Culture combined with Kidney capsule 
grafting can be used to test thymic epithelial progenitor cell function. 
In previous work, our lab has established a protocol for using reaggregate fetal thymic 
organ culture to test the potency of thymic epithelial progenitor cell (Bennett, Farley 
et al. 2002; Gordon, Wilson et al. 2004; Sheridan, Taoudi et al. 2009). Briefly, E12.5 – 
E14.5 thymic lobes from WT embryos are dissected and the whole thymic lobes are 
then dissociated and used as carrier cells. A defined number of “test” cells are then 
mixed with these carrier cells and this cell mixture is reaggregated, cultured in vitro 
overnight, and then transplanted under the kidney capsule. As the carrier cell 
population contains all the developing TECs and naïve T-cells, they offer a strong 
inductive environment for TEC differentiation. 
 
To develop this system to assay the presence, and potency, of thymic epithelial 
progenitor cells in aged Foxn1R/-;Rosa26CreERt2 mice, the ‘test’ cell population also 
required induction with 4OHT.  If the test cells have thymic epithelial progenitor cell 
identity, they should be able to give rise to mature TECs after induction. 
  
4.2.5.1.3 MHC Class II haplotype can be used to identify the test cells within 
a graft 
In order to use this system to test the functional properties of Plet1+ TECs from aged 
Foxn1R/-;Rosa26CreERt2 mice, it was also necessary to identify cells of different origins 
within a mixed graft.  The Foxn1R/R line was original generated from 129 ES cells and 
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was then backcrossed onto a C57BL/6 background.  This strain was later crossed first 
with Foxn1+/- mice, and then with Rosa26CreERt2, both also on a C57BL/6 background, 
to generate Foxn1R/-; Rosa26CreERt2 (R/-;CreERt2) mice (Nowell, Bredenkamp et al. 
2011)(Chapter 2). The MHC haplotype of both 129 and C57BL/6 mice is b (H-2b). 
So, in order to be able to distinguish the putative progenitor cells isolated from R/-
;CreERt2 mice from the carrier cells, carrier cells of another haplotype were required. 
CBA fetal thymus cells were therefore used as carrier cells, as CBA mice are MHC 
haplotype k (H-2k). 
 
4.2.5.2 Identification of optimized conditions for 4OHT 
administration to test cells.  
Tamoxifen has been used as an oestrogen antagonist to treat the breast cancer for 
decades. However, adverse effects of tamoxifen, including increasing the risk of 
endometrial cancer, was also observed (Jordan 2003). CreERt2 activity was also 
reported to be able to cause direct hematological toxicity and illegitimate 
chromosomal recombination (Higashi, Ikawa et al. 2009).  
 
My initial data from flow cytometric cell sorting of Plet-1 positive cells from the R/-
;CreERt2 mice suggested that a maximum of 250 Plet-1+ cells could be collected from 
a single R/;CreERt2 mouse (data not shown).  Therefore, given the low cell numbers 
available, it was important to minimize the possible adverse affects of 4OHT 
treatment by determining the optimum dose and most appropriate delivery method for 
4OHT treatment.  The aim was to maximise both cell viability and the efficiency of 
reactivation of the Foxn1R allele in R/-;CreERt2 thymic epithelial progenitor cells. 
 
I initially tested 2 different methods (named as Method B and Method C) for 
delivering tamoxifen. In Method B I first made a mixed reaggregate containing both 
sample cells and carrier cells, then cultured the reaggregate culture in 1uM 4OHT to 
overnight (O/N), before grafting it under the kidney capsule of CBAxC57BL/6 
recipients. In Method C, I first grafted the mixed reaggregates containing the test 
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cells, then treated the grafted mice with tamoxifen in the drinking water continually 
for 3 weeks, starting at day 2 after grafting. Both methods had previously been used to 
induce Cre mediated recombination in laboratories in CRM. However, the efficiency 
of recombination and toxicity effects on low number of cells had not previously been 
tested. 
 
To determine which of these treatments had the best outcome, I compared them using 
EpCAM+ fetal thymic cells from E12.5 CBA;C57BL/6 embryos as test cells, as these 
were not limited in number. In these experiments, the carrier cells used were E13.5 
CBA thymus cells. To make the reaggregates, a ratio of 1,000 test cells : 200,000 
carrier cells was used. One reaggregate for Method B, two for Method C and one 
control reaggregate were analyzed. All of these were successfully grafted into 
CBAxC57BL/6 F1 recipient mice but after three weeks, grafts were recovered only 
from the Method C graft recipients (c1 and c2).  
 
H-2Kb-positive cells were observed on 3 out of 6 slides analysed in graft c1 and 4 out 
of 11 slides analysed in graft c2 (every 10 slides were checked, 3 sections on each 
slide). On each slide, several H-2Kb positive area were observed and these co-
expressed the epithelial marker PanK (Figure 4.11). Positive and isotype controls 
were conducted at the same time (Figure 4.14). 
 
Method B was tested using TECs obtained from E12.5 sGFP;Rosa26CreERt2 embryos 
(sGFP;CreERt2) (Gilchrist, Ure et al. 2003). One small H-2Kb+ area was found in 
each of the resulting grafts (Gb1 and Gb2). These cells also co-expressed PanK, and 
appeared to contribute well to the H-2Kb TEC network in the grafts on morphological 
grounds (Figure 4.12). 
 
To determine whether expression of CreERt2 had any toxic effects on the cells, I also 
tested TECs obtained from E12.5 sGFP;Rosa26CreERt2 embryos (sGFP;CreERt2) 
using Method C (graft Gc1)  Consistent with the high viability of cells treated with 
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Method C, demonstrated via analysis of grafts c1 and c2 (Fiure 4.10), graft Gc1 
demonstrated a strong contribution from H-2Kb+ cells. However, none of these co-
expressed PanK. Additionally, they did not appear to contribute to TEC-like structures 
(Figure 4.13).  
 
The data described above suggested that the test TECs survived within both the 
Method B and Method C grafts.  However, when sGFP;Rosa26CreERt2 test TECs were 
used, the TEC-derived cells in the grafts retained their TEC character and were able to 
contribute to TEC networks only when Method B was used.  I therefore chose to use 







Figure 4.11 H-2Kb Staining suggested a contribution of E12.5 CBA;C57BL/6 thymic 
epithelial cells to the grafts by using Method C. 1,000 EpCAM+ cells from E12.5 
CBA;C57BL/6 fetal thymi (test TECs) were reaggregated with 200,000 dissociated E12.5 
CBA fetal thymus cells. Reaggregates were cultured overnight and subsequently 
transplanted under the kidney capsule of F1 (CBAxC57BL/6) mice. 2 days after 
transplantation, recipient mice were fed with 4OHT water for 3 weeks until grafts were 
collected.  The upper and lower panels are representative of the two grafts recovered 
after tamoxifen treatment. H-2Kb (green) marks the cells derived from the test TECs. 
PanK (red) was used as a general epithelial cell marker. Both grafts showed a good 
contribution of test TECs to the grafts, but these cells did not co-express the epithelial 





Figure 4.12 H-2Kb Staining demonstrating contribution of E12.5 sGFP;CreERt2 
thymic epithelial cells to grafts generated by Method B. 1,000 EpCAM+ cells from the 
E12.5 sGFP;CreERt2 fetal thymus (test TECs) were reaggregated with 200,000 
dissociated E12.5 CBA fetal thymus cells. Reaggregates were cultured over-night in 1μM 
4OHT in reaggregate medium and were then transplanted under the kidney capsule of 
F1 (CBAxC57BL/6) mice. Grafts were recovered and analyzed 3 weeks later. One green 
area was found in each of the two grafts analysed. Sections were stained for H-2Kb to 
localize the contribution of the sGFP;CreERt2 cells. As the silent GFP should be 
reactivated by 4OHT-induced Cre-mediated recombination, the green signal indicated 
either a contribution of un-reactivated cells (no GFP) or of reactivated cells (with GFP). 
Both cases indicated the viability of the test TECs in the grafts generated by Method B. 
Note that all green cells co-express the epithelial cell marker panK (red). Scale bar for 




Figure 4.13 H-2Kb Staining suggested a contribution of E12.5 sGFP;CreERt2 thymic 
epithelial cells to the grafts after treatment with Method C. Samples were prepared 
as Figure 4.11 described. H-2Kb+ cells could be detected and indicating the presence of 
cells derived from the test TECs, but these cells failed to show any epithelial structure. 
PanK staining was largely absent from the whole graft. Scale bar for x40 is 75 μm; for 









Figure 4.14 Wild type C57B/6 thymus staining profile of H-2Kb and PanK and their 
isotype controls. A 6 week old male C57BL/6 thymus was used as a positive control for 
H-2Kb and PanK staining. Staining was conducted at the same time as the samples 
showed in Figures 4.11-4.13. Isotype controls for both H-2Kb and PanK are shown in the 
bottom panel. Note the difference in H-2Kb positive signal strength difference between 





4.2.5.3 Purification of Plet-1+EpCAM+ cells from aged R/-;CreERt2 
mice 
In order to directly assess whether TEPCs were present in the thymi of aged R/-
;CreERt2 mice, I next isolated putative TEPCs by flow cytometric sorting using Plet1.  
Thymi were dissected from twelve R/-;CreERt2 mice, aged from 6 months to 12 
months. There were obvious differences in the size and morphology of the thymic 
rudiments among these mice, even between those of the same age, consistent with 
spontaneous reversion of the R allele having occurred to different extents in different 
mice (see sections 4.2.2 and 4.2.4).  
 
The thymi from these mice were independently dissociated, stained and sorted to 
obtain Plet-1+EpCAM+ cells. The number of cells obtained varied widely between the 
different samples, as described in Table 1. At least 60 cells from each sample were 
used for genotyping, to determine the presence or absence of cells carrying a reverted 
Foxn1R allele. 
 
To determine whether or not the individual pools of purified cells included cells that 
had undergone tamoxifen-independent reversion of the R allele, PCR analysis of 
genomic DNA was performed using two primer pairs. The first pair (called T) was 
designed to detect the SV40Tag cassette in the Foxn1R allele (Nowell, Bredenkamp et 
al. 2011) and was used to detect the unrecombined R allele within the R/-;CreERt2 
cells. The second pair (called GF/GR; Nowell et al 2011) detects the wild-type Foxn1 
allele.  Since these primers flank the LoxP site that remains after recombination of the 
R allele, they were used to determine whether cells in which spontaneous reversion 
had occurred were present in the sample. As GF anneals to the region of Foxn1 65bp 
upstream of the point of insertion of the R allele, and the GR anneals to the region of 
Foxn1 225 bp down-stream of the point of insertion of the R allele, if there is no 
deletion of the loxP-flanked cassette, no product will be generated due to the length 
(8kb) of the inserted cassette. If cells in which spontaneous reversion had occurred 
were present, a PCR product of about 470bp would be generated. The null allele in 
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the R/-;CreERt2 mice was generated by insertion of a stop cassette into the 3 exon of 
Foxn1(Nehls, Kyewski et al. 1996), down-stream of the GR annealing point. So we 
would also expect to see a 290bp product corresponding to the null allele in all R/-
;CreERt2 mice. In summary, for the non-recombined R allele, we would expect to 
generate a 611bp T product and a 290bp GF/GR product, but not a 470bp GF/GR 
product, using these two primer pairs.  
 
The PCR results are shown in Figure 4.15 and Table 4.3. Of the twelve samples of 
sorted cells, three contained only cells that had not undergone any spontaneous 
reversion. To achieve a reasonable cell number for making a cellular reaggregate, 
these samples were pooled and reaggregated with 200,000 dissociated E13.5 CBA 
fetal thymus cells. A carrier cell-only reaggregate was also made. As described above 
for Method B, these reaggregates were cultured overnight at the present of 1μM 





Figure 4.15. Genotyping result of sorted Plet-1+EpCAM+ cells. 60 cells from each 
sorted Plet-1+EpCAM+ sample were used for genotyping. The left image shows the 100 
bp DNA Ladder (BioLabs) used for electrophoresis. The sample numbers match those in 
Table 4.3. The presence of a 611bp product using the T primers (top right image) 
indicates the presence of an unrecombined R allele (samples 3, 7, 8, 9, 10 and 11), as 
does the presence of a 290bp (bottom right image; samples 3, 4, 5, 6, 7, 8, 9, 10 and 11) 




























1 Ladder         
2 RL3 8 30 All n n n   
3 SQ30 7.5 525 60 ++++ y n Y 465 
4 SQ40 7.5 206 60 n y y   
5 UR11 5.5 355 60 n y y   
6 UR40 5.8 120 60 n y n   
7 UR44 5.8 139 60 ++ y n Y 79 
8 UR31 5.8 269 60 + y y   
9 PN10 10 337 60 ++ y y   
10 PN3 10 139 60 +++ y y   
11 MQ3 12 22 All + y n Y* 0 
12 RL30 8 33 All n n n   
13 UR41 5.8 20 All n n n   
14 H2O         
Table 4.3. Summary of cell numbers and genotyping results for Plet-1+EpCAM+ cells isolated from aged R/-;CreERt mice. 
Sample numbers matche those in the two gel photographs in Figure 4.15. The presence of a 611bp product (samples 3,7,8,9,10 and 11) using the T 
primers indicates the presence of an unrecombined R allele, as does the presence of a 290bp but not a 470bp GF/GR product (samples 3, 7 and 11). 
*: All cells had been used for genotyping, so no cells left for making reaggregates. 
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4.2.5.4 Graft result 
The two recipient mice were sacrificed 1 month after grafting. No grafts were found 
on the kidneys of either mouse. The entire kidneys were sectioned and analysed, but, 
no TEC-like tissue was observed (not shown). It seems likely that this experiment 
failed for technical reasons. (For example, dissociated cells were exposed to sub-
optimal conditions (on ice) for too long because the experiment procedures took a 
long time and reaggregates were only grown for 6 hours before transplanting them to 
the kidney and this was probably insufficient time). 
 
4.4 Discussion 
The work described in this chapter first demonstrates the occurrence of tamoxifen-
independent Cre-mediated recombination in R/-;CreERt2 mice. Within an individual 
mouse, the detection of multiple ‘reactivated’ regions containing different sized foci 
of thymus tissue suggested the occurrence of multiple tamoxifen-independent 
recombination events over time. Analysis of groups of R/-;CreERt2 of different ages 
then provided evidence for accumulation of tamoxifen-independent recombination 
events with age, and suggested that a thymic epithelial progenitor cell pool existed 
until at least 6 months old. I analyzed the effect of age-related thymic involution 
phenomenon on the number of intrathymic DP cells. Interestingly, I found no 
decrease in DP cell numbers over the life span within the R/-;CreERt2 thymi 
generated by tamoxifen-independent recombination, further suggesting the existence 
of a functional thymic epithelial progenitor cell pool. 
 
Due to technical limitations, I was not able to monitor the changes occurring within 
the thymus of each individual mouse over time. Therefore, our analyses relied on 
statistical analysis of a sample group; the accuracy of the data would be improved if 




It is not clear why no tamoxifen-independent Cre-mediated recombination was 
observed in our initial experiments (Chapter 3), but this was observed at in later 
experiments.  It is possible that we inadvertently selected a sub-strain of 
Rosa26CreERt2 mice in which tamoxifen-independent Cre-mediated recombination 
occurred more frequently than in the original strains.  However, an important issue 
that should also be addressed is whether the dosage of the RosaCreERt2 allele affects 
the rate of tamoxifen-independent Cre-mediated recombination. The method used in 
our lab for genotyping this strain did not distinguish heterozygotes and homozygotes 
forRosaCreERt2, and thus our sample group may contained both zygosities. This may 
explain why a range of phenotypes was seen within each age-group (see e.g. male 
uninjected, Figure 4.5). To address this issue, further analysis using mice in which 
homozygotes and heterozygotes at Rosa26CreERt2 were identified would be 
necessary; this was not performed due to cost and time considerations. Despite this, 
samples analyzed here still suggested that a thymic epithelial progenitor cell pool 
existed until between 6 and 10 months old.  
 
The data presented in 4.2.5 “Establishment of a transplantation-based assay for 
testing progenitor cell persistence within Foxn1R/-; Rosa26CreERt2 mice” section 
demonstrate that through an overnight 4OHT treatment, TEPCs could survive in such 
low cell number (1000 per reaggregate).  
 
They also demonstrate that Plet-1+ cells that show no evidence of tamoxifen-
independent recombination were present within R/-;CreERt2 thymi up to 12 months 
old. This is consistent with data presented in 4.2.2 and 4.2.4, which suggest 
generation of new thymic epithelial cells following tamoxifen-independent 
recombination of the R allele in aged R/-;CreERt2 mice. Unfortunately, however, the 
attempt to provide direct evidence to support the presence of functional TEPCs in 
aged R/-;CreERt2 mice, and to determine the progenitor-progeny relationships, failed 
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for technical reasons. 
 
Due to the relatively low number of collected Plet-1+ cells within the aged R/-
;CreERt2 mice, an in vivo assay method would be preferable, as this would minimize 
the loss of cells during the in vitro procedures. For example, BrdU injection could be 
used after 4OHT injection. If there is a progenitor cell pool persisting within the aged 
R/-;CreERt2 mice, that can give rise to new TECs when the Foxn1R allele is reverted, 
we would expect to see cluster of BrdU+ mature TECs, distinct from pre-generated 
mature TECs, which are likely to be BrdU-negative. It is possible that the pre-
generated TECs might continue to proliferate and cells generated by these TECs 
would also be BrdU positive. However, we expect this proliferation to be at a much 
lower level compared to the proliferation of progenitor cells when they give rise to 
mature TECs, especially within an old thymus. A series of control experiments 
should be conducted to investigate this. The proliferation marker Ki-67 could also be 
used here, but again an appropriate control group is needed to distinguish the 




Chapter 5:  Investigation of the potential for 
deriving TEPCs/TECs from Embryonic Stem 
Cells. 
5.1 Introduction 
A major aim of this work was to derive thymic epithelial cells from mouse 
embryonic stem (ES) cells. ES cells are derived from the inner cell mass of the 
preimplantion embryo at the blastocyst stage of development and hold the potential 
to differentiate into all three primary germ layers and all subsequent cell types 
derived from them. The epithelial component of the thymus has a single origin in 
development, and is derived from the third pharyngeal pouch endoderm (Chapter 1). 
Therefore, to obtain thymic epithelial cells or thymic epithelial progenitor cells from 
ES cells, the first step should be to differentiate the ES cells into definitive endoderm 
cells, specifically into foregut endoderm cells from which the third pharyngeal pouch 
is derived. 
 
Definitive endoderm (DE) induction can be achieved through formation of 3-
dimensional embryoid bodies (EB) in the presence of an appropriate exogenous 
stimulus, such as Activin A. The use of this approach for giving rise to DE derivative 
cell-types, such as hepatic cells, has been demonstrated (Kubo, Shinozaki et al. 2004; 
Gouon-Evans, Boussemart et al. 2006) (also see Chapter 1). However, the potential 
for using ES cells through EB formation for deriving TEC related cells from ES cells 
has been rarely reported.  
 
Previous work in this laboratory showed that genes related to primitive streak 
formation and definitive endoderm formation can be detected by RT-PCR in EBs 
formed spontaneously by the hanging-drop method (Chapter 2) for hanging drop 
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method (T. Gaskell and C. Blackburn, unpublished).  Foxn1, a TEC and skin lineage 
specific gene (Nehls, Pfeifer et al. 1994) was also detected although at low-level and 
at later stage (Figure 5.1 IIE). Further co-culturing of EBs with E12.5 thymic lobes 
was demonstrated to increase Foxn1 expression to levels detectable by reporter assay 
(A. Farley and C. Blackburn, unpublished). A Foxn1-LacZ reporter ES cell line 
(Nehls, Kyewski et al. 1996) was used in these experiments. When Foxn1-LacZ EBs 
at day 7 after EB formation were co-cultured with E12.5 fetal thymic lobes, β-
galactosidase+ cells could be found on day 11, while EB-only or fetal thymic lobe-
only controls showed very few or no β-galactosidase+ cells (A. Farley and C. 
Blackburn, unpublished).  Further in situ staining showed that most of the cells 
expressing Foxn1 also expressed Pax1 (A. Farley and C. Blackburn, unpublished), 
therefore suggesting a primary TEC lineage character rather than a skin lineage 
character (Figure 5.1). This study provided the first evidence to show that 
spontaneously formed EBs can be induced to form TEC-like cells, and thus 
demonstrated the possibility for using ES cells to generate the TEC lineage. 
 
In this chapter, I will first demonstrate that Foxn1-expressing cells can be generated 
in EBs made from Foxn1-LacZ reporter ES cells through two different co-culture 
methods, and that a method has been established for sorting LacZ expressing cells. 
Second, through testing of existing and modified protocols for generating anterior 
definitive endoderm in EBs, I will demonstrate that the TEPC-related genes and cell 
surface markers can be induced, thus establishing the possibility of using ES cells to 










Figure 5.1. ES cells give rise to Foxn1+/Pax1+ cells when co-cultured with fetal 
thymic lobes. I. Diagram showing co-culture protocol. II. After 7 days of EB formation 
culture, EBs derived from the Foxn1-LacZ ES cells were co-cultured with the E12.5 fetal 
thymic lobes for a further 3 days. β-galactosidase+ activity was tested through X-gal 
staining (A-D). EBs were then hybridised with a DIG-labelled antisense Pax1 probe 
followed by an alkaline phosphatase-coupled anti-DIG antibody.  Pax1 expression is 
revealed by BM-purple staining (C-D).  D) shows detail from box in C); blue cells are 
present throughout this Pax1-positive outgrowth. In all EBs examined, most β-
galactosidase+ cells were also Pax1-positive. (n>=3) E) Gene expression profile during 7 
days EB formation culture (n>=3). (A. Farley and T. Gaskell and C. Blackburn, Centre for 
Regenerative Medicine, University of Edinburgh, unpublished). 
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5.2  Results 
5.2.1 Foxn1 positive cells can be induced using an embryoid 
body plus fetal thymic lobe co-culture system. 
I first repeated the EB plus fetal thymic lobe (FTL) co-culture experiments described 
in the introduction, using the same Foxn1-LacZ reporter cell line. Thus, EBs formed 
through a hanging drop method on day 7 were co-cultured with dissected C57BL/6 x 
CBA E12.5 thymic lobes at a ratio of 5 to 5 per well of a 96 well-plate. EBs only (5 
per well) and thymic lobes only (5 per well) were also cultured as controls. EB 
culture medium (GMEM/FCS without LIF) was used for both EB formation and co-
culture (as in Figure 5.1 I). After 8 days, cells were fixed and stained with X-gal. 
Undifferentiated OKO ES cells, an Oct-4-LacZ reporter ES cell line derived from 
E14 (Mountford, Zevnik et al. 1994) were used as a positive control for X-gal 
staining. As expected, OKO cells were β-galactosidase+, but with a variety of levels 
of staining intensity. That was consistent with Oct4 expression by all ES cells 
(Chambers, Silva et al. 2007) (Figure 3.2). Almost no blue cells were observed 
within the fetal thymic lobes only wells or the wild type E14tg2a EBs only wells. A 
considerable number of blue cells were observed in the Foxn1-LacZ EBs plus fetal 
thymic lobes co-cultures (Figure 5.2B), suggesting that these ES cells were 
expressing Foxn1.  Surprisingly, there were also some β-galactosidase+ cells within 
the Foxn1-LacZ EBs only samples (Figure 5.2B). This suggested that the Foxn1 
expression detected here might due to the spontaneous differentiation of EBs.  
 
These data, together with the data shown in Figure 5.1 established that β-
galactosidase, reporting Foxn1 expression, could be detected both in the presence or 
absence of fetal thymic lobes, thus indicated the possibility of deriving TECs from 
ES cells using this and other protocols. In vivo, X-gal staining in the Foxn1-LacZ 
reporter mouse is only detected when Foxn1 is expressed at functionally relevant 
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levels, suggesting that such levels were also achieved here. 
 
5.2.2  Isolation of viable β-galactosidase+ cells by flow 
cytometry. 
In order to establish a protocol for analysis of the putative TECs derived from 
Foxn1-LacZ ES cells, we tested the whether a fluorescein-di-β-D-galactopyranoside 
(FDG) staining protocol could be used to collect the Foxn1 expressing cells. FDG is 
a fluorogenic substrate of β-galactosidase and that permits vital staining of cells with 
LacZ expression.  
 
More than 93% of undifferentiated OKO cells were positive for FDG staining 
(Figure 5.3), consistent with the known Oct-4 expression profile and the X-gal 
staining shown in Figure 5.2.A. Few cells within the undifferentiated E14tg2a and 
Foxn1LacZ ES cells were FDG positive, indicated a background for FDG staining 
(Figure 5.3). PI staining indicated a high viability (>90%) within all test samples 
(Figure 5.3). Collectively, this suggested that FDG staining could be used to isolate 







Figure 5.2. LacZ expression can be detected in Foxn1-LacZ EBs. (A) 
Undifferentiated OKO ES cells. (B) Foxn1LacZ ES cell-derived EBs were co-cultured 
with E12.5 CBA x C57B/6 fetal thymic lobes. Controls were Foxn1LacZ EBs only, Lobes-
only and E14tg2a EBs only. Blue cells were found within Foxn1LacZ-derived EBs plus 
lobes co-cultures and were also present in Foxn1LacZ-derived EBs-only cultures, but 
not in E124tg2a-derived EBs-only cultures. The single blue cell in lobes-only cultures 






Figure 5.3: ß-galactosidase expression in live, undifferentiated ES cells can be 
detected by flow cytometry using FDG staining. FDG staining was conducted on the 
undifferentiated wild type mouse ES cell line E14tg2a, and two undifferentiated  ß-
galactosidase reporter ES cell lines: OKO (reporting Oct4 expression) and Foxn1-LacZ 
(reporting Foxn1 expression). An inhibition of lysosomal β-galactosidase using a 
chloroquine procedure was conducted prior to FDG staining, to exclude non-specific 
staining. The profiles shown here were first gated for cells (FSC/SSC), and then gated 
on live cells by excluding PI+ cells (PI/SSC). The FDG positive regions were established 
using untreated/unstained cells for each individual cell line (Histogram: FDG). Data 




5.2.3 Induction of Foxn1 positive cells in compact 
reaggregate organ culture of dissociated EB and fetal 
thymic lobe cells. 
As described above, Foxn1+ cells can be generated via EB formation and EB plus 
FTL co-culture. However, based on the frequency of cells observed upon X-gal 
staining, the efficiency of inducing Foxn1+ cells is very low. In the co-culture system, 
the fetal thymic lobes and EBs were cultured in 96 well-plates, as the limited culture 
media volume used was thought to increase the induction efficiency of fetal thymic 
lobes, either through secreted factors or through direct cell to cell contact. 
Unpublished data from this laboratory also suggested that the Foxn1+ cells were most 
likely to appear at the confluence of the EBs and fetal thymic lobes. However, the 
capsule surrounding the fetal thymic lobes, and the compact structure of EBs, may 
significantly block cell:cell communication.  
 
Cellular reaggregation was used to identify the Plet-1+ epithelial cells in E12.5 third 
pharyngeal pouch as thymic epithelial progenitor cells (Bennett, Farley et al. 2002). 
The fetal thymic cells reaggregated with the progenitor cell candidates were believed 
to offer important stimuli for thymic epithelial progenitor cell differentiation and 
TEC maturation. Recently, a compaction reaggregation organ culture (CoROC) has 
been devised in this lab (Sheridan, Taoudi et al. 2009), in which the reaggregated 
cells can be cultured on filter paper raft floating on the surface of culture medium. 
Such reaggregates can be cultured in vitro and tested directly without need for in 
vivo grafting.  
 
Therefore I next used the compact reaggregate organ culture method described above 
to test whether Foxn1 expression could be induced more efficiently in comparison 
with the previous co-culture system. Foxn1-LacZ EBs were cultured until day 7 and 
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then dissociated whole E12.5 fetal thymic lobes (which contain epithelial, 
mesencymal and haematopoietic cells) were also dissociated. 40,000 Foxn1-LacZ EB 
cells and 400,000 FTL cells were used to make each reaggregate. Reaggregates were 
subsequently cultured on a floating polycarbonate filter paper raft (Millipore) on 
GMEM/FCS medium without LIF for 9 days. Flow cytometry analysis after FDG 
staining indicated that although there was substantial cell death, a small 
subpopulation of viable cells (1.36%) was FDG positive, suggesting that Foxn1 





Figure 5.4 Detection of Foxn1 expression within CoROC system through FDG vital 
staining of Foxn1-LacZ cells. Reaggregates were generated as described in the text 
were dissociated and stained by FDG. Cells were first gated for cells (FSC/SSC) and 
dead cells were then gated out through on the basis of 7-AAD staining (7-AAD/SSC). 
Unstained E14tg2a ES cells (red line) provided the negative control. Undifferentiated 
OKO ES cells (orange line) and undifferentiated Foxn1-LacZ ES cells (blue line) 
provided the positive control and background control, respectively.  A small population of 
FDGlo cells was present specifically in the Foxn1-LacZ CoROC cells, indicating 




5.2.4 Expression of TEPC related genes and cell surface 
markers during Activin A induced EB differentiation to 
anterior definitive endoderm.  
Both of the two FTL-co-culture methods described above led to generation of Foxn1 
expressing cells at a low efficiency. This might largely due to heterogeneity within 
the spontaneously formed EBs. Therefore, I investigated whether generation of EBS 
under conditions that enrich for induction of anterior definitive endoderm (ADE) 
cells might improve the outcome of the co-culture experiments.  
 
Two different EB to ADE differentiation cultures were tested using wild-type 
E14tg2a ES cells and a novel reporter line “Plet1-GFP” in which GFP is knocked in 
to the Plet-1 locus (T. Gaskell and C. Blackburn, unpublished). On day 7 in both 
protocols, the differentiated EBs were very large. These EBS were partially 
dissociated using Collagenase/Dispase and the cells released by this treatment were 
collected. These cells are marked as “outer cells” in Q-RT-PCR result and “outer” in 
FACS profile. The EBs were then further treated with trypsin to complete the 
dissociated and these remaining cells were collected. These cells are marked as 
“inner cells” for Q-PCR and “inner” for FACS.  
 
I first tested a previously published protocol for ADE induction in EBs (Morrison, 
Oikonomopoulou et al. 2008). ES cells were cultured on un-coated dishes in 
GMEM/FCS media, to allow spontaneous EB formation for two days. From day 2 to 
day 7, they were cultured in N2B27, Activin A and EGF. As GMEM were used for 
the first two days, this protocol was named “G”. Cells on day 4 and day 7 were 
collected and analyzed by Q-RT-PCR and flow cytometry. In both cell lines tested, 
the pluripotency marker Oct4 (Ying, Nichols et al. 2003)was down-regulated and 
almost undetectable on day 7. Sox17, the definitive endoderm (DE) and anterior 
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visceral endoderm (AVE) marker (Yasunaga, Tada et al. 2005), was induced by day 4 
and decreased at later stages. Hex, a marker for anterior character during ES to ADE 
differentiation (Morrison, Oikonomopoulou et al. 2008), was also expressed, and, in 
contrast to Sox17, its expression increased at later stages of culture. Plet-1 expression 
was detectable in the ES cells by Q-RT-PCR. An obvious increase in expression was 
detected during the EBs differentiation. Plet-1 expression on day 7 was also 
confirmed by flow cytometric analysis (Figure 5.5 and 5.6). 
 
The second protocol used was a modified, serum-free, medium defined culture 
system developed for these experiments (see Chapter 2).  Here, dissociated ES cells 
were cultured on un-coated dishes in N2B27, BMP4 and Activin A to allow EB 
formation. From day 2 to day 7, they were cultured in SF5 base medium (see Chapter 
2), EGF, Activin A and FGF4. As N2B27 was used for the first two days, this 
protocol was named “N”. Cells on day 4 and day 7 were analyzed as above. Oct4 and 
Sox17 showed a similar profile to that observed for the “G” protocol, while Hex was 
first up-regulated earlier and then down-regulated at later stage. Plet-1 expression 
was also detected at day 7 by Q-RT-PCR and flow cytometric analysis (Figure 5.5 
and 5.6).   
 
This confirmed that the Activin A based induction led to ADE differentiation in EBs,  
as expected, and that the TEPC related marker, such as Plet-1 could be detected in 









Figure 5.5 Gene expression profile in cells generated via two different EBs to ADE 
differentiation protocols for two independent ES cell lines. E14 and Plet-1-GFP 
reporter (MD1GFP) ES cell lines were used to test two different EBs to ADE 
differentiation protocols: protocol G and protocol N, as described in Chapter 2. 
Undifferentiated ES cells (first column in each data set), E12.5 thymic lobes, and 
classical day 9 spontaneously differentiated EBs (as used in the co-cultures) (last two 
columns in each graph) were used as controls. On day 7, cells first dissociated from EBs 
by Collagenase/Dispase are marked as “day 7 (out)”, cells dissociated from EBs in the 
following trypsin treatment are marked as “day 7 (in)”. Error bars are based on technical 





Figure 5.6 Plet-1 can be detected at day 7 in cells generated using both EBs to 
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ADE differentiation protocols. E14 and Plet-1-GFP reporter (MD1GFP) ES cell lines 
were used to test two different EBs to ADE differentiation protocols, G and N. 
Expression of the epithelial marker EpCAM and TEPC marker Plet-1 was analysed on 
day 7 by flow cytometry. Cells first dissociated from EBs by Collagenase/Dispase are 
marked as “outer”, cells dissociated from EBs in the following trypsin treatment are 





Both the previous work in this laboratory and that presented here demonstrates that 
Foxn1 expression can be induced in ES cell-derived cells, through co-culture of EBs 
and FTLs. Furthermore, using 2 different EBs to ADE protocols, Plet-1 was found to 
be induced. Collectively, this suggested the possibility for using ES cells to derive 
TEPCs/TECs through induced EBs formation. The next step would be more detailed 
characterization of gene expression, modification of existing protocols to increase the 
TEPC related genes expression, such as Plet-1, and linking of FTL induction affect 
on final Foxn1 expression. 
 
However, due to the time limitations and the heterogeneous character of EBs, I 
moved to a more specific step-wise monolayer differentiation method which is 
described in Chapter 6. Issues that are relevant to both chapters 5 and 6 are included 




Chapter 6 Investigation of the use of a 
monolayer protocol for anterior definitive 
endoderm induction from ES cells for 
generating TEPCs 
6.1 Introduction 
The EBs plus FTLs co-culture strategy to induce ES cells to TEPCs described in 
Chapter 5 resulted in generation of TE lineage cells at low efficiency. EB formation 
leads to generation of cells from all three germ layers at the beginning of ES cell 
differentiation (Smith 2001), which may lower the efficiency for generating the 
derivatives of a specific germ layer, and furthermore, the three-dimensional 
interactions within EBs make this approach hard to control. Therefore, we wished to 
attempt to generate TEPCs under more defined conditions. 
 
Our collaborators Gillian Morrison and Austin Smith (University of Cambridge) 
have derived a new monolayer method for efficiently differentiating ES cells that 
have previously been cultured in 2i medium (Ying, Wray et al. 2008) into anterior 
definitive endoderm cells. 2i medium-cultured ES cells are anticipated to give a 
higher output of a particular target cell population due to their homogeneity 
compared to ES cells grown in GMEM/FCS plus LIF (Chapter 1). Use of completely 
defined conditions should also improve consistency between experiments. I therefore 
tested this new anterior definitive endoderm differentiation protocol (2i ADE), with 
the expectation of using it as the first step for deriving TEPCs/TECs from ES cells.  
6.2 Results 
6.2.1 Morphological changes during 2i ADE differentiation 
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To differentiate ES cells to ADE, cells grown in 2i medium (Ying, Wray et al. 
2008)were first taken into N2B27 medium supplemented with CHIRON 99021 
(inhibitor of glycogen synthase kinase-3), Activin A, FGF4, Heparin and PI-103 
(inhibitor of Phosphatidylinositol 3-Kinase) and cultured for 2 days. From day 2 to 
day 7, they were cultured in SF5 base medium with the same factors plus EGF (see 
Chapter 2 for details). The cells were examined every day for morphological 
changes, and samples were also collected every day to determine the gene expression 
pattern within the culture, by Q-RT-PCR and flow cytometry.  
 
The morphology of cells varied slightly between each culture and between each 
individual well within the same culture, but was generally as shown in Figure 6.1. 
Small compact colonies appeared on day 1 and grew continually until day 2. 
Considerable cell death was also observed, which might suggest a selection progress 
due to the specific cell culture conditions. On day 2, the medium was changed. 
Starting from day 3, the cells piled up and formed larger more compact colonies. Flat 
elongated cells also started to appear surrounding the compact colonies and these 
finally linked the colonies between day 5 and day 7. Cell death dramatically dropped 
after the first medium change, but cells again started to lose adhesion to the culture 





Figure 6.1. Morphological changes occurring during a typical 7 day differentiation 
culture using the 2i ADE protocol. E14tg2a were cultured in 2i Medium (Day 0) then 
were differentiated to DE cells using the protocol described in the text (Day 1 – 7). Cells 
were cultured on gelatin coated 6 well plates. Cells were checked and images of 




6.2.2 Characterisation of cells generated via 2i ADE 
differentiation. 
To determine whether the protocol outlined above generated ADE cells, I analyzed 
expression of markers associated with ADE in the differentiated cells.  
 
Cxcr4 stains developing definitive endoderm (DE) but not visceral endoderm in vivo 
(McGrath, Koniski et al. 1999). It has also been previously identified as a mesoderm 
and definitive endoderm cell surface marker and shown to mark DE cells during ES 
cell differentiation (Yasunaga, Tada et al. 2005). In the 2i ADE differentiation 
protocol used here, Cxcr4+ cells started to emerge from day 1 and encompassed 
about 90 percent of cells at around day 4 - day 5. The percentage of cells expressing 
very high levels of Cxcr4 dropped afterwards, but most cells in the population 
continued to express this marker (Figure 6.2).  
 
The transcription factor Sox17 is used as a marker for both definitive endoderm and 
visceral endoderm (Yasunaga, Tada et al. 2005) and Hex is used to demonstrate 
anterior positional identity in endodermal cells (Morrison, Oikonomopoulou et al. 
2008). In the 2i ADE differentiation, both Sox17 and Hex were induced. The peak 
values for both genes expression were reached at the time at which the percentage of 
Cxcr4+ cells was highest, suggesting the anterior definitive endoderm character of 
the Cxcr4+ cells rather than anterior visceral endoderm or mesoderm (Figure 6.3). In 
contrast, the pluripotency markers Oct4, Nanog, and Rex1 were lost during 
differentiation (Figure 6.3). From these data, we conclude that 2i ADE protocol 











Figure 6.2 Cell surface marker expression during 2i ADE differentiation. E14tg2a 
ES cells previously maintained in 2i medium were differentiated using the 2i ADE 
differentiation protocol. A) Cxcr4 expression during the 7 days differentiation culture. B) 
Plet-1 and EpCAM expression profiles during the 7 days differentiation culture. Data are 




6.2.3 Expression of known regulators of thymus development 
during 2i ADE differentiation. 
I next investigated whether any genes associated with thymus development were 
expressed.  
 
Tbx1 is important for the pharyngeal segmentation and structure formation and thus 
for thymus development, but is not expressed in thymus primordium after E10.5 
(Manley and Condie 2010). In the 2i ADE cultures, Tbx1 expression, although very 
low, was first detected on day 4 and remained expressed until at least day 7, which 
suggested the presence of pharyngeal endoderm cells. The detection of Tbx1 in 
control sample E12.5 thymic lobes, may be due to the presence of unseparated 
parathyroid dissected together with the thymic lobes (Figure 6.3). 
 
Hoxa3, a transcription factor required for early pharyngeal pouch patterning and 
thymus-parathyroid primordium formation (Su, Ellis et al. 2001), was found to be 
induced on day 4 and increased until day 6. As expected, Hoxa3 was detected in 
E12.5 thymic lobe controls (Figure 6.3).  Of note is that the anterior boundary of 
Hoxa3 expression is the 3pp. 
 
Pax1 and Pax9 are expressed in the pharyngeal endoderm from E9.0 and the third 
pharyngeal pouch (3pp) from E9.5. Furthermore, our unpublished data shows these 
factors are required together for induction of Foxn1 expression in thymic 
primordium. Mutation of either or both of these two genes caused impaired thymus 
formation (wallin; Hetzer-Egger; Zhou; Kelly and Blackburn unpublished). Like 
Tbx1 and Hoxa3, Pax9 expression was detected from day 4 during 2i ADE 
differentiation, with expression slightly increasing until day 7. Pax1 expression was 




IL-7 is expressed in third pharyngeal pouch independently of Foxn1 expression. Very 
low level IL-7 expression (n>5), was detected during 2i ADE differentiation 
including in undifferentiated ES cells, but it was unclear whether this represented 
expression above background (Figure 6.3 B).  
 
A very low level of Foxn1 expression can be detected within 3pp from E9 (Nehls, 
Pfeifer et al. 1994). Similarly, very low but reproducible Foxn1 expression was 
detected during the 2i ADE differentiation (Figure 6.3 B).  
 
Plet-1, a marker of the founder cells for thymic epithelial cell lineage (Depreter, 
Blair et al. 2008), was also up-regulated during 2i ADE differentiation. Very low-
level Plet-1 expression was detected in ES cells, while Plet-1 expression in E12.5 
lobes was around half of the expression level of differentiated ES cells on day 7 
(n>5) (Figure 6.3). 
 
In summary, Tbx1, Hoxa3 and Pax9 are all genes related to the third pharyngeal 
pouch formation and affect the thymus organogenesis in vivo. Their expression, 
together with the confirmed ADE markers, further indicated the presence of cells 











Figure 6.3 Gene expression pattern during 2i ADE differentiation. E14tg2a ES cells 
previously maintained in 2i medium were differentiated using the 2i ADE differentiation 
protocol. A) Data show gene expression relative to α–Tubulin in undifferentiated ES 
cells (ES), E12.5 fetal thymic lobes (L) and after 1, 2, 4, 5, 6 and 7 days of 2i ADE 
differentiation (the expression level detected in ES cells is taken as 1 for Oct4, Nanog, 
Rex1 and Plet-1; the expression level detected in E12.5 thymic lobes is taken as 1 for 
Hex, Tbx1, Hoxa3, Pax1, Pax9, IL-7 and Foxn1; the expression level detected at day 7 
of 2i ADE culture was taken as 1 for Sox17). Expression of the pluripotency markers 
Oct4, Nanog, Rex1 was lost during differentiation. The definitive endoderm marker 
Sox17 and the ADE marker Hex were up-reguated by day 4, as were the pharyngeal 
endoderm markers Plet-1, Tbx1, Hoxa3 and Pax9. B) IL-7 and Foxn1 were detectable at 
extremely low expression levels in comparison with E12.5 thymic lobes, which was set 
to 1. The data shown in A and B above are from a single representative experiment as 
biological  repeats (n>5) showed very similar trends but differences in relative 





6.2.4 Emergence and characterisation of Plet-1+EpCAM+ cells 
during 2i ADE differentiation. 
Plet-1 marks the founder cells for the thymic epithelial lineage from E9.5 (Depreter, 
Blair et al. 2008). Purified Plet-1+ epithelial cells from the thymus primordium at 
E12.5 were found to be able to generate functional thymus upon ectopic 
transplantation. The clonal level progenitor cell characteristic of Plet-1+ cells at 
E12.5 was also demonstrated (Rossi, Jenkinson et al. 2006). The expression of Plet-1 
in other tissues, such as postnatal kidney tissue, epithelial region of the pancreas 
from E11.5 and postnatal keratinocyte progenitor cells, has also been reported 
(Nijhof, Braun et al. 2006; Depreter, Blair et al. 2008).  
 
During 2i ADE differentiation, Plet-1+ cells were detected by flow cytometry on day 
4, 6 and 7. Epithelial cell adhesion molecule (EpCAM) staining confirmed the Plet1+ 
cells detected on day 6 and day 7 were epithelial, but Plet1 was not co-expressed with 
EpCAM on day 4 (Figure 6.2 B). 
 
As Cxcr4 indicates a DE identity, we hypothesized that the Cxcr4+EpCAM+Plet-1+ 
cells on day 6 and day 7 should be foregut endoderm progenitors and/or TEPCs. 
Therefore, these cells were purified by flow cytometric cell sorting and further 
analyzed for gene expression profile. The Cxcr4+EpCAM+Plet-1- cells on day 6 and 
day 7 were also sorted as controls. 
 
Both Plet-1+EpCAM+ and Plet-1-EpCAM+ cells on day 6 and day 7 showed an 
extremely low level of Nanog and Rex1 expression compared to ES cells.  However, 
Oct4 was expressed within Plet-1-EpCAM+ population on day 6. Although Oct4 
expression, together with Nanog and Rex1, fell on day 7, its expression in Plet-1- 
cells was still higher than in the Plet-1+ counterparts. This might suggest the 





Expression of endoderm markers was detected in both the Plet-1+ and Plet-1- 
populations within the day 6 and day7 EpCAM+ cells, with Hex expression being 
slightly higher in the Plet-1+ population. The high expression level of Plet-1 within 
Plet-1+EpCAM+ population, but low expression level within Plet-1-EpCAM+, as 
detected by QRT--PCR confirmed the fidelity of the MTS20 antibody in the sorting 
process. Hoxa3 and Pax9 were not enriched in any population but showed even 
lower profile than in unsorted cells. Thus suggested that the contribution of these 
genes expression on day 6 and 7 before sorting were mainly from EpCAM- cells 
(Figure 6.4).   
 
Interestingly, Foxn1 expression, although low, was found within the Plet-1-EpCAM+ 
population on day 6 and day 7 (Figure 6.4). This is consistent with the observation 
that epithelial cells within developing thymus lose Plet-1 and gain Foxn1 expression 
as they begin to differentiate (Nowell 2011).  Thus the Plet-1-EpCAM+ population 
might contain cells with maturing or mature TECs identity.  
 
Plet-1+ cells on day 4 were EpCAM low, which could indicate that they have 
mesoderm identity; Plet-1 is expressed in the mesonephros from E9.5 – E11.5 and 
therefore, it was possible that these Plet-1+ could represent early kidney progenitor 
cells.  Thus the Plet-1+EpCAMlow and Plet-1-EpCAM+ cells were isolated for further 
analysis (Figure 6.4). No expression of Pax2, an important gene associated with 
kidney development (Walther, Guenet et al. 1991; Torres, Gomez-Pardo et al. 1995), 














Figure 6.4 Gene expression pattern within sorted Plet-1- and Plet-1+ cells.  ES cells 
previously cultured in 2i medium was differentiated through 2i ADE differentiation 
protocol. Cells were first gated for Cxcr4, then Plet-1 positive (“+”) cells and Plet-1 
negative (“-“) cells were sorted for gene expression pattern analysis (A and B). All sorted 
cells were gated for Cxcr4 and EpCAM expression, except for the samples marked “*”, 
which were Cxcr4 positive and EpCAM negative. B shows the same data as A but 
excluding the E12.5 fetal thymic lobes, whose expression level was set as 1 (n=2 for 






6.2.5 Functional testing of Plet-1+ cells generated during 2i 
ADE differentiation. 
The results described above show that expression of some TEPC-related genes was 
induced in cells generated during the 2i ADE protocol. Therefore, I wished to test the 
potential for these cell populations to give rise to TEPCs or even mature TECs.  
  
To achieve this, I made use of the RFTOC assay described in Chapter 4 to test the 
potency of the ES-derived cells when differentiated within an actively differentiating 
fetal thymic microenvironment.  As summarized in Table 6.1 for experiments C, D 
and E, wild type E14tg2a ES cells were first differentiated through 2i ADE 
differentiation, and at a specified stage, Plet-1+EpCAM+ cells were sorted and 
reaggregated with dissociated CBA fetal thymic lobes (and MEFs in experiment E). 
In these experiments, the cells were not gated for Cxcr4.  The reaggregates were 
cultured for 1 or 2 days, then transplanted under the kidney capsule of the NOD.Cg-
Prkdcscid Il2rgtm1Wjl/SzJ (NOD/SCID) immunodeficient recipient mice. As the MHCII 
haplotype of E14tg2a ES cells is H-2b, and MHCII haplotype of CBA mouse is H-
2k, the contribution of the ES cell-derivatives to the grafts could be distinguished 
from the carrier cells using haplotype-specific antibodies. 
 
As expected, the carrier cells in the graft formed an organized and functional thymus 
structure (Figure 6.5, and 6.7-6.9). There was no H-2Kb staining within the carrier 
cells-only graft (Figure 6.5). The haplotype of NOD/SCID mice is g7 (Jax Mice 
database). Surprisingly, the kidney tissue from the NOD/SCID mice also stained H-
2kb positive. However, this could be easily distinguished from the grafted tissue by 




Figure 6.5 CBA fetal thymus cells graft shows no H-2Kb staining. E13.5 fetal thymic 
lobes were dissociated. 400,000 cells were reaggregated, cultured for 18 hours and 
subsequently transplanted under the kidney capsule of NOD/SCID mouse. 3 weeks 
later, the graft was recovered, cryosectioned and processed for IHC analysis. PanK 
(Green) was expressed in all cells in carrier cells-only grafts, while H-2Kb (Red) was not 
detected except in host kidney tissue. n=1 
 
 
Figure 6.6. Non-specific staining of H-2kb on kidney tissue. Image shows example 
from experiment E illustrating the different signal intensity of H-2Kb staining between the 









Culture time before 
grafting 
Results 




NOD/SCID  Tiny reaggregate,  
grown for 1 week 
before grafting. 
Teratoma (Fig. 6.10) 






NOD/SCID  42 hours Teratoma (Fig. 6.10) 





NOD/SCID  18 hours Good graft. 
ES contribution detected but no thymus like tissue (Fig. 
6.7) 





NOD/SCID  18 hours Hollow graft. 
ES contribution detected but few and no thymus like 
tissue (Fig. 6.8) 





NOD/SCID  42 hours Good graft. 
ES contribution detected, most tube-like, few thymus-
like (Fig. 6.9) 





NOD/SCID  42 hours Good graft. 
No detection of ES, may be due to staining failure (Data 
not shown) 




For experiments C, D and E (Figures 6.7-6.9). Plet-1+EpCAM+ cells on day 7 were 
sorted and their differentiation potential was tested as described in Table 6.1. The ES-
derived cells marked by H-2Kb (red) mainly formed tube-like structures. Some of 
them were also PanK positive (green), and thus were not likely to be endothelial 
cells. Also, as no folds were detected within the tubes, they were unlikely to 
represent mature intestinal epithelium (Figure 6.7-6.9). Notably, a thymic epithelial 
cell-like region contributed by ES cell-derivatives was found in Experiment E. As 
shown in Figure 6.9, cells morphologically TEC-like and positive for both H-2Kb 
and PanK were localized within a thymus like area (PanK positive and densely 
packed “Cortex” area and PanK positive less densely packed “Medulla” area. Cell 
density was indicated by Dapi staining). The less dense of Dapi staining suggested a 
possible medullary lineage character for these cells.  
 
I also used AGFP 97 ES cells (Experiments A and B in Table 6.1), with the aim of 
distinguishing the ES cells-contributed regions within grafts. As no Plet-1 positive 
cells were found in these experiments, I purified all the EpCAM+ cells on day 7 of 2i 
ADE differentiation and used these cells to generate RFTOCs for grafting. Teratoma 
formed from both of these grafts (Figure 6.10) suggesting the existence of 
undifferentiated ES cells within this population on day 7 of two 2i ADE 
differentiation. This is consistent with the Q-RT-PCR analysis of the Plet-1-EpCAM+ 







Figure 6.7 Contribution of ES cell-derivatives to grafts in experiment C. 6,200 Plet-
1+EpCAM+ cells from day 7 2i ADE differentiation culture were reaggregated with 
220,000 carrier cells. The reaggregate was cultured 18 hours and then transplanted 
under the kidney capsule of a NOD/SCID recipient mouse. 3 weeks later, the graft was 
collected, cryosectioned and processed for PanK (Green), H-2Kb (Red) and DAPI (Blue) 
staining. A and B shows that the differentiated ES cell-derivatives (H-2Kb positive and 
red on image) mainly contributed to non-thymus-like structures in graft. C shows the 




Figure 6.8 Contribution of ES cell-derivatives to the graft in experiment D. 3,800 
Plet-1+EpCAM+ cells from day 7 2i ADE differentiation culture were reaggregated with 
200,000 carrier cells. The reaggregate was cultured for 18 hours and then transplanted 
under the kidney capsule of a NOD/SCID recipient mouse. Three weeks later, the graft 
was recovered, cryosectioned and processed for PanK (Green), H-2Kb (Red) and DAPI 
(Blue) staining. A, B and C show the cystic structure of graft. A low level contribution 






Figure 6.9 Contribution of ES cell-derivatives to graft in experiment E. 
  
 
Figure 6.9 Contribution of ES cell-derivatives to graft in experiment E. 13,000 Plet-
1+EpCAM+ cells from day 6 2i ADE differentiation culture were reaggregated with 
300,000 carrier cells (Table 6.1). The reaggregate was cultured for 42 hours and then 
transplanted under the kidney capsule of a NOD/SCID recipient mouse. Three weeks 
later, the graft was recovered, cryosctioned and processed for PanK (Green), H-2Kb 
(Red) and DAPI (Blue) staining. Panels A and B show that the differentiated ES cell-
derivatives (H-2Kb positive and red on image) mainly contributed to non-thymus-like 
structures in graft. C shows the carrier cells (H-2Kb negative) generated a thymus-like 
structure. D Magnified image shows the possible contribution of ES cell-derivatives to a 










Figure 6.10 EpCAM+ cells on day 7 of AGFP 97 2i ADE differentiation, when 
reaggregated with carrier cells and grafted under the kidney capsule, formed 
teratomas. A-B) shows the dissected grafts from experiment A and B described in Table 
3, respectively. C-F) are selected Masson’s trichrome staining slides from the 
experiment B graft. Tissue were provisionally identified as probably C) muscle or 





In summary, sorted Plet-1+EpCAM+ cells on either day 6 or day 7 contributed to the 
thymus grafts but mainly formed tube-like rather than thymus-like structures, and 
thus suggested that most Plet-1+EpCAM+ cells might be committed to different 
endodermal cell lineages rather than being thymus lineage progenitor cells or a 
mutlipotent endodermal progenitor cell type. This is consistent with the lack of 
Hoxa3 and very low Pax9 expression within the sorted Plet-1+EpCAM+ population 
on day 6 and day 7 compared with the whole 2i ADE differentiation culture. Cells 
sorted on the basis of EpCAM expression alone on day 7 gave rise to teratomas after 
grafting. Therefore, I concluded that to generate TEPCs from ES, a more specific 
induction protocol would be required.  
6.2.6 Withdrawal of FGF4 leads to down-regulation of ADE 
markers and loss of Plet-1 expression 
It has been reported that Fgf4 promotes the posterior identity of endoderm cells 
during the anterior-posterior patterning of the primitive gut tube (reviewed in Zorn, 
Wells 2009; Dessimoz, Opoka et al. 2006).  It’s also been demonstrated that FGF4 
promotes the outcome of ADE cells from the differentiating mouse ES cells 
(Morrison, Oikonomopoulou et al. 2008). Therefore I tested whether withdrawal of 
Fgf4 from the 2i ADE differentiation culture could lead to development of cells with 
a more anterior, 3pp/TEPC-like identity.   
 
Ffg4 is present throughout the original 2i ADE induction protocol. I tested the effect 
of withdrawing of Fgf4 from the first day of ADE induction.  This led to no 
significant difference in expression of pluripotency markers (Figure 6.12). No 
difference in Cxcr4 expression was observed in the presence or absence of Fgf4 
(Figure 6.13 A). However, Sox17 and Hex induction was much lower in the “no 
Fgf4” condition. Plet-1 expression was not detectable by flow cytometry at any point 
in the “no Fgf4” condition (Figure 6.13 B); its absence was further confirmed by Q-
RT-PCR (Figure 6.12). The pharyngeal marker Hoxa3 was expressed at higher levels 
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in the absence of Fgf4, but there was a lack of Tbx1 expression and less Pax9 
induction. FgfR2IIIb, the receptor for Fgf7 and Fgf10 (Ornitz, Xu et al. 1996), is 
required for the proliferation of TEPCs after formation of the common thymus-
parathyroid primordium (Revest, Suniara et al. 2001). FgfR2IIIb expression was 
observed in both conditions, but was higher in cells cultured in the presence of Fgf4.  
Both Foxn1 and IL-7 were detected in cells generated under both conditions, but at 
extremely low expression levels compared to whole E12.5 fetal thymic lobes (Figure 
6.12). 
 
Collectively, these data suggested that the presence of Fgf4 was beneficial for 









Figure 6.11 B 
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Figure 6.11 Comparison of cell surface marker expression pattern following ADE 
differentiation in the presence and absence of Fgf4. ES cells previously cultured in 
2i medium were differentiated through 2i ADE differentiation protocol. In parallel 
cultures, conditions were identical except that Fgf4 was withdrawn from day 1 (“–FGF4” 
treatment). A The Cxcr4 expression pattern was identical between the +FGF4 and –
FGF4 treatments. B Plet-1 expression was undetectable in cells differentiated in the 
absence of Fgf4. There were also fewer EpCAM+ cells in cells differentiated in the 
absence of Fgf4. An undifferentiated ES cell culture in 2i medium was used as a control. 
MTS-20 was used here to mark Plet-1 expression (Depreter, Blair et al. 2008). 





Figure 6.12. Comparison of gene expression patterns in cells generated by ADE 
differentiation in the presence and absence of Fgf4. ES cells previously cultured in 
2i medium were differentiated through 2i ADE differentiation protocol. Fgf4 was 
withdrawn from day 1 (“–FGF4” treatment). Undifferentiated ES cells and cells at 1, 2, 4, 
5, 6 and 7 days after differentiation were analyzed by Q-RT-PCR. In the absence of 
Fgf4, the endoderm makers Sox17 and Hex were induced less strongly; No induction of 
Tbx1 or Plet-1 was observed; Pax9 induction was maintained at a low level. Hoxa3 
could be detected and showed a higher level induction than in the presence of Fgf4. 
Both Foxn1 and IL-7 could be detected but at an extremely low level.  Data are shown 
normalized to α-tubulin. (the expression level detected in ES cells is taken as 1 for Oct4, 
Nanog, Rex1 and Plet-1; the expression level detected in E12.5 thymic lobes is taken 
as 1 for Hex, Tbx1, Hoxa3, Pax1, Pax9, IL-7 and Foxn1; the expression level detected 




6.2.7 Investigation of the potential for induction of TEPCs 
through co-culturing of 2i ADE differentiated ES cells with 
fetal thymic lobes.  
Previous data have shown that the third pharyngeal pouch related genes Tbx1, Pax9, 
Hoxa3 and Plet-1 are induced in some cells during the 7 day 2i ADE differentiation. 
Meanwhile, the mature TEC markers Foxn1 and IL-7 were not strongly induced. 
These data also revealed that expression of the DE and pharyngeal endoderm 
markers arose at around day 4. Therefore, I hypothesised that if a specific stimulus 
could be given at that time point, more TEPC-like cells might be generated. To test 
this hypothesis, I therefore further induced the cells by co-culturing the 
differentiating ES cells with dissociated cells from fetal thymic lobes. Cell 
morphology changes and gene expression pattern were closely monitored.  
 
I used the AGFP97 ES cell line (Gilchrist, Ure et al. 2003) in this co-culture system. 
GFP is ubiquitously expressed in transgenic mice derived from this line, and is 
anchored to the cell membrane (Figure 6.14). The same differentiation response of 
this cell line to the 2i ADE differentiation induction was first confirmed by 
comparing several key gene markers expression to the wild type E14 ES cells 
including Cxcr4 by FACS and Sox17 by QRT-PCR. Plet-1 within AGFP97 2i ADE 
differentiation was induced but at a lower level than in E14Tg2a cells (Figure 6.13).  
 
AGFP97 ES cells were then induced to ADE using the 2i ADE differentiation 
protocol and differentiated cells on days 4, 5 and 6 were each co-cultured with intact 
E12.5 CBAxC57BL/6 fetal thymic lobes (FTLs) for a further period (2, 4 and 7 
days). ES cell-derivatives only and fetal thymic lobes only were also cultured as 




The co-cultured ES cell derivatives were purified from the co-cultures based on GFP 
expression and the purity was confirmed after sorting. From the gene expression 
patterns summarized in Figure 6.15 and 6.16, it is evident that in two different co-
culture conditions (Table 6.2), although to different extents, Sox17, Plet-1 and Pax9 
expression was higher in the co-cultured ES cell-derivatives compared with the ES-
derivatives only. Hoxa3 was up-regulated in condition B, Pax1 was up-regulated in 
condition A. This suggested that both fetal thymic lobes and the culture conditions 
could affect the outcome of ES cell differentiation.  
 
Moreover, the up-regulation of Foxn1 and IL-7 expression observed in co-culture 
was specific to condition B, strongly suggesting that TEPC/TEC-like cells might 
exist within the population of differentiating ES cell-derivatives generated under 
these conditions (Figure 6.16). 
 
Collectively, these data suggested that the induction of the differentiating ES cells by 
co-culturing with FTLs induced generation of cells with characteristics of TEPCs, 






Figure 6.13 Comparison of cell surface marker and gene expression between the 
AGFP97 and wild type E14 ES cell lines. AGFP97 and E14 were cultured and 
induced to ADE using 2i ADE differentiation protocol. Both cell lines showed a similar 
profile for Cxcr4 staining over the differentiation period. The Sox17 expression pattern 
was also similar between the two cell lines. Plet-1 was induced in both cell lines in 2i 
ADE differentiation, but at much lower levels in AGFP97 compared with wild type E14. 
QRT-PCR data are shown normalized to α-tublin and relative to the expression levels in 




Figure 6.14 GFP distinguishes the AGFP97 ES cell-derivatives from the fetal 
thymic lobe cells in co-culture. Images are representative of co-culture Condition A. 
(A) AGFP97 ES cells maintained in 2i medium. GFP expression can be detected in all 
cells. (B) Cells were differentiated using 2i ADE differentiation protocol and cells at days 
4, 5 or 6 were further co-cultured with E12.5 fetal thymic lobes. (C-H) shows day 6 
differentiated AGFP97 cells after 2, 4 and 7 days of co-culture with FTLs. Cell 
morphology was assessed on day 2 (C, F), 4 (D, G) and 7 (E, H) of co-culture. F-H 
shows that GFP expression was exclusively contributed by the AGFP97 ES cell-derived 
cells rather than the FTLs and FTLs-derived cells. Lobes only samples were also 




 Condition A Condition B 
Medium:   
2i ADE stage (d0-d2) N2B27+ 
CHIRON 3μM, 





Same as Condition A 
 
2i ADE stage (before co-
culture) 
SF5 Base+ 
All factors added during d0-d2 
plus EGF 20ng/ml 
 
Same as Condition A 
 










Observations:   
Cells 
(both co- and not co- 
cultured) 
 
Survived, proliferated strongly 
(by eyes) (Figure 6.12) 
Massive cell death, no 
obvious proliferation of 
remaining cells (by eyes) 
FTLs 
 
Survived, and grew well 
(Figure 6.12) 
Survived, and grew well 
Q-RT-PCR   
Genes up-regulated in +lobe 
co-culture compared with –
lobe control 
Sox17 Plet-1 Tbx1 Pax1 Pax9 
Foxn1 
Sox17 Plet-1 Hoxa3 Pax9 Fgf7 
Foxn1 IL-7  
Table 6.2 Summary of the results from the two conditions used for co-culturing ES cells with 






Figure 6.15 Gene expression pattern of ES cell-derivatives in co-culture condition 
A. AGFP 97 ES cells were differentiated using the 2i ADE method and cells were then 
placed into co-culture with E12.5 CBAxC57BL/6 fetal thymic lobes (FTLs) at day 4 
(d4+), day 5 (d5+) and day 6 (d6+) of ADE differentiation, with 10 FTLs per well of a 6-
well-plate. Medium was changed as described for condition A in Table 6.2. ES cell-
derivatives were co-cultured with FTLs for a further 2, 4 and 7 days, then purified based 
on GFP expression (grey bars). “ES Cell-derivatives only” (black bars) were cultured 
under identical conditions as controls. Data show Q-RT-PCR analysis of cells for the 
markers shown. Y axis represents the expression level relative to α-tubulin. For Oct4, 
Nanog and Rex1, the expression level in ES cells was set as 1. For the other genes, the 
expression level in E12.5 thymic lobes was set as 1. Technical repeats n = 3, Biological 




Figure 6.16 Gene expression pattern of ES cell-derivatives generated in co-culture 
Condition B. AGFP 97 ES cells were differentiated using the 2i ADE method and cells 
were then placed into co-culture with E12.5 CBAxC57BL/6 fetal thymic lobes (FTLs) at 
day 4 (d4+) and day 5 (d5+) of ADE differentiation. (10 FTLs were placed in one well of 
a 6-well-plate). Medium was changed as described for Condition B in Table 6.2. ES cell-
derivatives were co-cultured with FTLs for further 2 to 3, 4 or 7 days, then purified 
based on GFP expression (grey bars). “ES Cell-derivatives only” (black bars) were 
cultured under identical conditions as controls. Data show Q-RT-PCR analysis of cells 
for the markers shown. Y axis represents the expression level relative to α-tubulin. For 
Oct4, Nanog and Rex1, expression in ES cells was set as 1. For the other genes 
expression in E12.5 thymic lobes was set as 1. Technical repeats n = 3, Biological 




In this chapter, I first confirmed that the 2i ADE differentiation protocol developed 
by our collaborators G. Morrison and A.G. Smith, can be used to generate anterior 
definitive endoderm marker. I further demonstrated the expression in the cell 
population generated via this protocol of pharyngeal endoderm markers and of genes 
with known roles in thymus development. Additionally, I showed that Plet-1+ 
epithelial cells were also present within the culture. Using a functional assay, I 
detected a possible contribution of cells generated via this protocol to TEC networks, 
but most cells contributed to non-thymus structures in this assay.  This suggested that 
a more specific induction protocol was required. I therefore tested the outcome of 
co-culturing the differentiating cells in 2i ADE cultures with fetal thymic lobes.  In 
these conditions, genes with known roles in thymus development were specifically 
induced, which strongly suggested the possibility of inducing TEPCs/TECs from ES 
cells by using optimised differentiation protocols. 
 
6.3.1 ES cells to anterior definitive endoderm differentiation 
The 2i ADE differentiation protocol developed by Morrison and Smith relies on 
TGFbeta signalling, by Activin A, to induce ADE cells from ES cells, which mimics 
the mechanism of endoderm formation during the normal embryonic development 
and also has been demonstrated to be the first step to induce the DE cells from both 
human and mouse ES cells (Kubo, Shinozaki et al. 2004; D'Amour, Agulnick et al. 
2005). A putative mesendoderm intermediate cell population was found during 
Activin A-mediated endoderm induction from mouse ES cells in vitro (Tada, Era et 
al. 2005) and Cxcr4 was demonstrated to mark this cell population and its 
derivatives: mesoderm and definitive endoderm (Yasunaga, Tada et al. 2005). 
Recently, through a novel lineage tracing method, this intermediate ‘mesendoderm’ 
cell population was shown not to exist in the early mouse embryo during gastrulation 
(Tzouanacou, Wegener et al. 2009). Therefore, the ‘mesendoderm’ observed in vitro 
178 
 
in definitive endoderm induction mediated by Activin A may be a mixed cell 
population containing both mesoderm and definitive endoderm cells. Most cells 
within our 2i ADE differentiation expressed Cxcr4. Two distinct populations, 
Cxcr4+EpCAM+ and Cxcr4+EpCAM-, were observed as early as day 4; these may 
represent the epithelial cell property of DE cells and mesenchymal cell property of 
mesoderm cells, respectively.  This would be consistent with the dual role of Activin 
A in induction of both mesoderm and definitive endoderm (Zorn and Wells 2009) 
and with the existence of both germ layers in other endoderm induction protocols 
(Kubo, Shinozaki et al. 2004; Yasunaga, Tada et al. 2005; Morrison, 
Oikonomopoulou et al. 2008). In summary, the 2i ADE differentiation protocol 
generated a heterogeneous population, and thus either an optimized protocol for 
more specific induction of ADE, or a protocol for purification of ADE cells from the 
mixed population is required for future work. For the former, use of a high dose of 
Activin A might give an improved outcome, as it has been demonstrated that high 
doses of Activin A lead to an enrichment of endoderm cells in the differentiating 
population while lower doses lead to an enrichment of mesoderm (Green and Smith 
1990). For the latter, the Hex reporter cell line (HexRedStar) was constructed and 
used for test ADE specific induction protocol (Morrison, Oikonomopoulou et al. 
2008), could be useful for these purposes. 
 
6.3.2 Role of Activin A in defining anterior-posterior identity 
during definitive endoderm differentiation.  
The time period for Activin A in inducing ADE is crucial. In human ES cells, short 
(3 days) Activin A treatment induces both foregut and hindgut endoderm lineage 
cells, while 4-5 days of Activin A treatment mainly gives rise to anterior endoderm 
lineage cells (Spence, Mayhew et al. 2011). However, a prolonged exposure to 
Activin A is not good for the very anterior foregut endoderm, such as pharyngeal 
endoderm derivatives. Evidence comes from a recent report that an inhibition of 
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TGF-beta signalling, together with the inhibition of BMP signalling, after the initial 
Activin A induction most efficiently induced the pharyngeal endoderm lineage from 
human ES cells (Green, Chen et al. 2011). In our culture conditions, Activin A was 
present from the beginning to the end. Although there are several other differences in 
our culture system, such as the presence of Fgf4, identification of the optimum time 
window for Activin A addition and withdraw could be crucial for future work aiming 
to generate TEPCs from ES cells. 
 
6.3.3 Combination of markers for identifying ADE cells. 
None of genes used here to mark the ADE can exclusively mark this lineage. Sox17 
marks both definitive endoderm and visceral endoderm (Yasunaga, Tada et al. 2005). 
Cxcr4 marks both definitive endoderm and mesoderm during ES cell differentiation 
(Yasunaga, Tada et al. 2005). Endogeneous Hex can be detected within mesoderm 
derived hematopoietic/endothelial precursors in addition to ADE derivatives 
(Morrison, Oikonomopoulou et al. 2008). Therefore, we tested all the three markers 
within the culture and believed that it would be enough to confirm the presence of 
ADE cells.  However, a recent report suggested that Sox17 was also expressed in 
some hematopoietic cells after E9.5 during mouse embryo development (Choi, 
Kraus et al. 2012), and Cxcr4 was expressed in both primitive endoderm (including 
parietal endoderm and visceral endoderm) and definitive endoderm in mouse embryo 
and thus was suggested as a pan-endoderm marker (Drukker, Tang et al. 2012). 
Therefore, the additional markers may be required to accurately distinguish the ADE 
cell identity. Thus, more detailed, step by step, monitoring of changes in phenotype 
during differentiation, and a careful selection of more gene and cell surface markers 
are required to better describe the differentiation process and the cell outcome.  
 




In this 2i ADE protocol, mouse ES cells (ESCs) were initially cultured in 2i medium, 
a culture condition that maintains ES cells in the so called “ground state” 
pluripotency. This state is equated to inner cell mass (ICM) cells from 3.5 dpc mouse 
blastocysts (Nichols and Smith 2009; Nichols and Smith 2011). Between the ICM-
stage and the occurrence of gastrulation at around 5.0 dpc, cells in the embryo pass 
through a state called epiblast, as described before in gastrulation section. So, to 
differentiate the ESCs to definitive endoderm, it may be beneficial to mimic this 
progression. It has been demonstrated that a new pluripotent cell type can be derived 
from postimplantion epiblast and, also from the preimplanted embryo. These are 
called epiblast stem cells (EpiSCs). It has been demonstrated that the EpiSCs 
represent a different pluripotency state to ESCs. EpiSCs require Activin A and FGF2 
to maintain their pluripotent state, similar to human ES cells (hESCs), while ESCs 
require LIF-STAT3 signalling. EpiSCs also share the similar epigenetic status as 
hESCs, such as DNA methylation and female X choromosome inactivation, while 
ESCs are different (Brons, Smithers et al. 2007; Tesar, Chenoweth et al. 2007; Najm, 
Chenoweth et al. 2011). In consideration of the differences in cell source origins, 
genetic and epigenetic status, the EpiSCs are believed to represent a “primed” state 
which is about to differentiate, while ESCs are believed to represent a more naïve 
and primitive pluripotent state (Nichols and Smith 2009; Marks, Kalkan et al. 2012). 
So, to differentiate ESCs to definitive endoderm, the ES cells may need to pass 
through an EpiSCs state first, as it is these epiblast cells that are ready for 
gastrulation to occur. Many successful endoderm derivation protocols are based in 
human ES cells (D'Amour, Agulnick et al. 2005; D'Amour, Bang et al. 2006; Seguin, 
Draper et al. 2008; Green, Chen et al. 2011), a cell type sharing a similar genetic and 
epigenetic state to mouse EpiSCs (Tesar, Chenoweth et al. 2007). So, a link between 
ESCs and EpiSCs should be constructed, as well as applying the knowledge from 
human ESCs in differentiating definitive endoderm cells to mouse ESCs. It has been 
demonstrated that ESCs can readily differentiate to EpiSCs when cultured in Activin 
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A and FGF2 medium for several passages (Guo, Yang et al. 2009). However, this is 
apparently a low efficiency method, as the transition in vivo from ICM to Epiblast, is 
transient. To improve the efficiency of the ESCs to EpiESCs transition in terms of 
definitive endoderm generation, application of FGF2 may be needed in combination 
with Activin A. Also the “epiblast” genes, such as Fgf5, and “primitive streak” 
genes, such as Mid1 and Brachyury, should be monitored during the differentiation 
process. Spontaneous EB formation may also be a solution as it mimics the 3D 
embryo structure, and may thus offer important cell-to-cell adhesion stimulus. 
However, it may remain a low efficiency approach, as all three germ layers would be 
generated.  The successful derivation of EpiSCs from preimplantion 129 mouse 
embryos, a strain which has been previously demonstrated to be biased for ESCs 
derivation, relies on a different experimental procedure, such as medium formula and 
embryo manipulation method (Najm, Chenoweth et al. 2011). This may point to a 
new direction to identify key factors, especially from the extraembryonic cells, in 
directing the ESCs to EpiSCs transition. 
 
6.3.5 Expression pattern of genes with known roles in 
thymus development. 
During 2i ADE differentiation, Tbx1, if detectable, was found to be on from about 
day 4 and maintained at a low levels thereafter. This low expression in the ADE 
culture is not surprising, as Tbx1 is not restricted to a particular germ layer or 
anterior: posterior axis position. For example, Tbx1 expression is expressed in the 
mesoderm and its derivatives, such as the mesoderm core of pharyngeal arches and 
secondary heart field. It is also expressed the lung epithelium and the posterior 
sclerotome (Chapman, Garvey et al. 1996; Hu, Yamagishi et al. 2004; Xu, 
Morishima et al. 2004). Also, Tbx1 has been shown to be expressed exclusively in 
the parathyroid domain before and after thymus/parathyroid primordium formation 
and is likely to regulate GCM2 expression and thus specify the parathyroid rather 
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than thymus fate (Liu, Yu et al. 2007). Therefore, during an optimum TEPC 
induction protocol, we would expect to detect  Tbx1 expression in cells upstream of 
3rd pharyngeal pouch cells in the differentiation hierarchy, and would then identify 
cells that had down-regulated Tbx1 as this is a characteristic of cells that acquire 
thymic epithelial cell fate in vivo.  
 
It was disappointing to find only a very low level of Pax1 expression in the 
differentiating cultures, as Pax1 is highly expressed in the 3rd pharyngeal pouches 
prior to thymus/parathyroid formation. However, Pax1 and Pax9 have been show to 
be at least partly redundant in skeleton development (Peters, Wilm et al. 1999) and 
more recently, in developing TECs (M. Kelly and C. Blackburn, unpublished). So 
the strong expression of Pax9 may still indicate (or lead to) the presence of cells with 
pharyngeal pouch identity within the induced anterior definitive endoderm 
population.  
 
Foxn1 is exclusively expressed within thymus and skin. Its expression was detected 
both in the original 2i ADE differentiation culture conditions and in the the co-
cultured ES cell-derivatives, strongly suggesting the existence of TEPCs/TECs like 
cells. Single cell analysis, such as immunocytochemistry, would help to tell whether 
the Foxn1 expression reflected a general transcriptional state within the whole cell 
population or the high expression from certain individual cells.  
 
As each genes described above may have a multiple expression location during 
embryo development, analysis of phenotype of cells at single cell level is crucial and 
will improve the conducted work. This will give information on what proportion of 
each cell expressing each marker, and which markers are expressed together. 




6.3.6 Plet-1 expression during 2i ADE differentiation 
The data presented here demonstrate for the first time that an epithelial cell 
population with Plet-1 expression can be detected during ES cell differentiation to 
definitive endoderm culture. Inami and colleagues reported that a small population of 
Plet-1+ cells could be found on day 14 of an induced pluripotent stem cells to thymic 
epithelial cells differentiation protocol (Inami, Yoshikai et al. 2011). However, my 
interpretation of the forward and side scatter characteristics of this population is they 
are not viable cells.  
 
Although Plet-1 was found to be expressed by differentiating AGFP97 cells in 2i 
ADE differentiation by Q-RT-PCR, I failed to detect its expression by flow 
cytometry in this cell line. This may suggest that this line responds differently to the 
protocol in expressing this protein. Also, as the wild type E14 used here had been 
cultured in 2i medium for many passages (>10), but the AGFP97 ES cells had only 
recently been transferred from GMEM/FCS+LIF to 2i (<3 passages), the failure to 
detect Plet-1 in AGFP97 2i ADE differentiation through flow cytometry might 
reflect a difference in transcriptional and epigenetic states between these two cell 
lines (Marks, Kalkan et al. 2012). And thus long-term in 2i medium culture probably 
increase the response of cells to the inductions.  
 
We were excited that a viable epithelial cell population with Plet-1 expression could 
be observed during the 2i ADE differentiation. However, Plet-1 expression is found 
in a variety of cell types, such as early developing kidney and pancreatic duct. It is 
also expressed in 1st and 2nd pharyngeal pouch endoderm, which gives rise to 
different organs. Given the heterogeneity within 2i ADE cell culture described in the 
result, this might explain why we found that these cells mainly contributed to 
structures other than the thymus regions in the functional assay. In this respect, the 
loss of Hoxa3 expression within this cell population may be significant, since Hoxa3 
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may play a role in specifying 3pp identity (Manley and Condie 2010).  
 
It is also important to note that Plet-1 is not expressed in the human thymus either 
during embryonic development or in the adult (Depreter, Blair et al. 2008). So a 
combination of markers, other than Plet-1, would help for isolating TEPCs from 
human ES cell differentiation cultures. 
 
6.3.7 Further development of the co-culture system. 
Co-culture within condition A led to cell proliferation, and maintenance of 
pluripotency marker expression. This was probably due to expansion of remaining 
undifferentiated ES cells, or reprogramming of the differentiated cells back to ES 
cells in response to the withdrawal of differentiation stimulus, such as Fgf4 and 
Activin A. CHIRON, as one of the two inhibitors which can maintain the ES cells in 
ground state pluripotency (Ying, Wray et al. 2008), was maintained in the co-culture 
medium, might have promoted the maintenance or reprogramming processes. 
Therefore, to exclude the interference of these cell populations, cell surface markers 
of pluripotency , such as Tra-1-81 and SSEA4, could be used to gate out pluripotent 
cells before analysis. 
 
Co-culture within condition B led to massive cell death, but some viable cells 
survived. FTLs-only grew well within the same medium and thus excluded the 
possibility of contamination. This suggests that this condition imposes a stringent 
selection for growth of particular cell types. Cells co-cultured in this condition 
expressed relatively high levels of Foxn1 and IL-7, suggesting induction or 
expansion of TEPCs and/or TECs by this protocol. Function testing of cells cultured 




Chapter 7 Concluding remarks  
The overall aim of my PhD project was to generate TEPCs from ES cells. Therefore, 
it was very useful to understand the characteristics of TEPCs in vivo.  In particular, it 
was of interest understand how stable the TEPC cell type is in vivo in the absence or 
at low levels of expression of Foxn1, a specific regulator of TEC differentiation .  
 
Using a conditionally revertible Foxn1 mouse model, I have clearly demonstrated 
that a fully functional TEPC population persist postnatally up to 4 months old in the 
presence of low Foxn1 expression (seven percent of wild type Foxn1 mRNA levels). 
When Foxn1 expression was restored to fifty percent of wild type mRNA expression 
levels, these persisting progenitor cells gave rise to a mature thymus structure 
containing both cTECs and mTECs, that was functional in terms of supporting T cell 
development. Further, statistically-based analysis of tamoxifen-independent 
reversion of the Foxn1R allele in R/-;CreERt2 mice indicated that in this model, 
TEPCs could persist until between 6 months and 10 months old in vivo.  
 
To my knowledge, this is the first report demonstrating that a functional TEPC 
population can persist long-term in vivo in the presence of low-level Foxn1 
expression. Bleul and colleagues previously demonstrated that clonal reactivation of 
a Foxn1 null allele in neonatal mice up to 14 days old resulted in generation of an 
intact thymus (Bleul, Corbeaux et al. 2006). My data considerably extend this 
finding, demonstrating that at low levels of Foxn1-expression, at least some cells in 
the TEPC population that arises during fetal development maintain a stable and 
functional TEPC identity until at least 6 months old. These findings provided 
important in vivo information relevant to the induction and/or expansion of stable 




In the fetal thymus, analysis of Foxn1R/- mice has demonstrated that, although the 
differentiation of TEC was blocked so that the thymus was never able to support T 
cell development, the earliest cortical and medullary cell lineage specification events 
occurred (Nowell et al 2011). Furthermore, medullary lineage-specific markers were 
expressed in a regionally restricted manner in the complete absence of Foxn1 
expression (Nowell et al 2011).  Thus it was also important to know whether these 
committed cTEPCs and mTEPCs could persist, and if so, for how long. Using our 
conditional revertible Foxn1 mouse model, I failed to detect generation of structures 
containing only cTECs or only mTECs upon reversion of the Foxn1R allele. This 
suggested that either only the common TEPCs could persist in vivo until the 
postnatal stage, or that generation of the cortical or medullary compartments depend 
on each other (Figure 7.1). Further work is required to judge which of these 
possibilities is true; the outcome of this analysis would be very important for 
projects aiming to direct ES cells differentiation to thymic epithelial lineage-





Figure 7.1 Early thymic epithelial lineage specification and persistence of 
common or lineage restricted progenitor cells at postnatal stage – summary of 
findings based on Figure 1.4. Dotted arrows represent the possible explanations. 
Thymus with both cortex and medulla was observed (Squared “√”). Cortical or 
medullary only areas were not observed in reactivated Foxn1R/-;CreERT2 thymus 
and thus marked by squared “×”.  
 
ES cells have the potential to generate all of the somatic cell types and are thus 
believed to hold great promise for regenerative medicine. Although the pluripotency 
of ES cells can be easily demonstrated by in vivo chimera analysis, determining how 
to generate a specific cell type by directed differentiation in vitro is complicated and 
has not been achieved for many cell types, including the TECs. In this thesis, I have 
demonstrated that Foxn1 expression can be observed in ES cell-derived cells in 
spontaneously formed EBs, and appear to be enriched by co-culture of EBs with 
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fetal thymic lobes (FTL). My work, together with previous findings from this 
laboratory (where Pax1 expression was also confirmed in the Foxn1 expressing cells 
of the co-cultured EBs and thus exclude the possibility of skin keratinocytes 
contribution), strongly indicated the possibility of using ES cells to generate TECs or 
TEC-like cells.  
 
As the epithelial component of the thymus is entirely derived from the third 
pharyngeal pouch, induction of ES cells to regionally specified anterior definitive 
endoderm appeared an appropriate first step for inducing TEPCs. In collaboration 
with G. Morrison (University of Cambridge), I used a novel ADE-specific induction 
protocol to differentiate ES cells to ADE cells in a monolayer adhesion culture (2i 
ADE differentiation). The third pharyngeal pouch (3pp) genes, such as Tbx1, Hoxa3 
and Pax1 were induced, and suggesting the existence of cells with 3pp identity in the 
2i ADE cell cultures. Plet-1 was also induced or up-regulated during the ADE 
induction. Moreover, a considerable Plet-1+EpCAM+ cell population was observed 
by flow cytometry at later stages of culture. It has previously been demonstrated that 
cells expressing these markers in the thymic primodium at E12.5 can give rise to a 
functional thymus when transplanted under the kidney capsule (Bennett, Farley et al. 
2002), and a single cell from this cell population could give rise to both cTECs and 
mTECs (Rossi, Jenkinson et al. 2006). Thus, this is the first demonstration, to my 
knowledge, that a cell population with the same cell surface marker expression 
profile as TEPCs can be induced from ES cells.  
 
Further analysis of gene expression, and functional testing of the Plet-1+EpCAM+ 
cell population, indicated that this population of cells may contain cell lineages other 
than TEPCs (Plet-1+EpCAM+ cell population showed a decrease in 3pp and TEPC 
related gene expressions in comparison with the whole cell population in 2i ADE 
differentiation culture before sorting. Plet-1+EpCAM+ cell population, when 
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reaggregated with the whole dissociated FTLs cells and grafted under the kidney 
capsule, mainly formed tube-like epithelial structure). However, given that 3pp 
related genes were expressed in the population of differentiated cells generated by 
the 2i ADE differentiation culture, and that some contribution of the ES-derived Plet-
1+EpCAM+ cells to TEC networks in the functional test was observed, it is possible 
that some of the Plet-1+EpCAM+ cells may be TEPCs.  Therefore, a better, thymus-
specific induction of the differentiating ES cells within the 2i ADE differentiation is 
needed in order to generate TEPCs or TECs more efficiently. Several 3pp related 
genes were found to be up-regulated immediately in the differentiating ES cells 
when co-cultured with the FTL. Moreover, when “TEPC medium (i.e. basal medium 
supplemented with Egf and Fgf7)” was used for the co-culture, a considerable 
expression level of Foxn1 and IL-7 was detected in the co-cultured ES cell-
derivatives. These data suggest that both FTL stimulation and the appropriate culture 
medium are important for inducing TEPCs/TECs.  Functional testing of these co-
cultured ES cell-derivatives is now needed. As Foxn1 is also expressed in the skin, 
although it is unlikely that ectodermal lineages would be induced in specific ADE-
induction conditions and subsequent co-cultures, the absence of gene expression 
related to skin needs to be confirmed to further indicate the TEPC/TEC identity of 
Foxn1 expressing cells.  Analysis of the co-expression of Foxn1 and markers known 
to be expressed in TEPC and/or TEC, but not in skin keratinocyte lineages would 
also address this issue. 
 
Recently, a protocol for generating anterior foregut endoderm (AFE) from human ES 
cells, has been reported (Green, Chen et al. 2011), and the anterior foregut endoderm 
derivatives such as thyroid and lung were demonstrated to be induced using this 
protocol (Longmire, Ikonomou et al. 2012; Mou, Zhao et al. 2012). Data from 
mouse, human and induced pluripotent stem (iPS) cells collectively indicate that 
inhibition of transforming growth factor (TGF-β) signalling after the definitive 
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endoderm specification results in a highly enriched AFE population. In contrast to 
ADE, which also contributes to pancreas and liver generation in embryo 
development, AFE has a more anterior character, and its contribution is limited to 
pharyngeal endoderm derivatives, such as thyroid, parathyroid and thymus, and 
respiratory system, such as trachea and lung. When this PhD project started, no AFE 
specific protocol had been published, and the ADE protocol had just been developed. 
It would be interesting to test whether the inhibition of TGF-β signalling in the later 
stages of our 2i ADE protocol results in induction of stronger induction of the 3pp-
related genes we have already detected, and further, whether 3pp-like cells can be 
generated. However, the difference between human ES cells and mouse ES cells in 
response to signalling pathway manipulation needs to be considered. For example, 
bone morphogenic protein (BMP) signalling inhibition is required together with 
inhibition of TGF-β signalling to induce AFE in human ES, but it is not required in 
mouse ES cells and human iPS (Longmire, Ikonomou et al. 2012; Mou, Zhao et al. 
2012). Moreover, in one of my recently conducted cultures, inhibition of BMP and 
TGF-β signalling at later stage of 2i ADE differentiation, resulted predominantly in 
generation of mesoderm cells. This suggested that TGF-β signalling can play 
different roles depending on the different cell states and when in cooperation with 
different factors, such as FGF4 and PI-103 in the 2i ADE differentiation protocol. 
These factors will need to be considered in further work aiming to develop an 
optimized protocol for generating TEPCs/TECs. 
 
In this study, I have demonstrated the long persistence of TEPCs in mice that can 
express only very low levels of Foxn1. I have also characterized several ES cell 
differentiation protocols, with respect to their ability to support generation of cells 
expressing 3pp and TEPC related genes. Through consideration of the outcome of 
testing existing protocols, I then developed an improved protocol for supporting 
development of cells expressing 3pp and TEPC related genes.  I showed that several 
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genes known to be required for thymus development were induced, and also 
demonstrated the expression of cell surface markers characteristic of early thymus-
lineage cells, during ES cell differentiation in this novel protocol.  Collectively, these 
results represent an important advance towards development of a protocol allowing 
differentiation of ES cells to thymic epithelial progenitor cells at high efficiency.  
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